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ABSTRACT
Intrinsically disordered proteins (IDPs) are functional proteins that lack stable tertiary structures
under physiological conditions. IDPs are key components of regulatory networks that dictate
various aspects of cellular decision-making, and are over-represented in major disease pathways.
For example, about 30% of eukaryotic proteins contain intrinsic disordered regions, and over
70% of cancer-associated proteins have been identified as IDPs. The highly heterogeneous nature
of IDPs has presented significant challenge for experimental characterization using NMR, X-ray
crystallography, or FRET. These challenges represent a unique opportunity for molecular mod-
eling to make critical contributions. In this study, computer simulations at multiple scales were
utilized to characterize the structural properties of unbound IDPs as well as to obtain a mechanistic
understanding of IDP interactions. These studies of IDPs also reveal significant limitations in the
current simulation methodology. In particular, successful simulations of biomolecules not only
require accurate molecular models, but also depend on the ability to sufficiently sample the com-
plex conformational space. By designing a realistic yet computationally tractable coarse-grained
protein model, we demonstrated that the popular temperature replica exchange enhanced sampling
is ineffective in driving faster reversible folding transitions for proteins. The second original
contribution of this dissertation is the development of novel simulation methods for enhanced
sampling of protein conformations, specifically, replica exchange with guided-annealing (RE-GA)
method and multiscale enhanced sampling (MSES) method. We expect these methods to be highly
useful in generating converged conformational ensembles.
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Chapter 1
Introduction
1.1 Intrinsically Disordered Proteins
Intrinsically disordered proteins (IDPs) refer to functional proteins that lack stable tertiary struc-
tures under physiological conditions1–6. The discovery of IDPs has challenged the traditional
structure-function paradigm, which states that protein function is closely related to its three-
dimensional structure. The existence of functional disordered proteins has been recognized for
many years. For example, many small polypeptide hormones, such as monomeric glucagon,
are unstructured in aqueous solution and fold upon binding to their receptors7. The prevalence
of IDPs, however, have only been recently recognized since the availability of vast library of
gene sequences, which allows us to perform gene-based functional analysis and intrinsic disorder
prediction8,9. IDPs have low content of bulky hydrophobic amino acid residues (Val, Leu, Ile,
Met, Phe, Trp and Tyr) and high content of polar / charged (Gln, Ser, Glu, Lys) and structural
breaking (Pro) amino acid residues10,11. By capturing this strong sequence signature of IDPs,
it is predicted, surprisingly, more than 30% of eukaryotic proteins contain extended disordered
segments12,13. This apparent prevalence of IDPs suggests that some proteins require the absence
of stable 3D structure to carry out functions, and the heterogeneity can offer great advantages
in functions. Indeed, the majority of known disordered proteins or regions are involved in cell
signaling or regulation14. Importantly, IDPs are overly presented in different diseases including
cancer, cardiovascular diseases, neurodegenerative diseases and diabetes15–17. A large number of
disease-related mutations are found in the predicted disordered regions18. About 20% of these
mutations could elevate the level of residual structures, thus causing dysfunctionality of these
1
proteins in cell signaling and regulation pathways17.
The disordered properties have several advantages for the functional roles of IDPs19–25. For
instance, IDPs often fold into stable structures to carry out functions, and the folding process is
associated with specific binding26. This process is referred to as “coupled binding and folding” of
IDPs. The delicate enthalpy-entropy compensation of the coupled binding and folding allows IDPs
to achieve high-specificity and low affinity binding, which is considered as a crucial advantage in
cell signaling and regulation. In addition, IDPs possess structural plasticity, which could allow
IDPs to bind different targets and adopt different structures8. This makes IDPs the hubs in the cell
signaling network, and enables one-to-many (one disordered region could bind to many partners)
and many-to-one (multiple disordered regions could binding to one site) signaling. The very
C-terminal segment of p53 (residue 374 to 388) is a good example of structural plasticity. It is
capable of forming all three major secondary structure types (α-helix, β-sheet, irregular structure)
upon binding to four different targets, namely, S100ββ, sirtuin, CBP and cyclin A217.
Because of the high involvement in cell functions and diseases, there has been an increasing
interest in studying structures and functions of IDPs using both experimental and theoretical
methods. However, little is known about the structural properties of IDPs, and how intrinsic
disorder mediates protein functions.
1.1.1 Experimental methods for characterizing structural properties of unbound IDPs
One major research focus is what structural properties of the disordered unbound IDPs are im-
portant for them to efficiently interact with multiple targets. Pre-existing folded-like structures
have been observed in unbound IDPs3. It has been suggested that these folded-like structures
might provide initial binding interface to facilitate the coupled binding and folding of IDPs27–29.
In contrast, recent mechanistic studies emphasize the crucial role of conformational flexibility
in coupled binding and folding of IDPs30–34. Better understanding of interaction mechanisms
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requires performing detailed structural characterizations for unbound disordered IDPs. These
characterizations include describing key sub-states in the ensemble, calculating the population of
each sub-states, measuring the timescale of inter-conversion between these states, and estimating
the free energy barriers separating different interconverting sub-states35.
Many experimental methods can be used to characterize the ensemble properties of unbound IDPs.
Spectroscopic methods such as nuclear magnetic resonance (NMR) have been extensively used to
study the structural properties of IDPs26,36–38. NMR is one of the most comprehensive techniques
that could offer detailed insights into the structures and dynamics of disordered proteins. Recent
advances in NMR technology have allowed the resonances of several unfolded proteins and partial
folded proteins to be fully assigned39–41. Many other techniques also give important structural in-
formation. Circular dichroism (CD) can provide secondary structure information of non-globular
proteins and can be used to detect disorder-to-ordered transitions42. Small angle X-ray scatter-
ing (SAX) data describe the overall shape of the protein, and hydrodynamic experiments can
determine the size-distribution over the protein43,44. Single molecular techniques such as single
molecular Fo¨rster resonance energy transfer (sm-FRET) are also unique techniques for providing
distance information in disordered structures45–47. Indeed, sm-FRET has been successfully used
to study several large IDPs, such as α-synuclein48–50, prions45, and p5351.
However, faithful structural interpretation based on the experimental measurements still remain
an important challenge in structure properties characterization of unbound IDPs52. It is almost
impossible to crystalize disordered unbound form of IDPs, making it difficult to obtain detailed
structural information from X-ray crystallography methods. The structure characterizations from
NMR are also limited. This is mainly because of the heterogeneous nature of IDPs, and it remains
a challenging problem to interpret the individual structural properties of flexible systems based on
the ensemble average measurements53. Single molecular techniques such as sm-FRET, are limited
to the requirement of attached donors and acceptors. These covalently attached chromophores
could have large impact on the sensitive disordered ensembles of IDPs. In addition, most sm-
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FRET can detect the distances that are greater than 20 A˚, limiting the application of sm-FRET to
small IDPs, where it is the case for most of the regulatory IDPs. As a result, it is very difficult
to determine IDP structural ensembles based on experimental data alone. This has become a
fundamental limitation for understanding structure basis of free IDPs.
1.1.2 Experimental methods for mechanistic characterization of IDP interactions
Besides the structural properties of unbound IDPs, a mechanistic understanding needs to be es-
tablished based on how the structural properties of IDPs can contribute to the robust interactions
with their targets, and how theses properties are modulated by cells, e.g. through post-translational
modification, switch in environmental conditions, and interactions with salt and membranes. How-
ever, only a few published studies aim to directly investigate the mechanism of IDP interactions.
Most of the IDPs mechanistic studies focused on coupled binding and folding mechanisms of
regulatory IDPs26. It is well recognized that coupled binding and folding of IDPs is highly
associated with their activity and is modulated by many cellular events such as phosphorylation,
acetylation, and interactions with other proteins54. This indicates coupled binding and folding
of IDPs is an inherent feature of IDP function and regulation. Therefore, understanding the
mechanism of IDPs interactions is of fundamental importance and high biological relevance.
Several experimental techniques have been proven to be very useful to detect the coupled bind-
ing and folding events of IDPs. NMR relaxation dispersion experiment is a useful technique
to determine the rates of exchange and chemical shift differences between different conforma-
tional states. And it can provide information about intermediate states based on the chemical
shifts55–57. For example, in the study of kinase-inducible activation (KID) domain of cAMP
response element-binding protein (CREB), NMR relaxation dispersion analysis complemented
with NMR titration, and provided unparalleled details on the mechanism of KID binding to KIX
domain of CREB-binding protein (CBP)32. Hydrogen-deuterium exchange combined with mass
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spectrometry is another powerful tool to characterize the backbone flexibility and key intermediate
states during the coupled binding and folding process58. φ-value analysis that probes the effects of
point mutations on the folding kinetics can also be used to understand the folding pathway at the
structural level involves only one single transition state59. Other techniques such as temperature-
jump spectroscopy and stop-flow analysis can also be performed to infer the baseline mechanisms
of coupled binding and folding based on the important kinetic information31,60,61.
Limitations exist for mechanistic investigation of IDPs using experimental methods. The disorder
to order transitions along the coupled binding and folding pathway significantly complicate the in-
teraction mechanisms of IDPs. For example, NMR relaxation dispersion analysis is limited to slow
exchange in microsecond to millisecond timescale. It is not applicable to fast inter-conversion
between conformational states. Another important limitation is that only a few states can be fitted
with dispersion curves. For complicated interactions with multiple intermediate states, relaxation
dispersion could lead to uncertainty in interpretation of derived kinetic parameters62. φ-value
analysis can be laborious to map out key interactions in the transition state using point mutations.
Furthermore, φ-value analysis is strictly based on a two-state model system. The interpretation
can be complicated by the presence of any intermediate states.
1.1.3 Physics-based atomistic molecular modeling for characterization of unbound IDP
The significant challenges in experimental methods for studying IDPs represents a unique oppor-
tunity for molecular modeling to make critical contributions. One of my key research objectives is
applying molecular modeling techniques to obtain detailed structural properties of unbound IDPs
and to acquire the mechanistic understanding of IDPs interactions.
The reliability and accuracy of molecular modeling and simulations of IDPs highly depend on two
major components, namely, force field and conformational sampling. Most of the physics-based
force fields are parameterized using large range of experimental data and with important approx-
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imations. Therefore, they are referred to as empirical force fields. Different force fields such as
CHARMM force fields63, the AMBER force field64, the OPLS force fields65 and the GROMOS
force fields66, have been demonstrated successful applications on simulations of proteins. How-
ever, for highly heterogeneous and flexible IDPs, they tend to sample a broad conformational space
with numerous weakly populated subspaces separated by relatively small free energy barriers.
Therefore, successful and reliable simulations of free IDPs are pushing the limits of both the force
field accuracy and conformational sampling efficiency.
In recent years, important advances have been achieved in optimization of protein force fields for
simulations of protein conformational transitions67–71. Among all the successful protein force
fields, implicit solvent force field reaches a balance between accuracy and computational ef-
ficiency for atomistic simulation of IDPs1,72. Traditional explicit solvent force field explicitly
includes all the water molecules around the protein solute, dramatically increasing the size of the
system and the computational cost of the simulation. The idea of implicit solvent is to capture
the mean influence of water on proteins by directly estimating the solvation free energy73. Only
protein molecules need to be represented in atomistic level, thus reducing the system size about
10-fold and improving the simulation efficiency. For instance, using generalized Born (GB)
approximation74, GBSW implicit solvent force field is about 30 times faster than explicit solvent
force field for simulations of small proteins (less than 100 residues)75. The increase in efficiency
has allowed the optimization of implicit solvent force fields to be more realistic and reduce certain
systematic errors in the explicit solvent force fields76–80. For example, the optimized GBSW
protein force field could reproduce the structures and different stabilities of several α-helical and
β-hairpin peptides77,78,81. However, limitations also exist for implicit solvent force fields. In
implicit solvent force fields, the water is treated as continuum, which ignores some important
non-bulk water-protein interactions. Protein-water boundary in the continuum electrostatics is
also ambiguous to choose. Nevertheless, the compact system size of implicit solvent force field is
a great advantage for simulations of free disordered IDPs, where the more extended structures of
IDPs required larger water box and more water molecules to be accommodated in explicit solvent
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force fields.
1.1.4 Molecular modeling for mechanistic characterization of IDP interactions
In principle, direct simulations of IDPs coupled binding and folding using atomistic models
can provide a detailed description on IDPs interactions. Many computational techniques can be
performed to obtain mechanistic understanding on coupled binding and folding of IDPs. Free en-
ergy calculations, in particular, have played an important role in understanding protein folding82.
Free energy landscapes constructed by using proper reaction coordinates allow thermodynamic
clarification of coupled binding and folding mechanism30. A range of important mechanistic
features can be obtained from such calculations, including most probable pathways, intermediate
states, and transition states. However, free energy calculation are computationally expensive
to perform using atomistic force fields, because in atomistic model exhaustive sampling of the
IDP conformational space is difficult to achieve, especially in presence of a specific target. In
addition, limited number of reaction coordinates might be difficult to describe the complex binding
and folding interactions. For this, transition path sampling (TPS) techniques83–85 calculate an
ensemble of transition paths, and can provide the most detailed molecular description of such
coupled binding and folding. An important limitation is that TPS requires a predefined initial
state, which is difficult to choose for the heterogeneous free IDPs. Alternatively, temperature
driven unfolding/unbinding simulations started from a bound and folded complex structure can be
used to study the coupled binding and folding process of IDPs. The assumption is that binding
and folding is a reversed process of unbinding and unfolding. Unfolding and unbinding process in
the simulation at high temperature can be reversed back to infer the coupled binding and folding
pathway. However, a concern is that most probable transition state might depend strongly on
the temperature86. Despite such a caveat, high temperature unfolding simulations have been
successful for understanding interactions of many proteins including IDPs34,87–90.
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Coarse-grained representation of protein molecules (e.g. one amino acid residue is represented
by on bead) can significantly reduce the degrees of freedom of the system and can be applied to
study IDP binding and folding91. The reversible process sampled using this technique enables
mechanistic analysis such as calculation of free energy surfaces and transition of IDP interactions.
Specifically, topology-based coarse-grained modeling allows efficient simulation of IDP coupled
binding and folding process62,91–93. Topology-based modeling is based on the minimal frustration
theory of folded proteins, which argues that native contacts dictate protein energy landscape94.
Given a folded topology of a protein, the true protein energy landscape can be approximated by
constructing the effective energy based only on the native interactions95. Those effective energy
functions are often referred to as Go¯ or Go¯-like models. Go¯ models are simple yet very suc-
cessful for study of protein folding mechanisms. It has demonstrated impressive correspondence
between experiment and theory96–98. Importantly, there are significant differences of sequences
and binding interfaces between IDPs and globular proteins21. Original Go¯-like models require
careful calibration to balance intermolecular and intramolecular interactions, so that they do not
inherently favor particular type of events (e.g. binding vs. folding)62. Such calibration requires
integration with experimental data, including binding affinity and residual secondary structure.
Moreover, topology-based coarse-grained modeling can be readily extended and modified to study
how additional factors may affect the folding and binding92,99. This can be used to investigate how
different forces modulate IDPs interactions, such as electrostatic interactions, post-translational
modifications, and solution conditions. However, limitations of Go¯-like models need to be un-
derstood. For example, detailed atomistic information for the protein molecule is lost during the
coarse-graining process. Coarse-grained model is a poor description of the unbound state of IDPs.
In addition, Go¯-like models are difficult to model structural plasticity of IDPs. Therefore, the
observation and hypothesis generated by topology-based coarse-grained models need to be further
investigated using more detailed model such as atomistic models or experiments. This multi-scale
computational approach, integrated with experiments, would be an effective and powerful tool in
mechanistic studies of IDPs.
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1.2 Enhanced Sampling Techniques for Molecular Modeling
Reliable computer simulations of proteins not only require accurate molecular models but also
require sufficient sampling of the conformational space. My second major focus is to develop
novel methods for enhanced sampling of protein conformations. At present, generating atomistic
structure ensembles that are statistically representative of the accessible conformations under a
given set of thermodynamic conditions remains a challenging problem in simulations of pro-
teins100. The difficulty arises not only because of the large and complex conformational space
of proteins, but also due to significant free energy barriers that separate different conformational
subspaces. Traditional molecular dynamics (MD)101 and Monte Carlo (MC)102 sampling methods
are limited because proteins will frequently be trapped in numerous local energy minima. MD is a
very straightforward sampling technique. In MD, the forces and potential energy of the system are
defined by the force field. The movements of all the atoms are determined by solving the Newton’s
equation of motion numerically, which typically requires a very small time step on the order of
10−15 s. MC method propagates the conformation of the simulated system by making random
moves. The newly generated configuration will be subject to test using Metropolis criteria to
decide whether it is accepted or rejected.
1.2.1 Replica exchange method
The replica exchange (RE) method103–105, also known as parallel tempering, has emerged as
a relatively straightforward and powerful approach that can enhance conformational sampling.
The basic idea is to simulate multiple replicas of the system at different temperatures indepen-
dently using either MC or MD. Periodically, replicas attempt to exchange simulation temperatures
according to a Metropolis criterion that preserves the detailed balance and ensures canonical
distributions at all temperatures. The resulting random walk in the temperature space helps the
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replicas to escape the energy local minima and sample wider range in the conformational space.
Replica exchange molecular dynamics (REMD) in particular has been successfully applied to
protein simulations106–110. On the other hand, the true efficiency of REMD in sampling large-scale
protein conformational transitions needs to be rigorously benchmarked, and the dependence of
REMD simulations on the protein system and key parameters needs to be explored.
Extensive research based on both theories111–116 and simulations of small peptides110,117–119 have
generally confirmed that RE can accelerate sampling as long as there is a positive activation
enthalpy associated with conformational transitions of the protein. However, it is also recognized
that RE can be severely limited by the presence of sharp, cooperative conformational transitions
such as protein folding111,120. Replicas often segregate and only sampling distinct major confor-
mational states (e.g. protein folded state and unfolded state), and this segregation in the conforma-
tional space often lead to exchange bottlenecks near melting temperature (Tm) where the transition
occurs121. One possible strategy to resolve this issue is to increase the temperature diffusion
of replicas in RE simulations. Many methods have been previously proposed for this purpose,
such as more frequent exchange attempts119, global energy reassignment122, and non-equilibrium
switches123. More aggressive approaches attempt to reduce to number of replicas required for
effective temperature diffusion by directly reducing the number of particles that participate in
temperature exchanges124–126, but sometimes with undesirable consequences127.
Adaptive replica exchange methods
Adaptive RE methods are variations of original RE that aim to enhance the temperature dif-
fusion by recursively adjusting the distribution of simulation windows along the temperature
space128. They can effectively reduce or eliminate exchange bottlenecks by either equalize the
exchange acceptance rate (exchange equalization or EE)129 or maximize temperature diffusion
current (current maximization or CM)128,130. EE method assumes that REMD will provide the
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highest sampling efficiency if all the replicas spend equal amount of time at each temperature. As
proposed by Sugita and Yokomoto104 and Kofke129, this may be achieved through allocating more
simulation windows around Tm of the protein to equalize the exchange rate. Nonetheless, it is
not clear whether consideration of exchange efficiency alone is sufficient to optimize the sampling
efficiency, which is more directly measured by the frequency of conformational transitions, and
ultimately by the convergence of various thermodynamic properties of interest. The goal of CM
method, on the other hand, is to maximize the number of times that clients progress from the lowest
temperature to the highest temperature and back again, i.e., “round trips”. Arguably the number
of “round trips” is more directly related to the ability of RE to drive conformational transitions,
and thus CM could substantially improve the sampling efficiency130.
Replica exchange with guided annealing
Another strategy to overcome the replica segregation in conformational space is to design temper-
ature exchange schemes that could guide the trapped replicas at lower temperatures to visit higher
temperatures more frequently121. Such schemes may be generally referred to as RE with guided
annealing (RE-GA). A similar idea is the recently described convective RE method (cRE)131.
In cRE, the replicas take turn to be the “stick replica” and undergo convective annealing cy-
cles. Specifically, the exchange attempts are chosen such that the stick replica will first only
try to exchange to higher temperatures until reaching the highest temperature. Then, the stick
replica will only attempt to exchange to lower temperatures. When the stick replica reaches the
lowest temperature, the direction of exchange attempts is reversed again until the stick replica
returns to its original temperature. In principle, this modified exchange attempt patterns could
guide the folded replicas to visit higher temperatures more frequently and accelerate unfolding
and to guide the unfolded replicas towards lower temperatures to encourage folding transitions.
As formally proved by Spill et al.131, it appears that exchanging according Metropolis criteria
and balanced exchange biases towards both higher temperatures and lower temperatures would
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guarantee detailed balance and ensure the correct canonical ensemble to be generated by cRE
simulations. However, in the presence of slow cooperative conformational transitions, it will take
many more attempts for replicas occupying low-energy states to exchange to higher temperatures
than returning to lower temperatures, and vice versa for replicas occupying high-energy states.
Therefore, such RE-GA schemes lead to unbalanced exchange attempt probabilities and break the
detailed balance condition when conformational transitions are slow compared to the temperature
diffusion timescales, which is almost always the case for RE simulations of proteins.
Multiscale enhanced sampling
Fundamentally, the limited efficiency of RE in sampling cooperative transitions such as protein
folding can be attributed to large entropic component in the free energy barriers132,133. Pro-
tein folding rate only weakly depends on temperature and often displays anti-Arrhenius behav-
iors114,134, which makes tempering very ineffective in drive protein conformational transitions.
One way to enhance the crossing over entropic barriers is to use coarse-grained (CG) repre-
sentation, because CG models can significantly reduce the degrees of freedom of the system,
shrink the conformational space and allow faster reversible transitions. But this can only be
achieved at the expense of reduced details and accuracy. An ideal approach should involve
combining both CG model with atomistic model at the same time so that it could benefit from
both the faster transitions of the CG model and the ultimate details offered by the atomistic
model. The promise of such multiscale approach has been well recognized, and several clever
ideas have been proposed towards this goal125,135–139. Lwin and Luo purposed a dual resolution
sampling method136, which couples atomistic model for accuracy and coarse-grained model for
efficiency, aiming to cross the entropic barrier in protein folding process. However, this method
uses two sets of replicas, one for atomistic model and one for CG model, limited its use on large
systems. Lyman et al. developed the resolution exchange which exchange the shared essential
coordinates of CG model with a subset of coordinates in atomistic model (e.g. coordinates of
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protein backbone atoms)137. Although this exchange algorithm could allow novel conformations
sampled by CG model to be injected into atomistic ones, the method suffers from very low
exchange acceptance rate by directly exchanging the coordinates. Liu and Voth designed the smart
resolution replica exchange to achieve efficient exchange between different resolution and only
two replicas are required for simulating small peptides140. In smart resolution replica exchange,
before the coordinate-swapping between configurations at different resolutions, the coarse-grained
model is mapped to the atomistic configuration and the relaxation simulation is performed to avoid
“bad-contact” after exchange. However, the coarse-grained model lack information of the missing
atoms in atomistic model, and the relaxation process will apparently cause the detailed balance
condition to fail.
1.2.2 Representative competing enhanced sampling techniques
Besides RE-based enhanced sampling techniques, many methods were developed aiming to pre-
vent biomolecules such as proteins from being trapped at local energy minima. The conforma-
tional transitions of proteins can be treated as a series of rare events that climb up the free energy
barrier and moving from one energy basin to another. These rare events are directly related
to free energy barrier heights. Instead of using temperature to enhance the barrier crossing,
some enhanced sampling techniques utilize a bias potential to drive the transition across the
energy barriers. Umbrella sampling is one approach to bridge the gaps between free energy
barriers141. The Boltzmann-weighted distribution is inefficient for adequate sampling across free
energy barriers, thus is replaced by a specific bias potential to cancel the free energy barriers.
This bias potential will drive the molecular system from one state to another along the reaction
coordinate. In umbrella sampling, there are a series of windows each restrains the reaction
coordinate to a target value by a bias potential. From the improved sampling, all the simulation
windows can be combined and analyzed by weighted histogram analysis method (WHAM)142,
and the free energy landscape can be calculated. One limitation of umbrella sampling is that
13
the compensating bias potential energy requires the prior knowledge of different conformational
states. Accelerated molecular dynamics143 is an efficient way to simulate transitions between
high energy barriers without any advance knowledge of the location of conformational states.
It alters the potential energy landscape by adding bias potentials, such that the effective energy
barriers are reduced and the barrier crossing rates are enhanced. While the bias potentials are
added at the potential energy minima, the transition states (saddle points on the potential energy
landscape) remain unaltered. The statistics sampled on the bias potential are then corrected to
recover the canonical distribution. Similarly, metadynamics methods also include bias potentials
in the energy landscape144. In metadynamics simulations, the location of the system on a certain
reaction coordinate is determined and a positive Gaussian bias potential is added to the true
energy landscape at this location. This bias potential will discourage the system to come back
to the previous point. The accumulation of the Gaussian potentials is pushing the system to
explore the full energy landscape. The true free energy landscape along the reaction coordinate
can be calculated as the opposite of sum of the Gaussian potentials. Other sampling methods
such as Conformational Space Annealing (CSA)145 focuses on a population of conformations
rather than a single conformation to obtain the global minimum-energy structures. CSA method
searches the whole conformational space in the early stage of the sampling process by building
up “seed conformations”145. All the newly sampled conformations are modified from the “seed
conformations”. Then CSA narrows the search to smaller regions while maintaining the diversity
of the sampling. Such annealing in conformational space would find not only the global minimum
but also many other distinct low energy regions in the conformational space.
1.3 Organization of Dissertation
The overall structure of the study takes the form of eight chapters, including this introductory
chapter. The first contribution of my research is to utilize multiscale molecular modeling and
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simulation to understand the physical basis of how intrinsic disorder mediates IDPs functions.
Chapter 2, 3 and 4 present the simulations for a specific IDP complex, namely, nuclear co-activator
binding domain of the cyclic-AMP-response-element-binding protein binding protein (NCBD)
and the activation domain of the activator for thyroid hormone and retinoid receptors of the p160
co-activator (ACTR). Specifically, chapter 2 focuses on characterization of structural properties
of unbound IDPs as well as utilizing high-temperature induced unfolding/unbinding simulations
to gain insights on the coupled binding and folding mechanism of NCBD and ACTR. Both
simulations were performed using atomistic models in implicit solvent force field. In chapter 3,
topology-based coarse-grained model was used to directly simulate coupled binding and folding
events of NCBD and ACTR. Chapter 4 investigates the electrostatic interactions that affect coupled
binding and folding kinetics. The second section of the dissertation including chapter 5, 6 and 7
is about the development of advanced conformational sampling methodologies for more efficient
simulations of proteins. Chapter 5 begins by rigorously benchmarking the sampling efficiency of
conventional and adaptive RE simulations, and identifies the potential limitations in temperature-
based RE simulations. Chapter 6 examines the RE-GA schemes for enhanced sampling of protein
conformational based on theoretical and numerical analysis. It then further discusses the potential
usage of RE-GA on simulations of IDPs. Chapter 7 describes a multiscale enhanced sampling
(MSES) method where efficient topology-based coarse-grained models are coupled with all-atom
ones to enhance the sampling of atomistic protein energy landscape. The bias from the coupling
is removed by Hamiltonian replica exchange, thus allowing one to benefit simultaneously from
faster transitions of CG model and accuracy of atomistic force field. Finally, chapter 8 gives a
brief summary and critiques of the findings. Directions for further research are identified.
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Chapter 2
Residual Structures, Conformational Fluctuations, and
Electrostatic Interactions in the Synergistic Folding
of Two Intrinsically Disordered Proteins∗
Abstract
To understand the interplay of residual structures and conformational fluctuations in the interaction
of intrinsically disordered proteins (IDPs), we first combined implicit solvent and replica exchange
sampling to calculate atomistic disordered ensembles of the nuclear co-activator binding domain
(NCBD) of transcription coactivator CBP and the activation domain of the p160 steroid receptor
coactivator ACTR. The calculated ensembles are in quantitative agreement with NMR-derived
residue helicity and recapitulate the experimental observation that, while free ACTR largely lacks
residual secondary structures, free NCBD is a molten globule with a helical content similar to
that in the folded complex. Detailed conformational analysis reveals that free NCBD has an
inherent ability to substantially sample all the helix configurations that have been previously
observed either unbound or in complexes. Intriguingly, further high-temperature unbinding and
unfolding simulations in implicit and explicit solvents emphasize the importance of conforma-
tional fluctuations in synergistic folding of NCBD with ACTR. A balance between preformed
elements and conformational fluctuations appears necessary to allow NCBD to interact with dif-
ferent targets and fold into alternative conformations. Together with previous topology-based
∗Reprinted under the Creative Commons Attribution (CC BY) license. Zhang, W., Ganguly, D., and Chen, J.
(2012) “Residual structures, conformational fluctuations, and electrostatic interactions in the synergistic folding of
two intrinsically disordered proteins”, PLoS Computational Biology 8, e1002353.
Author Contributions: Conceived and designed the experiments: JC WZ. Performed the experiments: WZ JC.
Analyzed the data: WZ JC DG. Contributed reagents/materials/analysis tools: WZ JC. Wrote the paper: WZ JC
DG.
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modeling and existing experimental data, the current simulations strongly support an “extended
conformational selection” synergistic folding mechanism that involves a key intermediate state
stabilized by interaction between the C-terminal helices of NCBD and ACTR. In addition, the
atomistic simulations reveal the role of long-range as well as short-range electrostatic interactions
in cooperating with readily fluctuating residual structures, which might enhance the encounter
rate and promote efficient folding upon encounter for facile binding and folding interactions of
IDPs. Thus, the current study not only provides a consistent mechanistic understanding of the
NCBD/ACTR interaction, but also helps establish a multi-scale molecular modeling framework
for understanding the structure, interaction, and regulation of IDPs in general.
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2.1 Introduction
It is now widely recognized that many functional proteins lack stable tertiary structures under
physiological conditions1–3,5,6. Importantly, such intrinsically disordered proteins (IDPs) are highly
prevalent in proteomes12, play crucial roles in cellular areas such as signaling and regulation146,147,
and are often associated with human diseases such as cancers15,17,148. The concept that intrinsic
disorder can confer functional advantages has been discussed extensively19,20,22–24. For example,
the disordered nature of IDPs could offer several unique benefits for signaling and regulation,
including high specificity/low affinity binding, inducibility by posttranslational modifications, and
structural plasticity for binding multiple partners. The last property appears to be particularly
advantageous, and could support one-to-many and many-to-one signaling22,149. Nonetheless,
the physical basis of these proposed phenomena remains largely elusive. Specifically, how IDP
recognition and regulation are supported by the interplay of residual structures, conformational
fluctuations and other physical properties as encoded in the peptide sequence is poorly understood.
The current limit in mechanistic understanding of how intrinsic disorder supports function might
be attributed to two key challenges in characterizing IDPs. These challenges are broadly shared
by mechanistic studies of protein folding, misfolding, and aggregation in general150–153. The
first one is related to the difficulty in deriving detailed structural information of the disordered
unbound states37,154–156. In general, only ensemble-averaged properties can be measured for
disordered proteins except with single-molecule techniques (which have their own limitations in
spatial resolution, labeling need, and protein size46,47,157). Recovering the underlying structural
heterogeneity using averaged properties is a severely underdetermined problem52,53,158–160. It
is generally not feasible to construct a unique disordered structure ensemble that is consistent
with the available data. This fundamental limitation leads to significant ambiguity in the current
knowledge of the conformational nature of unbound IDPs. The second challenge is to further
clarify the functional roles of any putative conformational sub-states or other properties of an
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IDP in its recognition and regulation (i.e., “function”). In particular, whereas some IDPs re-
main disordered in complexes38,161, many fold into stable structures upon binding to specific
targets26. The roles of intrinsic disorder vs. residual structures in such coupled binding and
folding interactions have been under much debate26. On one hand, residual structures have been
observed frequently in unbound IDPs, and intriguingly, such residual structures often resemble
those in the folded complexes27–30,162. These observations have led to an attractive hypothesis that
preformed structural elements might provide initial binding sites to facilitate efficient recognition
(i.e., conformational selection-like mechanisms)24,27. On the other hand, evidence has accumu-
lated in recent years, from computation as well as experimentation, to support a central role of
nonspecific binding and emphasize the importance of disordered nature itself in promoting facile
IDP recognition30–33,59,62,90,93,163–165. In fact, all published studies that extend beyond examining
the unbound states alone have suggested induced folding-like mechanisms, at least at the baseline
level.
Precisely how the disordered nature contributes to binding, however, is less clear. One proposal
is that nonspecific binding of unstructured and presumably more extended conformations can
increase the capture radii to enhance the binding kinetics166,167; however, such “fly-casting” effects
is small with a theoretical maximum of ∼1.6-fold acceleration. Recent studies have shown that
unbound IDPs tend to be much more compact than previously assumed168–171, further reducing the
proposed fly-casting affects. In addition, the rate-enhancing effect due to increased size is likely
offset by slower diffusion172. Alternatively, the unbound state of IDPs is presumed heteroge-
neous and strongly fluctuating. More specifically, conformational sub-states in the unbound IDPs
should be marginally stable and separated by small free energy barriers (e.g., a few kcal/mol or
less). These conformational fluctuations could contribute to efficient IDP recognition by allowing
the peptide to fold rapidly upon (nonspecific) binding163,172, which is required for achieving
the diffusion-controlled maximum binding rate (otherwise folding becomes rate-limiting)173. It
should be noted that cellular events frequently modify the folding of IDPs to modulate their
activities, such as through phosphorylations or by binding of other proteins54. Therefore, in
19
contrast to globular proteins where folding often serves only to achieve the native structures,
folding and unfolding appears to be direct and inherent aspects of IDP function. This underpins the
importance and biological relevance of obtaining a mechanistic understanding of binding-induced
folding of IDPs beyond a subject of theoretical curiosity.
The challenge in detailed characterization of IDPs represents a unique opportunity for molecular
modeling to make critical contributions1. In particular, atomistic simulations could provide the
ultimate level of detail necessary for understanding the structure and interaction of IDPs. At
the same time, the dynamic and heterogeneous nature of IDPs also pushes the limits of both
the force field accuracy and conformational sampling capability. So-called implicit solvent is
arguably an optimal choice for de novo simulations of IDPs because of its necessary balance of
accuracy and speed73,174–176. The basic idea of implicit solvent is to capture the mean influence of
water by direct estimation of the solvation free energy, therefore reducing the system size about
10-fold. Important advances have been made to greatly improve the efficiency and achievable
accuracy of implicit solvent, such as via the popular generalized Born (GB) theory175. With
reduced system size, implicit solvent is also particularly suitable for replica exchange (REX)
simulations104,177,178, an enhanced sampling technique that has proven highly effective in sampling
protein conformational equilibria179. Importantly, improved efficiency with implicit solvent also
allows careful optimization to suppress certain systematic biases that have plagued explicit solvent
approaches180,181. For example, we have previously optimized the generalized Born with smooth
switching (GBSW) model75,76 together with the underlying CHARMM22/CMAP protein force
field69,182–184. The resulting GBSW protein force field not only recapitulates the structures and
stabilities of helical and β-hairpin model peptides with a wide range of stabilities77,78, but also
allows calculation of the conformational equilibria of small proteins under stabilizing and desta-
bilizing conditions81,185,186. Although inherent and methodological limitations remain in implicit
solvent74, initial applications of implicit solvent to modeling small IDPs have been reasonably
successful30,33,72,169,187–189, substantiating the notion that it is a viable approach for atomistic sim-
ulations of IDPs.
20
The current work focuses on the nuclear-receptor co-activator binding domain (NCBD) of the
transcription coactivator CREB-binding protein (CBP) and its interaction with the p160 steroid
receptor co-activator ACTR. CBP and its paralogue p300 are general transcriptional coactivators
that play critical roles in transcriptional regulation and participate in cell cycle control, differentia-
tion, transformation, and apoptosis190,191. The NCBD domain (residues 2059-2117 in mouse CBP)
is also known as interferon regulatory factor (IRF) binding domain (iBID) or the SRC1 interaction
domain (SID). It mediates the interaction of CBP with a number of important proteins, including
steroid receptor coactivators, p53 and IRFs3,192. The interaction of CBP with p160 coactivators
in particular is important for recruitment of CBP/p300 to transmit the hormonal signal to the
transcription machinery193. Besides the biological and medical significance, the NCBD/ACTR
interaction also offers unique opportunities for understanding the molecular principles of IDP
recognition. Both NCBD and the activation domain of ACTR that it interacts with (residues 1018-
1088 in human ACTR; hereafter referred to as ACTR) are IDPs. Their interaction is an example
of the “synergistic folding” mechanism194 (the other known example also involves NCBD, but
with the p53 transactivation domain, TAD195). In addition, four folded structures of NCBD have
been solved in complex with various protein targets besides ACTR194–197. In these complexes,
NCBD adopts two distinct tertiary folds that involve three similar helices, represented by the
NCBD/ACTR and NCBD/IRF3 complexes (see Figure 2.1). Therefore, NCBD represents one of
the few experimentally validated examples of structural plasticity, which is believed to be a key
functional advantage of intrinsic disorder22.
Interestingly, although free ACTR is largely devoid of residual structures, free NCBD contains
one the highest levels of residual structures with folded-like helical content and molten globule
characteristics198,199. In addition, even though nuclear magnetic resonance (NMR) relaxation
analysis has established that free NCBD is highly dynamic on picosecond (ps) to nanosecond
(ns) timescales199, it appears to have a strong tendency to adopt marginally stable tertiary folds,
allowing two NMR structures of the unbound state determined to date28,192. These structures
are presumably obtained by stabilizing various conformational sub-states under specific solution
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Figure 2.1: Two representative folded conformations of NCBD. (A) NMR structure of the NCBD/ACTR
complex (PDB: 1kbh194, model 1). Both NCBD and ACTR contain 3 helical structure segments, labeled
as Cα1 (blue), Cα2 (red) and Cα3 (magenta) in NCBD and Aα1, Aα2 and Aα3 in ACTR. See Methods for
specific residue ranges of these helical segments. Several key structural features are also marked, including
the poly-Q loop (yellow) linking Cα1 and Cα2, a buried salt-bridge between NCBD R2105 and ACTR
D1068, and several key charged residues adjacent to this buried salt-bridge. (B) X-ray crystal structure of
the NCBD/IRF3 complex (PDB: 1zoq196). (C) Overlay of the folded structures of NCBD in complex with
IRF3 (yellow) and ACTR (green). Only the structured segment (residues 2066-2112) is shown, and the two
structures are aligned using the backbone atoms of Cα2.
conditions. Particularly intriguing is that the latest NMR structure of free NCBD turns out to be
similar to the folded conformation observed when bound to ACTR28. Although such pre-existence
of folded-like conformations should be considered only as a necessary but insufficient condition
for conformational selection-like mechanisms, the unusually high level of residual structures
of NCBD strongly suggests a functional role of pre-folding in its coupled binding and folding
interactions. In this work, we first exploit implicit solvent-based atomistic simulations and REX
enhanced sampling to characterize the conformational properties of free NCBD and ACTR. The
roles of preformed structures vs. conformational fluctuation in the NCBD/ACTR interaction
are then directly probed using high-temperature unfolding and unbinding simulations in both
implicit and explicit solvents. Combined with our recent coarse-grained simulations and existing
experimental data, we aim to obtain a detailed mechanistic picture of how residual structures, con-
formational fluctuations, and electrostatic interactions contribute to efficient synergistic folding of
NCBD and ACTR.
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2.2 Results
2.2.1 Convergence and validation of the disordered structure ensembles
De novo calculation of the disordered ensembles for IDPs is challenging1, especially for NCBD
that is both of moderate size and apparently with a complex, solution condition-sensitive con-
formational equilibrium. Our previous works have suggested that implicit solvent coupled with
REX enhanced sampling could generate reasonably accurate disordered ensembles for small IDPs,
including a 28-residue segment of the kinase inducible domain (KID) of transcription factor
CREB169. In Figure S2.1, we first test the convergence of the calculated disordered ensembles
by examining the dependence of residue helicity on REX simulation time and by comparing
results from independent simulations initiated from dramatically different conformations (folding
vs. control; see Methods). The sequences of both domains are provided in Methods. Free
ACTR appears to be highly disordered with marginal residual helicity. The calculated residual
helicity profiles from the control and folding runs converge to similar ones (data not shown).
For NCBD, while the time evolution of the calculated residual helicity appears to stabilize over
the course of 100 ns in either the control or folding REX simulation, the final profiles from
these two independent calculations differ substantially, suggesting that the actual convergence
is rather limited. Nonetheless, both the folding and control simulations clearly suggest significant
residual helicity in all three helical segments that become stably folded upon binding to various
specific targets. Detailed analysis of the conformational ensemble (see below) demonstrates
that free NCBD is compact and contains substantial tertiary contacts. These conformational
properties of NCBD, coupled with the larger size, contribute to the difficulty of achieving better
convergence using the REX/GB protocol. In addition, the current surface area-based treatment
of nonpolar solvation can over-stabilize non-specific collapsed states74,200. This problem further
limits the ability to sufficiently sample accessible tertiary organizations of free NCBD and their
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inter-conversions, which is required for achieving good convergence.
Given the limited convergence achieved in the REX simulations of free NCBD and apparent
difficulties in substantially improving the level of convergence, we focus on semi-quantitative
or qualitative analysis of the conformational properties of NCBD. That is, although significant
conformational sub-states sampled by REX may be genuine, the relative stability (population) is
not likely to be reliable. Considering that NCBD is experimentally known to be highly helical,
the folding simulations (initiated with a fully extended conformation) should take longer to con-
verge, and the disordered ensemble calculated from the control simulation is likely more realistic.
Therefore, all the subsequent analysis is based on the ensemble of conformations sampled during
the last 60 ns of the 100 ns control REX simulation. In Figure 2.2, we compare the residue
helicity of NCBD and ACTR in the free and bound states. The results appear to be fully consistent
with the previous NMR secondary chemical shift analysis (Figure 2 of Ref.199), showing that all
three NCBD helices are largely formed in the unbound state and ACTR is largely free of residual
helices. Interestingly, the poly-Q segment of NCBD (residues 2082-2086), although disordered
in the NCBD/ACTR complex, is largely helical in the unbound state and extends Cα2. This
is fully consistent in the NMR chemical shift analysis199. Recent sequence correlation analysis
has revealed a link between sequence order and binding promiscuity201,202. One might expect
that the length of the poly-Q stretch might affect conformational flexibility, and furthermore, the
ability to interact with diverse targets. We also have analyzed the ensemble distribution of the
radius of gyration of free NCBD. The results, shown in Figure S2.2A, confirm that free NCBD is
highly compact. Despite a clear lack of convergence, the control and folding simulations appear
to sample a set of conformation sub-states with similar characteristic sizes. Direct comparison
of the calculated size profiles to one derived from a recent small-angle X-ray scattering (SAXS)
study28 is complicated by the different constructs used and uncertainty in proper inclusion of
the solvation shell for a heterogeneous ensemble. Nonetheless, one can estimate that including
the disordered N- and C-terminal tails (13 residues total) truncated in the current simulations
would increase the radius by 2-3 A˚, and that the solvation shell may add another 2-3 A˚ (estimated
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by comparing results from HydroPro203 and CHARMM). These corrections together bring the
calculated radius of the gyration profile close to the SAXS-derived profile that centers around
15.2 A˚ under “native-like” conditions28. Apparent agreement between NMR and SAXS on these
ensemble-averaged properties is not sufficient to validate the reliability of the simulations, but it
suggests that the simulated ensemble may offer a qualitative or even semi-quantitative characteri-
zation of the conformational properties of free NCBD.
Figure 2.2: Calculated residue helicity of NCBD and ACTR in the free and bound states. Results for the
bound state were calculated from a 100 ns control simulation of the complex (see Methods), and those for
the free peptides were calculated based the conformationals sampled at 305 K during the last 60 ns of the
control REX simulations.
2.2.2 Folded-like conformations in the unbound state of NCBD
Because all three NCBD helices are largely formed in the unbound state, the conformational
fluctuation of free NCBD mainly involves tertiary packing of these helices. For example, as
shown in Figure 2.1, when aligned using the central helix Cα2, the two representative folded
conformations of NCBD differ mainly in the orientation of Cα1 and slightly less so in that of
Cα3. Therefore, all conformations of the calculated ensemble first re-oriented by aligning Cα2
(to the -z axis) before the orientations of Cα1 and Cα3 were calculated. Note such analysis
also provides an effective description of the tertiary packing even when one or more of the three
NCBD segments are not in helical states. The results, shown in Figure 2.3, illustrate that NCBD is
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strongly fluctuating and samples a large number of helix configurations, as expected for a molten
globule. Intriguingly, free NCBD appears to substantially sample all three distinct conformations
that have been observed experimentally so far, either in complexes or in isolation. These folds are
represented by PDB structures 1kbh, 1zoq, and 1jjs, respectively. The Cα1 orientation of 1kbh and
Cα3 orientation of 1jjs appear to be least sampled. Nonetheless, conformational sub-states exist
with similar orientations, as marked by arrows in panels (C) and (D) of Figure 2.3. Specifically,
for 1kbh-like Cα1 orientation, the adjacent sub-state contains more parallel (with smaller helix
cross angles), and thus tighter, packing of Cα1 with Cα2, but with a helix interface similar to
that of 1kbh. Further structural analysis (see the following paragraph) suggests that such tighter
packing is likely a result of helix formation in the poly-Q segment (e.g., see Figure 2.2), which
shortens the Cα1-Cα2 loop and promotes tighter packing.
Clustering analysis was performed to further analyze the structural properties of the major con-
formational sub-states of free NCBD. The average structures of the six most populated clusters
identified using K-means clustering with a 3.0 A˚ radius are shown in Figure 2.4. Helix configu-
rations for all members of these clusters are shown in Figure S2.3. Interestingly, even though one
of the clusters (Figure 2.4D) is similar to the fold observed in 1kbh, most clusters are different
from either 1zoq or 1kbh on the whole domain level, as suggested by the large RMSD values.
Therefore, even though both individual Cα1-Cα2 and Cα2-Cα3 helix pairs sample all three distinct
PDB folds, these folded-like configurations of individual helix pair generally do not occur at the
same time. Notably, the folded conformations of NCBD in 1kbh and 1zoq have relatively similar
Cα2-Cα3 helix packing (see Figure 2.1C). The packing of Cα2 and Cα3 also appears to be more
restricted in free NCBD compared to that ofCα1 andCα2 (e.g., as indicated by a larger “inhibited”
red area in Figure 2.3D compared to Figure 2.3C). NCBD has a strong inherent propensity to
adopt Cα2-Cα3 configurations analogous to those in 1kbh and 1zoq. Such persistent folded-like
conformations of free NCBD could contribute to recruitment of specific targets such as ACTR
and IRF3, allowing NCBD to adopt different final structures by docking the more flexibly linked
Cα1 into different positions. Another interesting observation is that the poly-Q segment appears to
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Figure 2.3: Orientations of NCBD Cα1 and Cα3 with respect to Cα2 in the unbound state. All
conformations sampled at 305 K during the last 60 ns of the control REX simulation were first aligned using
the backbone atoms of Cα2, and then reoriented such that Cα2 was aligned with -z axis. The orientations
as observed in three distinct folds of NCBD, represented by PDB 1kbh, 1zoq, and 1jj (also see Figure 2.1),
are marked with “+”, “×”, and “∗”, respectively. Note that different colors for the same symbol may be
used in different panels for clarity. In panels (C) and (D), φ and θ are the inclination and azimuth angles of
the spherical coordinate system. Note that the PMFs were computed using sin(θ) instead of θ itself as an
order parameter to remove the Jacobian entropy contribution. The range shown corresponds to θ = 0 (top)
to pi (bottom). Contours are drawn at every kT up to 7 kT, with k being the Boltzmann factor.
be capable of readily switching between helical and coil states. Such conformational fluctuations
could allow NCBD to adapt to different substrates, extending the Cα2 helix when bound with
IRF3 but becoming more disordered when in complex with ACTR (see Figure 1).
2.2.3 Induced folding-like mechanism on the baseline level
Although the REX simulations provide intriguing insights into the possible residual structures of
free NCBD, how these conformational properties contribute to synergistic folding of NCBD with
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Figure 2.4: Averaged structures of the six most populated clusters of free NCBD. These clusters are
identified based on the conformations sampled at 305 K during the last 60 ns of the 100 ns REX control
simulation. All structures were aligned by minimizing the backbone RMSD of Cα2 (the red segments)
and visualized in the same view. The numbers below each structure are the population of the cluster and
backbone RMSD values from the folded conformations in 1kbh and 1zoq (see Figure 2.1). The protein is
colored in the same fashion as in Figure 2.1A-B.
ACTR is not obvious based on these equilibrium simulations alone. For this, one could calculate
the coupled binding and folding free energy surfaces30,164 or transition paths33 to more directly
clarify the recognition mechanism and probe the roles of residual structures vs. pre-folding
in specific finding. However, given the moderate size and relatively complex topology, such
calculations can be extremely demanding using an atomistic physics-based force field for the
NCBD/ACTR complex. Instead, temperature-induced unfolding and unbinding simulations may
be used to effectively infer the molecular processes of coupled binding and folding. A key
assumption is that binding/folding is largely a reverse of unbinding/unfolding. An important
concern is that the transition states or the most probable transition paths might depend on temper-
ature86. Nonetheless, high-temperature unfolding simulations have so far proven quite successful
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for studying folding and interaction of many proteins, including IDPs87–90.
A 100 ns equilibrium simulation of the complex was first performed at 300 K, which confirms
that the native fold (model 1 of PDB:1kbh) is very stable in the GBSW/MS2 implicit solvent (see
Figure S2.4). Subsequent pilot simulations suggest 475 K to be optimal for simulating unbinding
and unfolding of the NCBD/ACTR complex in GBSW/MS2 (e.g., see Figure S2.5). In Figure
2.5, we compare the time evolution of various fractions of native contacts computed from 50
independent unfolding simulations at 475 K. The fraction of native intermolecular interactions
(Qinter) is used to describe binding, and the fraction of native tertiary intramolecular interactions
(QNCBD) is used for folding of NCBD. As shown in Figure S2.6, ACTR is completely devoid of
any inter-helix tertiary contacts in the NCBD/ACTR complex. Because ACTR is largely free of
residual structures in the unbound state, the overall helicity (αACTR) is used to effectively monitor
(binding-induced) folding of ACTR. On the baseline level, all unfolding and unbinding kinetics
appear to be reasonably well represented by single exponential functions. The fitted kinetic data is
summarized in Table 2.1. The secondary (helix) unfolding of NCBD is predicted to be the slowest
process (αNCBD; green traces in Figure 2.5), which is expected given the high level of residual
structures in unbound NCBD; however, both the ACTR (helix) and NCBD tertiary unfolding
appear to be significantly faster than unbinding. This result suggests that binding occurs prior to
the folding of both ACTR and NCBD; that is, both ACTR and NCBD follow induced-folding-like
mechanisms on the baseline level in the GBSW/MS2 implicit solvent. Considering the apparent
tendency of NCBD to pre-fold (see above), this result is somewhat surprising, but it highlights
the importance of conformational fluctuations and nonspecific binding in specific recognition of
IDPs, even for IDPs with significant residual structures like NCBD. Significant heterogeneity
is apparent in the unfolding/unbinding pathways of NCBD/ACTR and is partially reflected in
substantial ruggedness that remains in the curves shown in Figure 2.5 (e.g., compared with a
previous explicit solvent unfolding simulation of the p53-MDM2 complex, where 10 independent
10-ns simulations at 498 K were sufficient to yield much smoother curves87). The complex
fully disassociates within 10 ns in only 6 out of the 50 independent runs. In examining the
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Table 2.1: Unfolding and unbinding kinetic constants at 475 K.
τ (ns) A B R2
Qinter 1.61 0.23 0.17 0.94
Cα1 0.26 0.37 0.00 0.97
Cα2 1.52 0.25 0.034 0.84
Cα3 2.20 0.24 0.23 0.94
Aα1 0.80 0.34 0.037 0.94
Aα2 1.39 0.26 0.26 0.86
Aα3 2.93 0.32 0.30 0.86
QNCBD 0.94 0.27 0.055 0.90
αNCBD 1.76 0.31 0.15 0.96
αACTR 1.38 0.20 0.13 0.89
All curves were fitted by single exponentials Ae(−t/τ) + B. R is the correlation coefficient of
fitting. See the captions of Figures 2.5 and 2.7 for the definitions of various contact fractions.
unbinding/unfolding characteristics at a lower temperature of 450 K (see Figure S2.7), we found
the heterogeneity of unfolding/unbinding pathways to be even more evident. In addition, the
complex appears trapped in some intermediate states and does not fully unfold/unbind even after
20 ns. Nonetheless, unfolding of either ACTR or NCBD appears to lag behind unbinding, which
is consistent with the induced-folding baseline mechanisms predicted at 475 K.
2.2.4 Binding and folding intermediates involving the NCBD and ACTR C-terminal segments
Indications are that binding-induced folding of NCBD and ACTR is not simply 2-state-like. For
example, decay of QNCBD and αACTR appears to pause at ∼2 ns (red and blue traces in Figure
2.5), which could suggest a common intermediate state where ACTR and NCBD are partially
bound and folded. The decay curves are too noisy (partially due to underlying heterogeneity) for
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Figure 2.5: Evolutions of various contact fractions of the NCBD/ACTR complex at 475 K. All contact
factions and helicities were computed by averaging results from 50 independent unfolding simulations.
Qinter and QNCBD denote the native fractions of intermolecular and NCBD tertiary intramolecular
contacts, and αACTR and αNCBD denote the overall helicities of ACTR and NCBD. Significant fluctuation
remains in the raw averaged contact fraction traces (grey traces), and thus 50-ps running averages (dotted
traces) are plotted for clarity. The solid traces correspond to the best single exponential fits (see Table 2.1
for the fitted kinetic constants). Note that both Qinter and QNCBD quickly decrease from above 0.8 to ∼
0.4 during the first 10-20 ps. The initial decay is out of the plotting range and not shown for clarity.
reliable kinetic fitting using double exponential functions. Therefore, we constructed (pseudo)
unbinding and unfolding free energy surfaces based on statistics collected from the first 5 ns of
the unfolding simulations. Note that the system is not at equilibrium during this time frame,
so the resulting free energy profiles are not equilibrated (and thus strongly dependent on initial
conditions). Nonetheless, the profiles provide qualitative approximations of the true free energy
surfaces204. As shown in Figure 2.6A, an intermediate state is evident atQinter ∼ 0.25 andQNCBD
∼ 0.15. Interestingly, a similar key intermediate state also has been predicted in our recent
topology-based modeling of the NCBD/ACTR complex163. A strong resemblance between the
free energy surface is shown in Figure 2.6A and the result derived from topology-based modeling
(Figure 5A of reference163). Both the atomistic simulations (see further analysis detailed in the
following paragraph) and topology-based modeling predict that the intermediate state mainly in-
volves the C-terminal segments of NCBD and ACTR. Such a prediction appears highly consistent
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with a recent H/D exchange mass spectrometry (H/D-MS) study58, where peptide segments within
the C-terminal regions of both NCBD and ACTR were found to have much larger protection
factors compared with those mapped into other folded regions of the complex.
Figure 2.6: Free energy surfaces of (un)binding and (un)folding of the wild-type and mutant NCBD/ACTR
complex. (A) Computed from the first 5 ns of 50 independent simulations of the wild-type NCBD/ACTR
complex (WT) at 475 K. (B) Computed from the first 5 ns of 50 independent simulations of the double-Leu
mutant complex (NCBD:R2105L/ACTR:D1068L; DM) at 450 K. Contours are drawn at every kT.
In Figure 2.7, we further examined the binding kinetics of individual NCBD and ACTR helices.
The kinetic data derived from fitting to single exponential functions is summarized in Table
2.1. The analysis shows that Aα3 and Cα3 unbind with the largest half times, τ = 2.93 ns
and 2.20 ns, respectively, which are greater than that of the overall intermolecular interaction
formation (τ = 1.61 ns). This result indicates that binding is mainly initiated by the C-terminal
helices. In contrast, the first helices of NCBD and ACTR unbind much faster then the second
and third helices. In fact, unbinding of Aα1 and Cα1 occurs even faster than folding of either
NCBD or ACTR (as described by QNCBD and αACTR, see Table 2.1). These kinetic rates are
consistent with a multi-stage synergistic folding process, where NCBD and ACTR first bind
rapidly through the C-terminal segments, forming intermediates that are mainly stabilized by
native-like interactions between α2 and α3 helices. This first step appears to be highly cooperative
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(e.g., see Figure 2.6A), although indications are that both induced folding and conformational
selection might contribute163. Interestingly, the transition between the intermediate and bound
states appears largely conformational selection-like where NCBD and ACTR folding precedes
Aα1 and Cα1 binding. Formation of the partially folded core appears to facilitate the rest of NCBD
to fold into native-like conformations, allowingAα1 andCα1 to rapidly form native intermolecular
interactions en route to the fully folded bound state. Taken together, even though the synergistic
folding of NCBD and ACTR follows an induced folding-like baseline mechanism (where binding
precedes folding on the overall level), detailed analysis reveals multiple stages of induced folding
and conformational selection. Such a mechanism closely resembles an “extended conformational
selection” recently proposed by Csermely et al.205,206 and is remarkably consistent with our recent
topology-based modeling of the NCBD/ACTR complex163.
Figure 2.7: Evolutions of the fractions of native intermolecular interactions of individual helices of the
NCBD/ACTR complex. The grey traces were calculated from averaging 50 unfolding simulations at 475 K
and the colored traces are 50-ps running averages.
2.2.5 Native and non-native salt-bridges in encounter complexes and intermediates
One of the most notable features of the NCBD/ACTR complex is a buried salt-bridge between
NCBD R2105 and ACTR D1068194 (see Figure 2.1A), which is also conserved in the interaction
of NCBD with p53 TAD195. Interestingly, this buried salt-bridge is part of a local network
of salt-bridges that could form between multiple complementary charges, including R2105 and
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K2108 of NCBD and D1060, E1065, and D1068 of ACTR (see Figure 2.1A). This network of
native and non-native salt-bridges appears to play a significant role in stabilizing the putative
intermediate state, either thermodynamically or kinetically. Although most individual salt-bridges
frequently break and reform during individual unfolding simulations (see Figure S2.8), on average
they largely persist throughout the 10 ns unfolding simulations at 475 K and hinder the transition
from the partially bound intermediates to fully disassociated ones (see Figure 2.8). Out of the 50
unfolding simulations at 475K, the complexes fully dissociate only by the end of 10 ns simulations
in six cases. The native salt-bridges, between NCBD R2105 and ACTR D1068 and D1060, are the
most protected. As shown in Figure 2.8, they are the most preserved and remain formed over 80%
of the time throughout the simulations (blue and black traces in Figure 2.8A). NCBD K2108 is ad-
jacent to R2015 and close enough to interact with ACTR D1068 and D1060, but these salt-bridges
are more solvent-exposed and thus slightly less preserved during high-temperature simulations.
The side chain of ACTR E1065 is positioned away from NCBD in the native structure. Partial
unfolding of Aα2 allows E1065 to rotate and participate in the salt-bridge network with 10-30%
probability by the end of the 10 ns simulation at 475 K (purple and red traces in Figure 2.8A).
The conformational heterogeneity of the intermediate state does not permit reliable free energy
calculations to quantify the contribution of salt-bridge interactions to stability. Nonetheless,
previous mutagenesis studies have suggested that the buried salt-bridge between NCBD R2105
and ACTR D1068 contributes minimally to binding affinity198. The salt-bridge network likely
could not significantly stabilize the intermediate state thermodynamically, either, which raises
a concern that the observed persistence of the local salt-bridge network is artificial, such as
due to over-stabilization of charge-charge interactions in the GBSW/MS2 implicit solvent. To
address this concern, we first examine the potential of mean forces (PMFs) between Arg and
Asp side chain analogs in TIP3P and GBSW/MS2. The results, summarized in Figure 2.8,
show that GBSW/MS2 actually slightly under-stabilizes the Arg-Asp interaction compared with
TIP3P, either in a constrained head-to-head configuration (which was used in the force field opti-
mization76) or when fully unconstrained. In particular, configurationally unconstrained Arg-Asp
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Figure 2.8: Native and non-native salt-bridges in the NCBD/ACTR interaction. (A) Evolutions of average
probabilities of various salt-bridge interactions during unfolding simulations at 475 K. Arg and Glu/Asp
residues were considered in contact if the carbonyl carbon and Arg CZ distance was no greater than 5
A˚, and Lys and Glu/Asp residues were considered in contact if the side chain carbonyl carbon and amide
nitrogen distance is no greater than 4 A˚. (B) Two representative final conformations after 10 ns simulations
at 475 K. NCBD and ACTR are colored orange and gray, respectively. The side chains of key charged
residues are also shown, including NCBD R2105 and K2108 and ACTR D1060, E1065, and D1068. The
snapshot on the top represents a case where all six possible salt-bridges are formed, and the one at the
bottom represents a case where only the native ones, between NCBD R2105 and ACTR D1068 and D1060,
are formed.
interaction is unstable in GBSW/MS2 (Figure 2.9B). Therefore, the observed stabilization effects
of salt-bridges on the intermediates are likely of a kinetic nature. Such kinetic stabilization arises
from substantial desolvation barriers in disassociation of salt-bridges, particularly in partially
folded protein environments where the side chain configurations are restricted (e.g., see Figure
2.9A). With a concentrated local network of salt-bridges, very large desovaltion barriers can be
expected for complete dissociation of NCBD and ACTR, which explains why only a small fraction
of the high-temperature simulations (6 out of 50) successfully reached the fully unbound state in
10 ns.
To further confirm that the observed salt-bridge network is not an artifact of implicit solvent, a set
of 10 unfolding simulations was performed in TIP3P explicit solvent at 500 K. Most simulations
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Figure 2.9: Potential of mean forces of the Arg-Asp interactions in implicit and explicit solvents. All
profiles were calculated using umbrella sampling and WHAM (see Methods). The center-of-mass (CM)
separation is used as the order parameter in the unconstrained PMF.
were terminated between 3 to 4 ns when the complex size exceeded the periodic box dimensions.
The lengths of these simulations are insufficient to capture degrees of unfolding and unbinding
similar to implicit solvent simulations, and the number of trials is insufficient to obtain smooth
curves for kinetic fitting. Nonetheless, visual inspection of simulation trajectories as well as
examination of the evolution of various contact fractions support an unbinding and unfolding
mechanism that is consistent with the one derived from implicit solvent simulations (see Figure
S2.9). The same set of native and non-native interactions, particularly the buried one between
NCBD R2105 and ACTR D1068 (blue trace in Figure S2.9B), persist and appear to stabilize
the partially unbound and unfolded intermediates. Note that the helical secondary structures are
substantially over-stabilized in these explicit solvent simulations (e.g., see the blue trace in Figure
S2.9A). This is a known artifact of the current version CHARMM22/CMAP explicit solvent force
field78,207,208.
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A double-Leu mutant complex follows a similar unfolding and unbinding mechanism
A control simulation of the double-Leu mutant complex, NCBD:R2105L/ACTR: D1068L, at 300
K suggests that the native fold remains stable in the GBSW/MS2 implicit solvent (data not shown).
A set of 50 unfolding simulations was carried out at 450 K to further investigate the role of the
buried salt-bridge in synergistic folding. The heterogeneity of the unfolding/unbinding pathway
observed in the wild-type complex (e.g., see Figure 2.5) is even more pronounced without the
buried salt-bridge. All averaged time traces of contact fractions remain very noisy (e.g., see Figure
S2.10). Most traces cannot be satisfactorily fitted to either single or double exponential functions,
preventing quantitative analysis of unfolding and unbinding kinetics. Nonetheless, the pseudo
binding and folding free energy surface computed from the first 5 ns of the unfolding trajectories
appears to resemble that from simulations of the wild-type complex (see Figure 2.6). In particular,
a similar intermediate state exists at Qinter ∼ 0.2 and QNCBD ∼ 0.15; however, the small free
energy barrier separating the intermediate and fully unbound states in Figure 2.6A is largely absent
in Figure 2.6B. Removal of NCBD:R2105L largely disrupts the local salt-bridge network. The
intermediate state appears to have much shorter resident times, and can quickly fluctuate to the
fully unbound state. Importantly, examination of the evolution of intermolecular contact factions
of individual NCBD and ACTR helices, shown in Figure S2.10, supports that the mutant complex
largely follows a similar, albeit more heterogeneous, unbinding and unfolding mechanism, with
the N-terminal α1 helices disassociated first (black traces in Figure S2.10B-C). These results
suggest the local salt-bridge network does not appear to fundamentally modulate the recognition
mechanism. Instead, it mainly augments a productive synergistic folding mechanism inherent
in (the topology of) the NCBD/ACTR complex, by transiently stabilizing a key on-pathway
intermediate state to facilitate complete folding en route to the specific complex.
37
2.3 Discussion
With one of the highest levels of residual structures, NCBD is an intriguing model system for
understanding the roles of residual structure vs. conformational fluctuations in coupled binding
and folding of IDPs. We have combined equilibrium and non-equilibrium simulations using
physics-based, atomistic protein force fields to characterize the conformational properties of un-
bound NCBD and ACTR and to understand how these properties facilitate efficient synergistic
folding of these two IDPs. The calculation recapitulates that free NCBD has folded-like helical
content, is strongly fluctuating, and samples a wide range of tertiary configurations, which is
consistent with the previous notion that free NCBD is a molten globule199. Intriguingly, the
calculated disordered ensemble of NCBD contains significant populations with helical packings
that are highly similar to all those previously observed experimentally in isolation and in complex
with various targets. Observations of such pre-folded conformations, especially for IDPs with
significant residual structures like NCBD, could be considered strong evidence for conformational
selection-like mechanisms, where such preformed structural elements provide initial binding sites.
Direct examination of the unfolding and unbinding pathways in high-temperature simulations,
however, shows that both ACTR and NCBD tend to unfold first before unbinding, suggesting an
induced folding-like baseline mechanism for their synergistic folding. This seemingly surpris-
ing result appears to be consistent with the observation that, although individual Cα1/Cα2 and
Cα2/Cα3 helical pair samples folded-like packing with substantial probability, these configura-
tions rarely occur simultaneously. Therefore, population of folded-like tertiary conformations
on the whole domain level is insufficient to support conformational selection-like mechanisms
on the baseline level. Further analysis reveals an on-pathway intermediate state that mainly
involves the C-terminal helices of ACTR and NCBD, which also has been predicted by a recent
coarse-grained simulation study using topology-based models163. Importantly, existence of such a
major intermediate state also appears to be consistent with a recent H/D-MS experiments showing
that peptide segments within the C-terminal regions of NCBD and ACTR have much larger
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protection factors compared with those mapped into other regions of the complex58. Our kinetic
analysis suggests that, once the initial mini folding core is formed, the N-terminal helix of NCBD
folds rapidly (Table 2.1), allowing subsequent facile binding and folding the ACTR N-terminal
helix en route to the final specific complex. Therefore, although the baseline mechanism is
induced folding-like, conformational selection actually occurs at local levels. Together with our
recent topology-based modeling study163, the atomistic simulations strongly support the prediction
that synergistic folding of NCBD and ACTR follows the “extended conformational selection”
mechanism205. Our topology-based modeling of the NCBD/ACTR interaction163 has revealed a
separate, albeit less prevalent, pathway where binding is initiated by the N-terminal α1 helices.
These mechanistic insights on synergistic folding of NCBD and ACTR, derived from the atomistic
and coarse-grained simulations, are summarized in Figure 2.10.
An intriguing interplay appears to exist among residual structures, conformational fluctuations,
and electrostatic interactions to facilitate the rate-limiting step of forming the partially folded
intermediates. The NCBD Cα2/Cα3 helix-turn-helix motif appear to be conformationally more
restricted (Figure 2.2D), whereas the C-terminus of Cα3 retains the least amount of helical content
and is considerably more heterogeneous (Figure S2.2B). Both features were also observed in the
previous NMR chemical shift and relaxation analysis199. Such a balance of residual structures
and conformational fluctuations is likely important for the NCBD C-terminal to act as a key
initiation point for coupled folding and binding to ACTR and other proteins. Another novel
insight provided by the current atomistic simulations is the role of a local network of native and
non-native salt-bridges in transiently stabilizing the intermediates. These salt-bridge interactions
likely do not contribute substantially to the thermodynamic stability of either the intermediates
or the final specific complex198, but substantial desolvation barriers involved in breaking up these
interactions in a conformationally restricted protein environment (e.g., Figure 2.9A) can extend
the resident time of the intermediates to allow the rest of the complex to fold with higher efficiency.
As demonstrated using a dual-transition state kinetic model173, efficient folding upon encounter
is necessary for achieving facile binding at or near the diffusion-limited basal binding rate, a
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Figure 2.10: Overall mechanism of synergistic folding of NCBD and ACTR. The schematic view is based
on the current atomistic simulations as well as the previous coarse-grained modeling163. It illustrates
that unbound ACTR is largely unstructured and NCBD has significant helical structures. The nonspecific
encounter complexes could evolve toward the bound state through two parallel pathways. The salt-bridge
network that plays a key role in stabilizing Intermediate I along the prevalent pathway is also illustrated.
highly desirable property for signaling and regulatory IDPs that need to constantly evade protein
degradation machinery in cell. IDPs are known to be enriched with charges12. NCBD and ACTR
are no exceptions, with +6 and -8 net charges, respectively (including the flanking loops that
remain disordered in the complex194). These enriched charges hinder (independent) folding and
can protest against aggregation. In addition, long-range electrostatic interactions between these
large numbers of complementary charges on NCBD and ACTR could dramatically enhance the
encounter rate, similar to electrostatic steering, which is known to be important in interactions
of globular protein209. Furthermore, the complementary pattern of charge, especially within
the predicted mini folding core involving the C-termini (Figure 2.1), suggests that long-range
electrostatic interactions could further promote folding-competent encounter complexes before
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transiently stabilizing the on-pathway intermediates via formation of short-range salt-bridge net-
work. These effects can enhance the efficiency of folding upon encounter to promote facile
recognition.
The current study also reveals important limitations in both the protein force field accuracy and
sampling capability, especially for modeling IDPs of moderate sizes and with complex residual
structures. These limitations underscore the importance of continual development of the protein
force field, with increased focus on balancing various competing interactions to allow an accurate
description of not only a few (native) folds but also the whole conformational equilibrium74,210.
Sampling methodologies clearly need to improve. The standard temperature REX-MD has failed
to achieve convergence for the disordered ensemble of NCBD within 100 ns. Besides limited sim-
ulation timescale, certain limitations of the implicit solvent protein force field also contributed. In
particular, current empirical protein models have been shown to contain a systematic bias to over-
stabilize protein-protein interactions211,212. Furthermore, simple surface area-based estimation of
the nonpolar solvation free energy employed in most current implicit solvent models also tends to
over-stabilize nonspecific compact protein states74. The standard temperature REX-MD clearly
has limited ability to sample alternative deeply trapped low energy states with high efficiency.
These limitations together have also prevented us from more directly investigating the proposed
mechanistic roles of electrostatic interactions using atomistic simulations. Despite these outstand-
ing limitations, the key mechanistic features derived from atomistic physics-based simulations,
coarse-grained topology-based modeling, and various biophysical measurements are remarkably
consistent, which suggests that an integration of multi-scale modeling and experimentation can
provide a viable approach for understanding the functional and control of IDPs.
2.4 Methods
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2.4.1 REX/GBSW simulations of free NCBD and ACTR
Only segments of the NCBD and ACTR domains that are structured in the complex are in-
cluded in the current simulations, which include residues 2066-2112 for NCBD (in mouse CBP
numbering; SALQD LLRTL KSPSS PQQQQ QVLNI LKSNP QLMAA FIKQR2105 TAKYV
AN) and residues 1040-1086 for the ACTR domain (in human ACTR numbering; E GQSDE
RALLD QLHTL LSNTD ATGLE EID1068RA LGIPE LVNQG QALEP K). The peptide termini
are neutralized using with either acetyl (Ace) or amine (NH2) groups. A previously optimized
GBSW/MS2 model was used in all implicit solvent simulations unless otherwise noted76. This
model adopts an effective approximation of the molecular surface for defining the solute-solvent
boundary, which is believed to be more physical compared to the van der Waals-like surface used
in the original GBSW model213,214. Importantly, the GBSW/MS2 model has also been carefully
optimized to balance solvation and intramolecular interactions and can reasonably capture the
competition between α and β secondary structures. Specifically for NCBD/ACTR, the structure
of the complex (PDB: 1kbh194) remains stable in the GBSW/MS2 force field for over 100 ns, but
substantially deviates from the native conformation in the original GBSW protein force field (see
Figure S2.4).
REX was used to enhance the sampling of the accessible conformational space of free NCBD
and ACTR. For this, the Multiscale Modeling Tools for Structural Biology (MMTSB) toolset215
(http://www.mmtsb.org) was used in conjunction with CHARMM63,216. The basic idea of REX
is to simulate multiple non-interacting replicas at different temperatures simultaneously. Period-
ically, one attempts to exchange the simulation temperatures between pairs of replicas based on
a Metropolis criterion derived from the detail balance principle. As such, not only the resulting
random walk in the temperature space facilitates the system to cross the energy barriers and exploit
the conformational space more efficiently, but proper canonical ensembles are also generated at
all temperatures, allowing direct calculation of thermodynamic properties for comparison with
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experiments. We performed two independent REX simulations for each peptide, initiated from the
folded structure extracted from the complex (control) and a fully extended conformation (folding),
respectively. Comparison of the calculated structure ensembles from these independent control
and folding runs with dramatically different initial conditions allows rigorous assessment of the
convergence. In each REX simulation, 16 replicas were simulated at temperatures exponentially
distributed from 270 to 500 K. SHAKE217 was applied to fix the lengths of all hydrogen-related
bonds, allowing a 2.0 fs molecular dynamics (MD) time step. Temperature exchanges between
neighboring replicas were attempted every 2 ps, and the total length of each REX simulation was
100 ns (50,000 REX cycles). Similar REX/GBSW protocols have proven effective in calculating
the disordered structural ensembles for other IDPs (albeit of smaller sizes than NCBD and ACTR
studied in the current work)30,169. All analysis was performed based on the conformations sam-
pled during the last 60 ns of the control simulation at 305 K (where most existing experimental
data were acquired), unless otherwise noted. The orientations of helical segments (1044-1058,
1063-1071, 1072-1080 in ACTR; 2067-2076, 2086-2091, 2095-2110 in NCBD) were calculated
using the Chothia-Levitt-Richardson algorithm218 as implemented in CHARMM. The K-means
clustering algorithm as implemented in the MMTSB toolset was used to cluster the calculated
disordered ensembles based on mutual Cα RMSD distances. Various clustering radii ranging
from 1.5 to 4.5 A˚ were tested before an optimal radius of 3.0 A˚ was used for the final clustering
results presented. All molecular visualizations were generated using the VMD software219.
2.4.2 Room temperature and high-temperature simulations of the wild-type and mutant
NCBD/ACTR complexes
The same peptide segments defined above were included the simulations of the complex. The
model 1 from the NMR ensemble (PDB: 1kbh) was first equilibrated in the GBSW/MS2 im-
plicit solvent using energy minimization and short MD with weak harmonic positional restraints
imposed on all backbone heavy atoms. Subsequently, a 160 ns unrestrained simulation was
43
performed at 300 K to examine the structural stability and dynamics of the complex near its native
basin. The native structure of the NCBD:R2105L/ACTR:D1068L double-Leu mutant complex
was prepared by computational mutagenesis and then equilibrated using a similar protocol as
described above. To identify the optimal temperatures for unbinding/unfolding simulations, a
series of pilot simulations was performed at temperatures ranging from 350 K to 500 K (e.g., see
Figure S2.5). At the optimal temperature, the complex should unfold/unbind within tractable time
scales (e.g., 10-20 ns) while retaining important details of the unfolding/unbinding pathways.
Once such optimal temperatures were chosen (450-475 K for the wild-type and 450 K for the
mutant), 50 independent high-temperature simulations of 10-20 ns in length were initiated from
the equilibrated native structures with different initial velocities. The results presented in this
work are averages computed from 50 unfolding simulations unless otherwise noted. For native
fraction analysis, a list of native tertiary contacts (shown in Figure S2.6) was first identified using
the equilibrated native structure based on side chain minimal heavy atom distances with a 4.2 A˚
cutoff. The native contacts were then divided into inter-molecular and intra-molecular categories.
In analysis of the high-temperature simulation trajectories, a contact was considered formed when
the minimal heavy atom distance between two side chains was no greater than 4.5 A˚. Helicity of
various helical segments was calculated based on the hydrogen bonding patterns using the COOR
SECS module of CHARMM.
2.4.3 Explicit solvent high-temperature simulations
Additional high-temperature unfolding and unbinding simulations of the wild-type complex were
performed in TIP3P water to examine the unfolding/unbinding pathway and in particular the
putative role of the buried salt-bridge between NCBD:R2105 and ACTR:D1068 in (transiently)
stabilizing the intermediate state(s). For this, the equilibrated NCBD/ACTR complex was placed
in a cubic water box with periodic boundary conditions imposed. The final solvated system
contains 9176 TIP3P water molecules and the box size is ∼65 A˚. Two potassium ions were
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added to neutralize the total charge. The proteins were described by the CHARMM22/CMAP
protein force field69,182–184. The particle mesh Ewald method was used for long-range electrostatic
interactions220, and the van de Waals interactions were smoothly switched off from 12 to 13 A˚.
Lengths of all hydrogen-related bonds were kept constant with SHAKE217, and the MD time step
was 2 fs. After 10 ps of NPT equilibration at 300 K, a set of 10 independent NVT productions was
carried out at 500 K up to 10 ns until the dimensions of the proteins exceed those of the periodic
box. The dynamic time step was reduced to 1 fs in the NVT production simulations for numerical
stability.
2.4.4 Free energy calculations
An umbrella sampling protocol77 was used to compute the PMFs between the side chains of
Asp and Arg, either constrained in a head-to-head configuration77 (see Figure 2.9) or allowed
to freely rotate. In the constrained setup, the side chains were allowed to move only in fixed
orientations along the reaction coordinate (indicated by a dashed line in Figure 2.9), enforced
using the MMFP module in CHARMM. For explicit solvent simulations, solutes were solvated
by either ∼710 TIP3P waters in a rectangular box (for the constrained PMF) or by ∼1040 TIP3P
waters in a truncated octahedral box (for the unconstrained PMF). Periodic boundary conditions
were imposed. Non-bonded and other setups are identical to those described above for explicit sol-
vent high-temperature simulations. Harmonic restraint potentials were placed every 0.5 A˚ along
the reaction coordinate with a force constant of 5.0 kcal/mol/A˚2. For each umbrella-sampling
window, the system was first equilibrated for 60 ps, followed by 2 ns (constrained PMF) or 4 ns
(unconstrained PMF) NPT production at 300 K and 1 atm. The final PMFs were calculated using
the weighted histogram analysis method (WHAM)142. The constrained PMF in GBSW/MS2
was computed by direct translation of the side chains along the reaction coordinate, and the
unconstrained PMF in GBSW/MS2 was computed in the same umbrella sampling protocol except
that implicit solvent was used instead of TIP3P waters. Convergence of the PMFs was examined
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by comparing results from the first and second halves of the data and was shown to be on the order
of 0.2 kcal/mol.
46
2.5 Supplemental Materials
Figure S2.1: Convergence of the calculated residue helicity of free NCBD. Residue helicities calculated
using different segments of the folding (A) and control (B) REX simulations are shown. Only conformations
sampled at 305 K were included in the analysis.
Figure S2.2: Additional conformational properties of free NCBD. (A) Distributions of the radius of
gyration, and (B) Cα root mean square fluctuation (RMSF) profiles at 305 K, calculated from the last
60 ns of control (red traces) and folding (black traces) simulations.
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Figure S2.3: Orientations of NCBD Cα1 and Cα3 with respect to Cα2. Conformations that belong to the
six most populated clusters of free NCBD sampled at 305 K are color-coded. See the caption of Figure 2.3
in the main text for additional information.
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Figure S2.4: Summary of control simulations of the NCBD/ACTR complex in GBSW and GBSW/MS2.
(A) Backbone RMSD as a function of time. (B) Number of helical residues as a function of time. (C) The
Cα RMSF profiles computed from the last 50 ns of the 100 ns control simulations. Helical segments of
ACTR and NCBD are marked. (D)-(E) The final snapshots overlaid with the PDB structure (shown in gray
cartoon). The results suggest that the NCBD/ACTR complex is unstable in GBSW both at the secondary
and tertiary levels. In contrast, the complex remains reasonably stable in GBSW/MS2, with significant
fluctuations mainly observed in the C-terminal segment of ACTR, and to a lesser extent in the NCBD
C-terminus (see panel C).
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Figure S2.5: Trial unfolding simulations in GBSW/MS2 at different temperatures. The numbers of helical
residues of NCBD and ACTR are monitored to detect the unbinding/unfolding of the complex.
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Figure S2.6: Tertiary contacts of the NCBD/ACTR complex. The contacts were derived based on the first
model of PDB:1kbh. Residues are considered in contact if the minimal heavy atom distance is no more than
4.2 A˚. The black bars indicate the ranges of all helical segments in NCBD and ACTR. Although there are
a large number of intermolecular contacts (62; black dots), there are only 11 (blue dots) and 19 (red dots)
tertiary intramolecular contacts for ACTR and NCBD, respectively.
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Figure S2.7: Evolution of various contact fractions in GBSW/MS2 simulations at 450 and 475 K. The grey
traces were calculated from averaging 50 independent simulations at corresponding temperatures, and the
colored traces are 50-ps running averages.
Figure S2.8: Distances between key charged residues during three representative unfolding simulations
at 475 K. For Arg and Glu/Asp pairs, the distance between the side chain carbonyl carbon and Arg CZ
distance is shown. For Lys and Glu/Asp pairs, the distance between the side chain carbonyl carbon and
amide nitrogen is shown.
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Figure S2.9: Evolution of various contact fractions during unfolding simulations in TIP3P at 500 K. All
curves were calculated from averaging 10 independent simulations of 3 to 4 ns in length (only the first
3 ns are shown). The grey traces were calculated from averaging 50 independent simulations, and the
colored traces are 50-ps running averages. The results are consistent with key observations derived from
GBSW/MS2 simulations. Specifically, 1) the baseline mechanism for coupled binding and folding of
NCBD is an induced folding-like one, where binding precedes folding (Panel A); Fitting of Qinter and
QNCBD traces to single exponential functions yields half times, τ = 0.35 ns and 0.25 ns, respectively. 2)
The C-terminal segments initiate binding (thus the first helices unbind the first; see black traces in Panels
C-D); 3) the local native and non-native salt-bridges persist in the partially unfolded and partially unbound
intermediate state (Panel B). Note that the helical secondary structures appear to be over-stabilized (e.g.,
see the blue trace in Panel A), which is a known artifact of the current version CHARMM22/CMAP explicit
solvent force field.
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Figure S2.10: Evolution of various contact fractions during unfolding simulations of the mutant
NCBD/ACTR complex at 450 K. The grey traces were calculated from averaging 50 independent
simulations, and the colored traces are 50-ps running averages. The simulations were 15 ns in length.
The complex unfolds rapidly and thus only results from the first 5 ns are shown.
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Chapter 3
Synergistic Folding of Two Intrinsically Disordered
Proteins: Searching for Conformational Selection∗
Abstract
Intrinsically disordered proteins (IDPs) lack stable structures under physiological conditions but
often fold into stable structures upon specific binding. These coupled binding and folding pro-
cesses underlie the organization of cellular regulatory networks, and a mechanistic understanding
is thus of fundamental importance. Here, we investigated the synergistic folding of two IDPs,
namely, the NCBD domain of transcription coactivator CBP and the p160 steroid receptor coac-
tivator ACTR, using a topology-based model that was carefully calibrated to balance intrinsic
folding propensities and intermolecular interactions. As one of the most structured IDPs, NCBD
is a plausible candidate that interacts through conformational selection-like mechanisms, where
binding is mainly initiated by pre-existing folded-like conformations. Indeed, the simulations
demonstrate that, even though binding and folding of both NCBD and ACTR is highly coop-
erative on the baseline level, the tertiary folding of NCBD is best described by the “extended
conformational selection” model that involves multiple stages of selection and induced folding.
The simulations further predict that the NCBD/ACTR recognition is mainly initiated by forming a
mini folded core that includes the second and third helices of NCBD and ACTR. These predictions
∗Reproduced with permission of Royal Society of Chemistry, from “Synergistic folding of
two intrinsically disordered proteins: searching for conformational selection”, D. Ganguly, W.
Zhang and J. Chen, Mol. BioSyst., 2012, 8, 198, Copyright 2012, Royal Society of Chemistry.
http://pubs.rsc.org/en/content/articlelanding/2011/mb/c1mb05156c.
Author Contributions: Conceived and designed the experiments: JC DG WZ. Performed the experiments: DG WZ
JC. Analyzed the data: DG WZ JC. Contributed reagents/materials/analysis tools: DG JC. Wrote the paper: DG JC
WZ.
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are fully consistent with independent physics-based atomistic simulations as well as a recent
experimental mapping of the H/D exchange protection factors. The current work thus adds to
the limited number of existing mechanistic studies of coupled binding and folding of IDPs, and
provides a first direct demonstration of how conformational selection might contribute to efficient
recognition of IDPs. Interestingly, even for highly structured IDPs like NCBD, the recognition
is initiated by the more disordered C-terminal segment and with substantial contribution from
induced folding. Together with existing studies of IDP interaction mechanisms, this argues that
induced folding is likely prevalent in IDP-protein interaction, and emphasizes the importance
of understanding how IDPs manage to fold efficiently upon (nonspecific) binding. Success of
the current study also further supports the notion that, with careful calibration, topology-based
models can be effective tools for mechanistic study of IDP interaction and regulation, especially
when combined with physics-based atomistic simulations and experiments.
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3.1 Introduction
Cellular signaling and regulation frequently involve proteins or protein segments that lack stable
tertiary folds under physiological conditions and instead exist as heterogeneous and presumably
dynamic ensembles of disordered structures1,3,15,146,147. Such intrinsically disordered proteins
(IDPs) often fold into stable structures upon binding to specific targets. It is important to un-
derstand the mechanisms of these coupled binding and folding interactions, as they underlie the
organization of regulatory networks for cellular signaling and decision-making. IDPs are also
extensively implicated in various human diseases including cancer, neurodegenerative diseases
and diabetes17. Mechanistic understanding of IDP interactions and regulation can thus aid in
assessing related human diseases and devising rational strategies to modulate IDP functions for
therapeutic purposes. In particular, signaling and regulatory IDPs arguably represent a novel class
of potential drug targets221. Several small molecules have been successfully developed to bind
IDPs and interfere with their interactions using high-throughput screening148,222,223. However,
the structural plasticity that allows IDPs to function as versatile regulators poses a significant
challenge for rational optimization of the potential drug molecules. The structure of the bound
IDP complex alone is not likely going to be sufficient. Instead, an in-depth understanding of how
coupled binding and folding occurs and how this process might be modulated by drug molecules
is expected to be necessary.
At the baseline level, coupled binding and folding could follow two ideal mechanisms, namely,
induced folding and conformational selection. These two extreme mechanisms differ in the
kinetic ordering of the binding and folding events: (nonspecific) binding precedes folding in
induced folding, and vice versa in conformational selection. Importantly, these mechanisms
emphasize different conformational properties of IDPs for interaction. Conformational selection
requires the pre-existence of folded-like conformations in the unbound state, and further argues
that such preformed structural elements play a main role in initiating recognition24,27,156. In
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contrast, induced folding emphasizes intrinsic flexibility and nonspecific binding for efficient
interaction. Under induced folding scenario, the specific features of the residual structures in the
unbound state do not directly affect recognition. Instead, it is the overall level of residual structures
that plays a functional role, which is to modulate the binding thermodynamics through the entropic
cost of folding. Therefore, such a seemingly semantic classification of the baseline mechanism
provides a necessary starting point for understanding how recognition of a specific IDP may be
regulated or modulated, such as by post-translational modifications, amino acid replacements,
cellular environment, and drug molecules. Note that actual IDP interactions are not expected to
follow either ideal mechanism exclusively. Both mechanisms could play roles, such as at different
stages of coupled binding and folding205,224. There might also be dependence on the solution
conditions225 and even the nature of the specific target.
Residual structures often persist in unbound IDPs3. Intriguingly, these residual structures often
resemble the folded conformations adopted in complexes27–29. Such observations have been
frequently considered as evidence for conformational selection-like mechanisms of IDP interac-
tions24,27–29,162. However, pre-existence of folded-like conformations is not sufficient evidence for
conformational selection. Instead, one needs to further clarify whether the preformed structures
play a significant role in initiating binding, such as by examining the free energy surfaces and
transition state ensembles of coupled binding and folding, or, more directly, by comparing the
time-scales (or equivalently rate constants) of binding and folding transitions173,225. For example,
previous atomistic simulations of the extreme C-terminus of tumor suppressor p53 reveal that,
while the free peptide appears to sample several distinct folded-like conformations observed
experimentally in various complexes, its interaction with one of its specific targets, S100B(ββ),
is mainly initiated by nonspecific binding of unfolded conformations30. Interestingly, the p53
peptide does not appear to be an unusual case, and evidence has recently accumulated to suggest
that induced folding is likely prevalent in IDP-protein interactions1,26. Induced folding has been
consistently observed in mechanistic studies of IDP interaction from experiments31,32,59 and sim-
ulations33,62,90,93,165. Additional evidence of induced folding comes from kinetic data showing
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that stabilizing native-like structures in unbound IDPs actually reduce the binding rate226,227.
Theoretical considerations based on the dynamic energy landscape view have predicted that in-
duced folding would prevail with stronger and longer-range intermolecular interactions228. This
appears to be the case for IDP-protein interactions: structural plasticity for adopting distinct folded
states is considered a hallmark of regulatory IDPs22,149; therefore, intermolecular interactions do
overwhelm intrinsic folding prior to binding and dictate binding-induced folding of IDPs.
Despite the compelling arguments that can be made above for the prevalence of induced folding,
conformational selection could play important or even dominant roles for some IDPs. One such
possible example is the nuclear-receptor co-activator binding domain (NCBD) of transcription
coactivator CREB-binding protein (CBP). It is one of the most structured IDPs that have been
characterized so far. Free NCBD is highly helical with molten globule characteristics198,199.
Four folded structures of NCBD have been determined, in complex with the trans-activation
domain (TAD) of tumor suppressor p53195, the p160 steroid receptor co-activator ACTR194, the
steroid receptor co-activator 1 (SRC1)197, and the interferon regulatory factor 3 (IRF3)196, respec-
tively. In these complexes, NCBD adopts two distinct folds, which mainly differ in the tertiary
packing of three similar helices. Two representative folded structures of NCBD, as observed
in the NCBD/ACTR and NCBD/IRF3 complexes, are shown in Figure 3.1. The structures of
NCBD in complex with SRC1 and p53 are similar to that with ACTR. NCBD appears to have
a strong tendency to pre-fold, and it is possible to stabilize various conformational sub-states
of the unbound NCBD by tuning the solution conditions. For example, two structures of free
NCBD have been determined by solution nuclear magnetic resonance (NMR)28,192. Intriguingly,
the recent NMR structure of free NCBD turns out to be very similar to the folded structure in the
NCBD/ACTR complex, and this was considered strong evidence for conformational selection in
coupled binding and folding of NCBD28. However, as we previously demonstrated in the case of
the p53 extreme C-terminus, pre-existence of folded-like conformations is only a necessary but
insufficient condition of conformational selection. Nonetheless, given the highly helical nature
and apparent tendency to pre-fold, NCBD does seem to represent one of the most probable cases
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of conformation selection, if any IDP could rely on preformed structures for efficient initiation of
specific recognition.
Figure 3.1: (A) The NMR structure of the NCBD/ACTR complex (PDB: 1kbh194, model 1). NCBD is
shown in green and ACTR in orange. All helices of NCBD and ACTR are labeled. (B) An overlay of two
representative folded structures of NCBD. The conformation in complex with ACTR is shown in green, and
the one with IRF3 in yellow (PDB: 1zoq196). Only the structured segment (residues 2066-2112) is shown,
and the two structures are aligned using the backbone atoms of the second helix (residues 2085-2093).
This work exploits topology-based modeling as an effective means to determine the mechanism
of NCBD/ACTR interaction and to test whether conformation selection indeed could play a dom-
inant role for highly structured IDPs like NCBD. The NCBD/ACTR interaction is particularly
interesting also because ACTR is an IDP as well. Such synergistic folding of two IDPs has not
yet been investigated in detail. Topology-based modeling is based on the conceptual framework
of minimally frustrated energy landscape for natural proteins98, which argues natural proteins
achieve efficient and robust folding by evolving to possess smooth, funneled underlying free
energy landscapes. There is a strong correlation between the free energy and fraction of native
contacts. In other words, native interactions largely shape the protein energy landscape and
non-native ones do not play significant roles. Therefore, given the folded topology, one can derive
a list of native contacts and construct effective energy functions that capture the gross features
of the true energy landscape. These energy functions are often referred to as Go¯- or Go¯-like
models. These models are extremely efficient and allow direct simulation of folding and unfolding
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transitions to characterize both kinetics and thermodynamics of folding. Indeed, topology-based
modeling has provided impressive correspondence between experiment and theory for many pro-
teins98,229. In principle, it should be applicable to binding-induced folding of IDPs, as binding and
folding are analogous processes230,231 and the topology of the folded complex ought to dictate the
gross aspects of recognition mechanism. However, there do exist important differences between
sequence and interfacial characteristics of IDPs and globular proteins. For example, IDPs are
enriched with charged and polar residues and lack large hydrophobic residues12. At the same
time, IDPs rely on more on hydrophobic contacts for interfacial interactions21. These differences
can translate into significant shift in the balance of local folding and intermolecular binding, which
subsequently determines important aspects of coupled binding and folding, such as whether the
baseline mechanism follows induced folding or conformational selection. Therefore, existing
Go¯-like models designed for globular proteins might not be directly applied to IDP complexes.
Using well-characterized model IDP complexes62, we have recently illustrated that, even with
sequence-flavoring, existing Go¯-like models need to be re-calibrated to balance the intrinsic fold-
ing propensities and the intermolecular interaction strength. Such calibration requires additional
(experimental) information including the binding affinity and the level of residual structures in the
unbound states. We have further shown that, once calibrated, topology-based models do not only
appear to predict the correct baseline mechanism of interaction, but are also capable of capturing
nontrivial specific details of binding-induced folding. For example, the calibrated Go¯-like model
predicts that the phosphorylated kinase inducible domain (pKID) of transcription factor CREB
initiates binding to the KIX domain of CBP via the C-terminus in disordered conformations,
followed by binding and folding of the rest of the C-terminal helix and finally the N-terminal helix.
This multi-step sequential binding-induced folding mechanism of pKID is surprisingly consistent
with several key observations derived from a recent NMR study32, and provides a molecular
interpretation of key NMR-derived kinetic rates. In this work, we applied a similar approach
to construct a balanced topology-derived model of the NCBD/ACTR complex and investigate the
mechanism of the synergistic folding of NCBD and ACTR. While important limitations clearly
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exist with such simplistic proteins models derived from the folded topology62, these models can
be expected to capture important aspects of the NCBD/ACTR recognition and provide an effective
means to generate initial insights that may be further investigated by detailed simulations and/or
experiments.
3.2 Methods
3.2.1 Topology-based modeling of NCBD/ACTR
An initial sequenced-flavored Go¯-like model was first derived from the PDB structure of the
NCBD/ACTR complex (PDB: 1kbh194) (see Figure 3.1A), using the Multiscale Modeling Tools
for Structural Biology (MMTSB) Go¯-Model Builder (http://www.mmtsb.org)232,233. The model
represents each residue using a single Cα bead and treats the Cα-based native interactions using
the Miyazawa-Jernigan (MJ) statistical potentials234 to provide residue-specific energetic biases.
In addition, it includes knowledge-based sequence-dependent, but native-structure independent,
pseudo-torsional potentials. The underlying idea is that sequence could provide differing statistical
weights to the populations of structural elements during folding to modulate their prevalence
as observable intermediates and affect folding kinetics. The sequenced-flavored Go¯-like models
have been shown to recapitulate subtle differences in folding mechanisms and kinetics that arise
from sequence differences in topologically analogous proteins235,236. Therefore, it is particularly
suitable for extension to modeling IDPs. The initial model was then calibrated by first uniformly
scaling the strengths of sets of intra-molecular native contact interaction strengths based on exper-
imental knowledge of the overall level of residual structures in unbound NCBD and ACTR. The
strengths of inter-molecular contacts were then scaled to match the simulated and experimental
binding affinities of the complex. Both NCBD and ACTR fold into three helices in the complex.
The three NCBD helices are (in mouse CBP numbering): α1 (2066-2076; Nintra=12, Ninter=13),
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α2 (2085-2092; Nintra=8, Ninter=8), and α3 (2094-2112; Nintra=18, Ninter=41); the three ACTR
helices are (in human ACTR numbering): α1 (1044-1058; Nintra=18, Ninter=32), α2 (1063-1071;
Ninter=9, Ninter=16), and α3 (1072-1080; Nintra=9, Ninter=12). Ninter denotes the numbers of
native inter-molecular contacts, and Nintra is the number of native contacts within the individual
helix. All 76 native intermolecular contacts and the corresponding strengths of interactions from
the original sequenced-flavored Go¯-like model are listed in the Supplemental Materials Table S3.1.
The total number of intra-molecular contacts is 49 for ACTR and 78 for NCBD. As shown in
Figure S3.1, while NCBD contains a small number of tertiary contacts that define the α1- α2
interface and the short α2- α3 turn, ACTR largely lacks tertiary contacts.
3.2.2 Simulation protocols
The complex was simulated in a 105 A˚ cubic box with periodic boundary conditions using CHARMM63,216.
Langevin dynamics simulations were performed with a dynamic time step of 15 fs and a friction
coefficient of 0.1 ps−1. Lengths of all virtual bonds were fixed with SHAKE217, and the cut-
off distance for non-bonded interactions was 25 A˚. For the calibration of the intra-molecular
interactions, free NCBD and ACTR were simulated at 300 K for 750 ns. Due to the tight
binding, enhanced sampling with replica exchange (REX)104 is necessary for reliable calculation
of KD to calibrate the intermolecular interactions. All REX simulations were performed with the
MMSTB Toolset232,233 with eight replicas spanning 270 to 370 K. The lengths of calibration REX
simulations range from 2 to 5 µs. Once the model was properly calibrated, a 30-µs production
simulation was initiated from the PDB structure near the melting temperature (Tm ∼ 315 K),
which was used to calculate all the free energy profiles shown in the rest of this paper. Ten
additional productions simulations were initiated from randomly selected folded and unfolded
conformations sampled in the REX calibration run (see Figure S3.2A). These simulations allow
better transition statistics for the construction of the conformational space network (CSN). As
summarized in Table S3.2, a total of 268 folding/binding and unfolding/unbinding transitions
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were sampled in all production simulations. Representative time traces of the fractions of inter-
and intra-molecular contacts are shown in Figure S3.2B.
3.2.3 Data analysis
All the analysis was carried out using CHARMM and additional in-house scripts. A given native
contact is considered formed if the inter-Cα distance is no more than 1 A˚ greater than the distance
in the PDB structure. For equilibrium simulations of free NCBD and ACTR, the helicity was
calculated as the fraction of 1-5 (backbone) native contacts formed. For REX simulations of
the complex, weighted histogram analysis method (WHAM) was used to combine information
from all temperatures to compute either Cv curves or unbiased probability distributions142. The
unbound state was identified as the one without any native intermolecular contacts formed, and
the dissociation constants were calculated from the bound and unbound probabilities as,
KD =
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V0
pub
2
1− pub (3.1)
where V0 is the periodic box volume in unit of A˚3. For production simulations at Tm, all free
energy surfaces are converted directly from the corresponding histograms. The surfaces were then
shifted such that the bound minima were at zero. Helix cross angles were calculated using the
Chothia-Levitt-Richardson algorithm218 as implemented in CHARMM.
To construct the CSN, all conformations sampled during all 11 production simulations at 315
K were first assigned to discrete microscopic states (nodes) using 8 fractions of native contacts
as descriptors, including the fraction of intra-molecular contacts of ACTR (QACTRintra ), the fraction
of tertiary contacts of NCBD (QNCBDintra−tert), the fractions of intermolecular contacts made by the
three ACTR helices (QACTR−α1inter , Q
ACTR−α2
inter and Q
ACTR−α3
intrer ), and the fractions of inter-molecular
contacts made by the three NCBD helices (QNCBD−α1inter , Q
NCBD−α2
inter and Q
NCBD−α3
intrer ). Distribution
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along each descriptor was divided evenly into 5 bins except forQNCBDintra−tert, where five non-uniform
bins were used with 0.1, 0.2, 0.4 and 0.8 as the dividing values. The reason for using non-uniform
sub-states is to resolve natural conformational states along QNCBDintra−tert without having to using
more bins. The total possible number of conformational states using the above setup is 58 =
390625. For clarity, only the most populated nodes with additional nodes from the transition
paths were included in the CSN. The transition paths were defined as those where the system
left either the bound or unbound state and entered the other state without revisiting the originating
state. The fraction of the total native intermolecular contacts formed (Qinter) was used as the order
parameter for defining the bound and unbound state for transition path identification. Qinter=0.15
was used as the upper bound of the unbound state, and Qinter=0.4 as the lower bound of the
bound state. Inclusion of nodes on the transition paths is necessary to preserve different transition
pathways when a limited number of nodes are used to construct the CSN. The resulting network
was visualized with stress minimization using visone (www.visone.de). The node sizes and link
thickness in the final CSN reflect the statistical weights in logarithmic scale.
3.3 Results and Discussion
3.3.1 Calibration of the sequence-flavored Go¯-like model
Previous NMR secondary chemical shift analysis has estimated that the free NCBD has native-like
helical content and the free ACTR is highly disordered with low residual helicity199. Figure 3.2A
compares the overall helicity distributions of unbound ACTR with different levels of scaling of
the strengths of all intra-molecular interactions. Clearly, it shows that the original sequence-
flavored Go¯-like model overestimates the residual structure level. The scaling factor of ACTR
intra-molecular interaction strengths was chosen to be 0.4 in the final model, which yields an
average helicity of ∼30%. Note that, due to the coarse-grained nature, the Cα-only model has a
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limiting helicity of near 20% even without any specific intramolecular interactions (e.g., see the 0.1
trace in Figure 3.2A). A helicity of ∼30% is thus near the “random coil” limit within the context
of the peptide model. For NCBD, it turned out that no scaling of the intra-molecular interaction
strengths was necessary. As shown in Fig 2b, all three helices of NCBD in the unbound state
are nearly as stable as in the bound state. It is interesting that sequence-flavoring alone correctly
predicts NCBD-α3 to be the least stable helix in the unbound state. This is consistent with the
results of NMR secondary chemical shift analysis199.
Figure 3.2: (A) Probability distributions of the overall helicity of the unbound ACTR, calculated with
various uniform scaling of the intra-molecular interaction strengths. (B) Probability distributions of the
helicities of three NCBD helical segments in the unbound and bound states. The unbound state was
calculated without any scaling of the intra-molecular interaction strengths, and the bound state distributions
were calculated from a 1-µs simulation of the complex using the final calibrated model (see main text).
Once the scaling factors of the intra-molecular interaction strengths were determined, multi-
ple REX simulations were carried out using different scaling of the intermolecular interaction
strengths. The free energy profiles as a function of Qinter with a few different scaling factors are
provided in Figure S3.3A. The original model yields KD ∼ µM, nearly two orders of magnitude
weaker than the experimental value of KD = 34 ± 8 nM198. The optimal scaling of the inter-
molecular interaction strengths turns out to be 1.1, which yields KD ∼ 23 nM and Tm ∼ 315 K.
The heat capacity as a function of temperature calculated from a 4.9-µs REX simulation using the
final model is shown in Figure S3.3B. Surprisingly, with sequence flavoring, the topology-derived
models appear to consistently predict strong structural fluctuations within the folded complex,
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such that the folded minimum centers at Qinter ∼ 0.6 even with substantial strengthening of
the intermolecular interactions (e.g., with scaling factors up to 1.5; data not shown). Further
examination of the list of all native intermolecular contacts (see Table S3.1) reveals that it contains
many contacts involving small hydrophobic residues and/or charged ones. These contacts are
weak in the MJ scale234, and frequently involve the C-termini of ACTR and NCBD. Indeed, the
root-mean-squared fluctuation (RMSF) profiles computed from a control simulation of the com-
plex at 300 K using the calibrated model reveal significantly elevated fluctuation at the C-termini
of both ACTR-α3 and NCBD-α3 (see Figure S3.4). Interestingly, a previous NMR relaxation
analysis has also revealed fluctuating contacts between ACTR-α3 and NCBD-α3199. In addition,
a recent H/D exchange mass spectrometry (H/D-MS) study58 showed that, within the folded
regions of NCBD and ACTR, peptide segments that map to the C-termini of both ACTR-α3
and NCBD-α3 had the smallest protection factors. Therefore, it appears that the strong structural
fluctuations predicted by the calibrated sequence-flavored model is realistic, and no adjustment to
the model was applied to further stabilize the complex.
3.3.2 The baseline mechanism: induced folding vs. conformational selection
With careful calibration, the final sequence-flavored Go¯-like model is able to reproduce the exper-
imental data on the binding affinity and the level of residual structures in the unbound proteins.
Therefore, the model properly reflects the balance between the intrinsic folding propensities of
NCBD and ACTR and the strength of their interactions. This balance should allow a reliable
prediction of the baseline mechanism. For this, we examine the free energy surfaces along
appropriate binding and folding reaction coordinates, where the most probable transition paths
can be identified as the minimum free energy paths connecting various basins. In the context of
topology-based modeling, the fractions of native contacts provide natural reaction coordinates for
describing folding, and analogously, binding237. Figure 3.3 examines the 2D binding and folding
free energy surfaces of NCBD and ACTR, using the total fractions of inter- and intra-molecular
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contacts as order parameters. Apparently, both NCBD and ACTR bind and fold in a highly
cooperative fashion, as QACTRintra and Q
NCBD
intra gradually increase together with Qinter. In particular,
even though the free NCBD is highly helical (see Figure 3.2B),QNCBDintra does not appear to increase
any faster thanQinter, i.e., folding does not precede binding on the whole protein level. Therefore,
on the baseline level, neither NCBD nor ACTR follows either induced folding or conformational
selection. Not surprisingly, folding of NCBD and ACTR are highly synergistic. As shown in
Figure 3.3C, neither protein displays any significant folding without binding (and folding) of the
partner.
Figure 3.3: 2D free energy surfaces of the synergistic binding and folding of NCBD and ACTR. QACTRintra
and QNCBDintra are the fractions of native intra-molecular contacts formed by ACTR and NCBD, respectively.
Contour levels are drawn at every kT. Figure prepared by DG.
3.3.3 A key intermediate state of the NCBD/ACTR interaction
The free energy surfaces in Figure 3.3 also reveal a key intermediate state of the NCBD/ACTR
interaction, at Qinter ∼ 0.25. To further characterize the nature of this state, conformations
sampled during the production simulation were grouped to three states: Qinter = 0 for the unbound
state, 0.21 < Qinter < 0.32 for the intermediate state (corresponding to 16 to 24 native contacts
formed), and Qinter > 0.5 for the bound state. Structural analysis of the resulting ensembles
reveals that in the intermediate state NCBD and ACTR mainly interact through the C-terminal
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segments that include both α2 and α3, while α1 helices from both proteins are largely unbound
(see Figure 3.4). At the intermediate state, α2 and α3 from both proteins are similarly folded
compared to the bound state, while α1 helices remain as (un)structured as in the unbound state (see
Figure S3.5). Further analysis of the helix-helix packing geometry including helix center distances
and cross angles (see Figure S3.6) demonstrates that the C-terminal segments of NCBD and ACTR
adopt highly folded-like tertiary conformations in this intermediate state, which is consistent
with the QNCBDα2α3−ACTRα2α3inter distributions shown in Figure 3.4B. Therefore, the C-terminal
segments of NCBD and ACTR appear to serve as a mini folding core prior to complete binding and
folding (e.g., see Figure 3.4C). As discussed above, NMR, H/D-MS and the current simulations all
suggest significant structural fluctuation in interactions between NCBD-α3 and ACTR-α3. The
observation that the C-terminal α2 and α3 regions of these two proteins form the key folding core,
and play a major role in initiating specific recognition can thus be surprising. Nonetheless, this
prediction is fully consistent with independent atomistic unfolding and unbinding simulations
using physics-based explicit and implicit solvent protein force fields34. Furthermore, it also
appears to be consistent with the recent H/D-MS study58, where peptide segments within the
α2 and α3 regions of both NCBD and ACTR were shown to have much larger protection factors
compared to those mapped into other folded regions of the complex.
3.3.4 Mechanism of coupled binding and tertiary folding of NCBD
NCBD is highly helical in the unbound state (see Figure 3.2B), and only forms a limited number
of tertiary intra-molecular contacts upon folding and binding to ACTR (see Figure S3.1B). The
total fraction of intra-molecular contacts (QNCBDintra ) is thus not a sensitive measure of NCBD
tertiary folding. To better understand the interplay between binding and NCBD tertiary folding,
Figure 3.5A examines the free energy surface as a function of Qinter and the fraction of tertiary
intra-molecular contacts of NCBD, QNCBDintra−tert. At the baseline level (e.g., assuming an inability
to resolve the details along the pathways connecting the unbound and bound states), it appears
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Figure 3.4: Probability distributions of the fraction of native intermolecular contacts formed (A)
by NCBD-α1, QNCBD−α1inter , and (B) between the C-terminal segments of NCBD and ACTR,
QNCBD−α2α3−ACTR−α2α3inter . The unbound state has no native intermolecular contact by definition and
is thus not shown. (C) A representative snapshot of the intermediate state, with all helical segments colored
and marked. Figure prepared by DG.
that the increase in Qinter precedes and thus presumably drives that of QNCBDintra−tert, i.e., an induced
folding-like mechanism. However, such a baseline mechanistic classification appears to break
down once the additional details of the transition pathways are taken into consideration. Instead,
conformational selection appears to play key roles during different stages of binding and tertiary
folding of NCBD. Specifically, the transition between the unbound and intermediate states follows
both induced folding and conformational selection-like pathways, as indicated by the yellow and
dark green dashed lines connecting states U and I in Figure 3.5A. Furthermore, the conformational
selection-like pathway has lower free energy barrier (by ∼ 1 kT), and is thus slightly favored.
More notably, the intermediate-bound transition appears to mainly follow conformational selec-
tion on the tertiary level, where NCBD quickly folds before forming additional native contacts
with ACTR (e.g., see the green dashed line connecting states I and B in Figure 3.5A). Such
a staged mechanism of coupled binding and tertiary folding of NCBD resembles the extended
conformational selection model recently discussed by Csermely, Palotai and Nussinov205, which
emphasizes a multi-stage mutual adjustment process that involves both induced folding and con-
formational selection.
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Figure 3.5: 2D free energy surfaces of coupled binding and tertiary folding of NCBD. QNCBDintra−tert is the
fraction of native tertiary intra-molecular contacts formed by NCBD. θα2−α3 is the cross angle between
NCBD-α2 and α3, and θα1−α2 is that between NCBD-α1 and α2. In panel (A), the unbound, intermediate
and bound states are marked with U, I and B, respectively. Contour levels are drawn at every kT. Figure
prepared by DG WZ.
With largely folded helices in the unbound state, the tertiary folding of NCBD mainly involves
packing of the three helical segments. The analysis above (e.g., see Figure 3.4) has shown that
the unbound-intermediate transition mainly involves the folding of NCBD-α2 and α3 and the next
step involves that of NCBD-α1. In Figure 3.5B and C, we directly examine the coupling between
intermolecular interactions and formation of native-like helix-helix packing as reflected in the
helix-helix cross-angles. The analysis shows that the transition pathways between the unbound
and intermediate states indeed have a very broad distribution, and there is a continuum between
two extreme mechanisms of induced folding and conformational selection for (binding-induced)
tertiary packing of NCBD-α2 and α3 (as indicated by multiple dashed lines in Figure 3.5B). In
the intermediate state, NCBD-α1 remains nearly as dynamic as in the unbound state, but with a
slight enrichment of folded-like conformations (also see Figure S3.6, red traces). These folded-
like conformations appear to play a key role in initiating the binding and folding of the rest of
the complex. One way to understand the conformational selection-like transition between the
intermediate and bound states is that, as the most stable helix, NCBD-α1’s packing with the
folded core of NCBD-α2 and α3 is defined by only a few degrees of freedom. Thus, NCBD-α1
can readily adopt native-like packing upon making of a few additional intermolecular contacts,
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which appears to drive the formation of the remaining intermolecular contacts.
3.3.5 Folding and binding of individual helical segments of NCBD and ACTR
We have further examined coupled binding and folding of individual helices of NCBD and ACTR.
As shown in Figure 3.6A-B, NCBD-α1 and α2 are very stable in the unbound state, and bind
largely as pre-folded helices as expected. The least stable helix of NCBD, α3 appears to fold
concurrently with binding (Figure 3.6C). In contrast to NCBD helices, all ACTR helices are
largely unstructured in the unbound state, and they appear to mainly follow induced folding-like
mechanisms. As shown in Figure 3.6D-F, Qinter increases faster than various Qintra of individual
helices during transitions, either between the unbound and intermediate states (ACTR-α2 and
α3) or between the intermediate and bound states (ACTR-α1). In other words, intermolecular
interactions drive the (secondary) folding of ACTR. Taken together, the current topology-based
simulation suggests that NCBD provides pre-folded structural elements on both secondary and
tertiary levels, which allow efficient binding of ACTR in unstructured conformations and drive
specific folding of ACTR during different stages of the recognition.
Figs. 7 and 8 further examine the sequence of binding of all ACTR and NCBD helices by
comparing the free energy projections along various combinations of the fractions of native in-
termolecular contacts formed by different helical segments. Examination of the minimum free
energy paths connecting various basins along these projections reveals detailed (kinetic) ordering
of binding and folding of individual segments. The analysis supports the above observation that
α2 and α3 from both proteins drive the recognition by forming the folded core at the intermediate
state. Specifically, binding of ACTR-α2 and α3 precedes that of ACTR-α1 (Figure 3.7D and E),
and binding of NCBD-α2 and α3 precedes that of NCBD-α1 (Figure 3.8D and E). Furthermore,
NCBD-α3 and ACTR-α2 appear to be the most frequently involved in initiating the recognition.
NCBD-α3 has the largest number of native intermolecular contacts (Ninter=41) and its role in
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Figure 3.6: 2D free energy surfaces of as functions of Qinter and the fraction of intra-molecular native
interactions formed within individual helices of NCBD and ACTR. Contour levels are drawn at every kT.
Figure prepared by DG WZ.
initiating binding and folding may thus be expected238. However, ACTR-α2 does not have the
highest density of native contacts and its role in initiating recognition is unexpected from simple
consideration of native contact density. Interestingly, these free energy surfaces also reveal a
co-existence of many parallel pathways of the NCBD/ACTR recognition. For example, Figure
3.8A shows that, along the dominant pathway (indicated by the yellow dashed line), QNCBD−α1inter
does not increase from near zero until Qinter exceeds ∼ 0.25. That is, NCBD-α1 binds only
after a signification number of native intermolecular interactions are formed). At the same time,
there exists a minor pathway where binding is initiated by NCBD-α1 (indicated by the green
dashed line in Figure 3.8A). These parallel pathways are also evident in Figure 3.8D. In fact, the
free energy surfaces shown in Figure 3.7 and 3.8 suggest that all helices of NCBD and ACTR
could initiate binding, albeit with different levels of prevalence. Such diversity in folding and
binding pathway is not surprising, and is actually expected to be generally true based on the
funneled energy landscape theory239. The importance of examining the recognition mechanism
using multiple sets of order parameters should also be emphasized. For example, the QNCBD−α1intra−tert -
Qinter free energy surface shown in Figure 3.5A alone could lead to an overly simplified view that
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the recognition occurs through a well-defined pathway that involves folding and binding of α2
and α3, followed by binding and folding of α1 helices. This is a limitation of free energy analysis
along pre-selected order parameters, which can mask important heterogeneity and complexity
along orthogonal degrees of freedom.
Figure 3.7: 2D free energy surfaces as functions of the fractions of native intermolecular contacts formed
by various segments of ACTR. Contour levels are drawn at every kT. Figure prepared by DG WZ.
3.3.6 Network analysis of the complex pathways of coupled binding and folding
CSN analysis does not rely on pre-determined order parameters as required in the traditional free
energy analysis, and can thus allow better visualization of the heterogeneous pathways of protein
folding and binding240–242. One of key challenges in constructing the CSN is the need to divide
the continuous protein conformational space into discrete microstates. The discretization has been
mainly achieved either by conformational clustering243–246 or by using a reduced set of (structural)
descriptors242,247. In the context of topology-based modeling, various fractions of native contexts
do provide natural reaction coordinates and are thus appropriate for defining microstates. Figure
3.9 shows a CSN of the synergetic folding of NCBD and ACTR derived from all 11 production
simulations, by including only the most populated 100 nodes and additional 200 nodes from the
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Figure 3.8: 2D free energy surfaces as functions of the fractions of native intermolecular contacts formed
by various segments of NCBD. Contour levels are drawn at every kT. Figure prepared by DG WZ.
transition paths. The total number of links is 15161. Including additional nodes does not change
the appearance of the CSN (e.g., see Figure S3.7). Even though powerful analysis can be done
to further analyze the kinetic portioning and connectivity of the conformational space, the goal
here is mainly to illustrate and visualize the complexity of multiple pathways of binding and
folding of NCBD and ACTR. With the nodes distributed with minimized stress (as implemented
in visone), the CSN shows a natural segregation of different (meta-)stable free energy states that
include the unbound (labeled in blue), intermediate (green), and fully bound (red) states. It furthers
illustrates the co-existence two main groups of recognition pathways. While the peptides mostly
initiate binding through the C-terminal α2 and α3 and go through the intermediate state toward
the bound state, they can also initiate binding through α1 helices (e.g., the link between nodes
37 and 218) and reach the bound state through an intermediate state that is mainly stabilized
by interactions between α1 helices (purple nodes). Interestingly, it appears that NCBD needs to
pre-fold with 0.4< QNCBSintra−tert <0.8 to initiate binding through α1. Along the major pathway,
the CSN shows three key routes initiated by nodes 202, 248 and 270. These routes appear to
correspond to conformational selection (node 202) and induced folding initiated by NCBD-α2
(node 248) and α3 (node 270) for the unbound-intermediate transitions observed from the free
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energy analysis (e.g., see Figure 3.5A). Transitions from the intermediate to bound state mainly
go through an intermediate state where NCBD become pre-folded (orange nodes), even though
highly cooperative binding and folding of α1 helices also appear possible (e.g., see direct links
between green and red nodes). Taken together, the CSN appears to provide a clear and concise
illustration of the heterogeneous pathways of the NCBD/ACTR recognition that is fully consistent
with the observations derived from analysis of multiple free energy surfaces.
Figure 3.9: The CSN of the synergetic folding of NCBD and ACTR. The nodes represent the
conformational microstates, and the links represent the transitions between them. The node sizes and link
widths reflect the statistical weights in logarithmic scale. The colors of the nodes are assigned according
to states of NCBD: blue: unfolded and unbound; green: partially folded and bind with ACTR through
NCBD-α2 and α3; orange, folded and bind with ACTR through NCBD-α2 and α3; red, folded and
bound; and, purple: partially folded and bind to ACTR through NCBD-α1. Representative snapshots
are shown for selected nodes, where NCBD and ACTR helices are colored using the same scheme as
in Fig. 4. The notation is the node ID (in bold fonts) followed by the bin indices (1 through 5) along
the 8 structural descriptors (QACTRintra , Q
NCBD
intra−tert, Q
ACTR−α1
inter , Q
ACTR−α2
inter , Q
ACTR−α3
inter , Q
NCBD−α1
inter ,
QNCBD−α2inter , Q
NCBD−α3
inter ; see Methods for detail).
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3.4 Conclusions
Topology-based modeling has been successfully applied to investigate the synergistic folding of
two IDPs with drastically different residual stabilities in the unbound states. Through careful
calibration based on additional experimental data besides the complex structure, the topology-
based model was able to properly capture the balance between the intrinsic folding propensities
of NCBD and ACTR and the strength of their intermolecular interaction. Subsequent simulations
revealed several important mechanistic features of the coupled binding and folding processes.
Despite a drastic difference in residual structural level, both NCBD and ACTR bind and fold
in a highly cooperative fashion on the baseline level that involves a key intermediate state. In the
intermediate state, the C-terminal helices α2 and α3 of NCBD and ACTR form a mini folding core
that allow rapid folding and binding of α1 helices. Interestingly, due to the highly structured nature
of the unbound NCBD, conformational selection appears to play significant roles in the formation
of both the intermediate state and the final specific complex. The binding-induced tertiary folding
of NCBD involves multiple stages of selection and induced folding, and is clearly an example of
“extended conformational selection”205,206. Importantly, key mechanistic features predicted by the
current topology-based modeling, such as regarding individual helix folding and binding, tertiary
folding, and intermolecular interactions, are surprisingly consistent with independent atomistic
simulations using implicit solvent protein force fields34. Several key aspects of the predicted
mechanism are also consistent with the protection factor mapping derived from a recent H/D-MS
study of NCBD/ACTR58.
Nonetheless, it is interesting to note that, even for an unusually structured IDP like NCBD, the
recognition is initiated by the more flexible C-terminal segment and with substantial contribution
from induced folding. Formation of the meta-stable mini folding core appears necessary for
conformational selection to play an even larger role during later stages of recognition, where
NCBD-α1 readily form native-like packing with the folded core and allows rapid binding and
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folding of the rest of the complex. Combined with existing experimental and theoretical evidence
(see Introduction), the current work further supports the notion that induced folding is very likely
the prevalent mechanism of specific IDP-protein interactions. Even when conformational selection
does play a role, it will likely be limited to the local (secondary) structure level and later stages
of the recognition process. A fundamental question is then why and how induced folding might
confer functional advantages for IDP recognition. The need for proteins to remain unstructured in
the unbound state is believed to arise from certain functional constraints, particularly in signaling
and regulation, such as to allow high specificity coupled with low affinity binding, inducibility
by posttranslational modifications, structural plasticity for binding multiple targets, and thermo-
instability for alloteric regulation6,20. It has also been proposed that disordered proteins could
enhance the (nonspecific) binding rate up to 1.6 fold due to larger capture radii (i.e., the fly-casting
effects166,167). However, recent studies show that unbound IDPs tend to be compact171,188,248 and
thus may not have much greater capture radii to have the full fly-casting effects. Furthermore, the
rate-enhancing affect due to increased capture radii will be largely offset by slower diffusion172.
Therefore, it is not obvious that intrinsic disorder itself could provide any significant kinetic
advantages.
Instead, it appears that while required for satisfying other functional constraints, intrinsic disorder
could lead to a kinetic bottleneck that must be overcome to allow facile recognition in signaling
and regulation. This bottleneck arises from the requirement of (partial or full) folding during
specific binding, as protein folding is usually a slow process (compared to translational and
orientational diffusion) with an estimated “speed limit” of µs249. Indeed, the recent dual-transition
state model developed by Zhou173 predicts that the diffusion-limited binding rate provides an
upper bound of the binding rate, which is achieved only if the protein can rapidly undergo folding
transition upon nonspecific binding. This limit corresponds to the case of induced folding. In
contrast, conformational selection arises in the limit of slow conformational transitions and ac-
tually defines the lower bound of the binding rate. Interestingly, existing experimental binding
rates show that IDPs bind no slower than globular proteins172. This suggests that IDPs are able to
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overcome the kinetic bottleneck of folding and achieve rates near or at the diffusion limit. This
is consistent with the notion that induced folding is the prevalent mechanism for coupled binding
and folding of IDPs. A key question is then how IDPs manage to fold so rapidly upon nonspecific
binding, often at rates beyond the traditional folding speed limit. The constraint of rapid folding
could explain why the interaction motifs of IDPs are usually short and often fold into simple
topologies with low contact orders upon binding. Furthermore, it is likely that IDPs (and their
binding targets) may exploit additional physical properties to achieve rapid folding. For example,
previous studies of IDP interactions30 and protein-DNA interactions250,251 have suggested that
long-range electrostatic interactions may play an important role.
While it is encouraging that simple models derived from the folded complex topology can reliably
predict important features of coupled binding and folding, several inherent limitations of such
models should not be overlooked. For example, topology-derived models can not faithfully
describe specific details of the unbound states, particularly non-native-like residual structures252,
or properly model the encounter complexes, a critical step that often involve transient nonspe-
cific contacts31,32. Importantly, non-native interactions can play an important role in stabilizing
nonspecific encounter complexes and/or folding intermediates, leading to nontrivial consequences
in binding and folding pathway and kinetics253,254. Given the prevalence of charges in IDPs,
long-range electrostatic interactions do not only modulate the conformational properties of the
unbound states188,255, but can also play a key role in the binding and folding interactions30. Explicit
charges could be introduced into the conventional topology-derived models to account for long-
range electrostatic interactions99,256. Nonetheless, even though more sophisticated Go¯-like models
might be exploited96, contributions of specific yet non-native interactions are not encoded in the
topology per se and can not be expected to be properly accounted for in topology-based modeling
in general. It is also important to emphasize that detail characterization of disordered protein states
and transient structures represent a broader challenge beyond topology-based modeling. Due to
the heterogeneous and dynamic nature of such states, experiments alone generally do not provide
sufficient restraints for unambiguous determination of the unfolded ensembles37,53,155. Arguments
79
can be made that de novo molecular simulations are necessary to provide the missing structural
detail of free IDPs1,72,169, even though such simulations are limited by both sample capability
and force field accuracy. At present, only small free IDPs could be modeled using physics-based
force fields with reasonable reliability, and direct simulations of the coupled binding and folding
processes are largely out of reach. As such, it is important to tightly integrate hypothesis-driven
topology-based modeling, physics-based de novo simulation, and various biochemical and bio-
physical characterizations to obtain better understanding of how the structure and interaction of
IDPs are precisely controlled and regulated.
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3.5 Supplemental Materials
Figure S3.1: Residue-residue intra-molecular contact maps of ACTR and NCBD in the complex. The
contact maps are derived from the PDB:1kbh, model 1. The solid bars mark the locations of helical
segments formed in the complex. Figure prepared by DG.
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Table S3.1: All 76 native intermolecular contacts identified from PDB:1kbh, model 1. Residues 1 - 47
correspond to ACTR residues 1040 - 1086, and residues 48 - 106 correspond to NCBD residues 2059 -
2117. Table prepared by DG JC.
Contacting Residues ij (kcal/mol) Contacting Residues ij (kcal/mol)
GLU 01 ILE 52 0.514847 ALA 22 SER 68 0.316466
GLU 01 GLN 85 0.223573 THR 23 SER 69 0.308593
GLN 03 GLN 85 0.242466 LEU 25 LEU 64 1.160374
SER 04 ARG 50 0.255062 LEU 25 PHE 90 1.146204
ASP 05 ARG 50 0.36055 LEU 25 ARG 94 0.634506
ASP 05 SER 51 0.256636 GLU 27 GLN 74 0.223573
GLU 06 ARG 50 0.357402 ILE 28 VAL 76 0.952546
GLU 06 SER 51 0.233019 ILE 28 LEU 77 1.108417
LEU 09 SER 51 0.617187 ILE 28 LEU 80 1.108417
LEU 09 SER 53 0.617187 ILE 28 PHE 90 1.076928
LEU 09 LEU 57 1.160374 ASP 29 PHE 90 0.547911
LEU 10 GLN 85 0.63608 ASP 29 ARG 94 0.36055
LEU 10 LEU 86 1.160374 ASP 29 TYR 98 0.43455
LEU 10 ALA 89 0.773058 ALA 31 LEU 77 0.773058
GLN 12 LEU 57 0.63608 LEU 32 LEU 77 1.160374
GLN 12 LEU 61 0.63608 LEU 32 MET 87 1.009226
LEU 13 SER 53 0.617187 LEU 32 PHE 90 1.146204
LEU 13 ALA 56 0.773058 LEU 32 ILE 91 1.108417
LEU 13 LEU 60 1.160374 ILE 34 PHE 90 1.076928
LEU 13 LEU 61 1.160374 ILE 34 ILE 91 1.029694
LEU 13 LEU 86 1.160374 ILE 34 ARG 94 0.571528
HSD 14 LEU 86 0.714803 ILE 34 THR 95 0.634506
HSD 14 ALA 89 0.379444 ILE 34 TYR 98 0.826589
LEU 16 LEU 61 1.160374 PRO 35 TYR 98 0.502251
LEU 16 LEU 64 1.160374 LEU 37 ILE 91 1.108417
LEU 16 LYS 65 0.530592 LEU 37 THR 95 0.683314
LEU 17 LEU 60 1.160374 VAL 38 THR 95 0.544762
LEU 17 LEU 64 1.160374 VAL 38 TYR 98 0.727399
LEU 17 VAL 76 1.020248 VAL 38 VAL 99 0.8691
LEU 17 LEU 80 1.160374 ASN 39 MET 105 0.464465
LEU 17 LEU 86 1.160374 GLN 42 LYS 92 0.203105
LEU 17 PHE 90 1.146204 GLN 42 THR 95 0.299147
SER 18 GLN 93 0.234594 ALA 43 THR 95 0.365274
SER 18 ARG 94 0.255062 ALA 43 ALA 96 0.428252
ASN 19 LEU 64 0.588847 ALA 43 VAL 99 0.63608
ASP 21 ARG 94 0.36055 LEU 44 GLN 106 0.63608
ASP 21 LYS 97 0.264509 GLU 45 LYS 92 0.283402
ALA 22 LEU 64 0.773058 LYS 47 LYS 92 0.018893
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Table S3.2: Summary of all 11 production simulations at 315 K. The average fraction of the unbound state
is above 0.5, indicating that Tm is actually slightly below 315 K. The five initial bound (b1 to b5) and
unbound (u1 to u5) conformations are shown in Figure S3.2a. Table prepared by DG.
Initial Conformation Time (µs) Ntrans Pub
1kbh Model 1 30 26 0.62
1100.pdb (b1) 30 29 0.5
6200.pdb (b2) 30 23 0.73
6800.pdb (b3) 30 21 0.6
700.pdb (b4) 30 16 0.69
7200.pdb (b5) 30 26 0.55
15230.pdb (u1) 30 29 0.61
4200.pdb (u2) 30 20 0.8
2900.pdb (u3) 30 20 0.78
19113.pdb (u4) 30 30 0.65
23510.pdb (u5) 30 28 0.62
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Figure S3.2: (A) Five bound and five unbound conformations randomly selected from the REX calibration
simulation using the final calibrated sequenced-flavored Go¯-like model. NCBD is shown in purple trace
and ACTR in cyan. (B) Representative time traces of the fractions of inter- and intra-molecular contacts
from one of eleven independent 30-µs production simulations at Tm = 315 K. Figure prepared by DG WZ.
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Figure S3.3: (A) The PMFs as functions of Qinter with three of scaling values of the intermolecular
interaction strength searched during model calibration. (B) The heat capacity as a function of temperature.
The curves were calculated from various segments of a 4.9-µs REX simulation of the NCBD/ACTR
complex using the final calibrated model. The simulation appears to reasonably converged after 4 µs.
Figure prepared by DG WZ.
Figure S3.4: The RMSF profiles of NCBD and ACTR in the bound state at 300 K. These profiles were
calculated from a 1-µs simulation of the folded complex using the final calibrated model.Figure prepared
by DG.
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Figure S3.5: Distributions of the fractions of intra-molecular contacts of various ACTR and NCBD helical
segments in the unbound, intermediate and bound states. See the main text for the state assignment criteria.
Figure prepared by DG.
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Figure S3.6: Distributions of the distances and cross-angles between NCBD helices in the unbound,
intermediate and bound states. The helix-helix distances were calculated as the distances between the
Cα atoms at the middle of the helices. See the main text for the state assignment criteria. Figure prepared
by DG.
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Figure S3.7: CSN of the synergetic folding of NCBD and ACTR, constructed by including the most
populated 200 nodes and additional 300 nodes from the transition paths. The nodes are colored in the
same fashion as in Figure 3.9 of the main text.
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Chapter 4
Electrostatically Accelerated Encounter and Folding
for Facile Recognition of Intrinsically Disordered
Proteins∗
Abstract
Achieving facile specific recognition is essential for intrinsically disordered proteins (IDPs) that
are involved in cellular signaling and regulation. Consideration of the physical time scales of
protein folding and diffusion-limited protein-protein encounter has suggested that the frequent
requirement of protein folding for specific IDP recognition could lead to kinetic bottlenecks. How
IDPs overcome such potential kinetic bottlenecks to viably function in signaling and regulation in
general is poorly understood. Our recent computational and experimental study of cell-cycle reg-
ulator p27 (Ganguly et al., J. Mol. Biol. (2012)) demonstrated that long-range electrostatic forces
exerted on enriched charges of IDPs could accelerate protein-protein encounter via “electrostatic
steering” and at the same time promote “folding-competent” encounter topologies to enhance the
efficiency of IDP folding upon encounter. Here, we further investigated the coupled binding and
folding mechanisms and the roles of electrostatic forces in the formation of three IDP complexes
with more complex folded topologies. The surface electrostatic potentials of these complexes
lack prominent features like those observed for the p27/Cdk2/cyclin A complex to directly sug-
gest the ability of electrostatic forces to facilitate folding upon encounter. Nonetheless, similar
∗Reprinted under the Creative Commons Attribution (CC BY) license. D. Ganguly, W. Zhang and J. Chen (2013),
“Electrostatically Accelerated Encounter and Folding for Facile Recognition of Intrinsically Disordered Proteins.”
PLoS Comput. Biol. 9(11): e1003363. doi:10.1371/journal.pcbi.1003363.
Author Contributions: Conceived and designed the experiments: JC DG WZ. Performed the experiments: DG WZ
JC. Analyzed the data: DG WZ JC. Contributed reagents/materials/analysis tools: DG WZ JC. Wrote the paper: DG
WZ JC.
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electrostatically accelerated encounter and folding mechanisms were consistently predicted for
all three complexes using topology-based coarse-grained simulations. Together with our previous
analysis of charge distributions in known IDP complexes, our results support a prevalent role
of electrostatic interactions in promoting efficient coupled binding and folding for facile specific
recognition. These results also suggest that there is likely a co-evolution of IDP folded topology,
charge characteristics, and coupled binding and folding mechanisms, driven at least partially by
the need to achieve fast association kinetics for cellular signaling and regulation.
90
4.1 Introduction
Cellular signaling and regulation are frequently mediated by proteins that, in part or as a whole,
lack stable structures under physiological conditions3,146,147. Such intrinsically disordered proteins
(IDPs) are highly prevalent in proteomes12 and over-represented in diseases pathways15,17. For
example, nearly one-third of eukaryotic proteins have been predicted to contain extended disor-
dered regions257, and about 25% of disease-associated missense mutations can be mapped into
predicted disordered regions18 (although cancer mutations appear to prefer ordered regions16).
The prevalence of intrinsic disorder suggests that protein conformational heterogeneity could
provide crucial functional advantages, for which many concepts have been proposed20,23,24,166,224.
Understanding the physical basis of how intrinsic disorder mediates protein function (and how
such functional mechanism may fail in human diseases258) is of fundamental significance and has
attracted intense interests in recent years35. Important progresses have been made on character-
izing the conformational properties of unbound IDPs and determining how these conformational
properties contribute to efficient and reliable interactions1,26,35,52,160,259,260.
A key recent recognition is that frequent requirement of protein folding for specific recognition of
IDPs could lead to kinetic bottlenecks34,173,261. As predicted by the dual-transition-state theory173,
the diffusion-limited encounter rate constant represents the upper bound for that of a coupled
binding and folding interaction. Importantly, the upper bound can be achieved only if the IDP
readily folds upon encounter, which requires folding rates on the order of 10 µs−1 or greater173.
That is, IDPs need to achieve folding rates beyond the typical µs−1 “speed limit” estimated for
folding of isolated proteins249 to maximize association kinetics. Therefore, the putative functional
advantages of intrinsic disorder, especially structural plasticity for specific interactions with nu-
merous partners22, come with a potential cost of slow binding kinetics. Such kinetic bottleneck
must be resolved for IDPs to be viable in cellular signaling and regulation. Interestingly, a recent
survey of binding kinetic data revealed that IDP binding was not systematically slower than that of
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globular proteins172. The implication is that most IDPs do manage to fold rapidly upon nonspecific
binding, and this is apparently consistent with the accumulating observations that IDP coupled
binding and folding tends to follow induced folding-like baseline mechanisms (i.e., bind then
fold)26,35. Several factors could contribute to efficient folding of IDPs upon binding, in particular
small interacting (and folding) domains and simple folded topologies with low contact orders.
There also appears to be a delicate balance between pre-folding and conformational flexibility
that allows an IDP to quickly fluctuate among accessible conformational states, especially upon
encounter35,205,262. Nonetheless, it is not yet clear how in general IDPs may achieve fast folding at
rates beyond the traditional µs−1 folding “speed limit” upon encountering their specific targets.
An important characteristics of IDPs is that they are enriched with charged and polar residues263.
Electrostatics can thus be expected to play key roles in IDP structure and function. For exam-
ple, the charge content can modulate compaction and other conformational properties of free
IDPs188,264; DNA search efficiency is controlled by charge composition and distribution in disor-
dered tails of DNA-binding proteins250,251. It has been also observed or speculated in a few cases
that electrostatics might be important for fast IDP recognition265–268. However, these discussions
have been often based on the classic electrostatic steering effects209, and the actual underlying
mechanisms of putative electrostatic acceleration were not known. Our recent computational and
experimental study of the p27-Cdk2/cyclin A interaction revealed that long-range electrostatic
forces could promote facile IDP recognition via an “electrostatically accelerated encounter and
folding mechanism”261. Specifically, the measured p27/Cdk2/cyclin A association rate constants
showed a strong salt-dependence, increased ∼12 fold when the ionic strength was reduced from
0.6 to 0.075 M. However, the salt-dependence is poorly described by an approximate Debye-
Hu¨ckel relation269 that mainly captures the electrostatic steering effects. Instead, simulations
using a series of topology-based coarse-grained models suggested that long-range electrostatic
forces exerted on a large number of charges on p27 did not only accelerate the encounter rate
(via the classical electrostatic steering effect209), but enhance the efficiency of p27 folding upon
encounter by promoting native-like encounter topologies.
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Analysis of surface charges in a set of existing IDP complexes further revealed that the vicinity
of IDP binding sites tended to be enriched with charges to complement those on IDPs261 (even
though the IDP binding interface itself is more hydrophobic than the rest of the protein surface
as previously observed21). Electrostatic forces are known to be a dominant long-range force that
can guide protein orientation in protein-DNA interactions270,271 and/or modulate early stages of
protein folding99,272,273. One implication of enriched charges near IDP binding sites is thus that the
electrostatically accelerated encounter and folding mechanism observed for p27 may be prevalent
in signaling and regulatory IDPs. Nonetheless, the ability for long-range electrostatic forces to
enhance folding upon binding can be surprising, as nonspecific interactions (electrostatic or van
der Waals) have been generally expected to accelerate binding but slow down folding253,274. It has
also been predicted that, while inter-chain electrostatic interactions facilitate binding of disordered
chaperone Chz1 to histone variant H2A.Z-H2B, intra-chain electrostatic interactions could lead to
premature collapse of Chz1 under low salt conditions and hinder the overall rate of forming the
specific complex275.
In the present work, we investigated the recognition mechanisms and the roles of long-range
electrostatic interactions in forming of three IDP complexes, namely, p53-TAD1/TAZ2, HIF-
1α/TAZ1, and NCBD/ACTR (Table 4.1). All these complexes have important biological func-
tions. For example, tumor suppressor p53 is considered one of the most important proteins in
cancer276; NCBD and TAZ1/2 are key regulatory domains of CBP, a key component of the general
transcriptional machinery that plays critical roles in cell fate regulation190. For understanding
IDP recognition, these systems involve more complex folded topologies than that of p27 in the
p27/Cdk2/cyclin A complex. As shown in Figure 4.1, both HIF-1α/TAZ1 and NCBD/ACTR
possess extensive binding interfaces, whereas the binding interface in p53-TAD1/TAZ2 is more
localized. Importantly, while strong charge complementary exists near the binding interface (as
expected), the surface electrostatic potentials of the folded substrates do not show prominent
features like those observed on Cdk2/cyclin A (e.g., see Figure 1 of reference261) to directly
suggest that long-range electrostatic forces could promote native-like (and thus more folding-
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Table 4.1: Key properties of three IDP complexes.∗
Namea Length KDb kon(M−1s−1) PDB IDP Fold Chargesc
p53-TAD1/TAZ2 39/90 2.7µM277 ∼108 d 2k8f helix/loops 8(-6),9(+9),4(+2)
HIF-1α/TAZ1 51/99 7nM278 1.3×109 279 1l8c helices/loops 11(-5),11(+7),10(+5)
NCBD/ACTR 59/47 34nM194 3.0×107 280 1kbh helices (both IDPs)
*. Data of p53-TAD1/TAZ2 and HIF-1α/TAZ1 are obtained by DG.
a. Abbreviations: ACTR: the activation domain of p160 steroid receptor co-activator; HIF-1α:
hypoxia-inducible factor 1 α subunit; NCBD: the nuclear-receptor co-activator binding domain
of CREB binding protein (CBP); p53-TAD1: the transactivation domain 1 of tumor suppressor
p53; TAZ1/2: the TAZ domains of CBP. The sequences of all IDPs involved (highlighted in bond
fonts) are provided in the Supporting Information.
b. The experimental KD values were measured at 308 K for p53-TAD1/TAZ2, 298 K for
HIF-1α/TAZ1, and 304 K for NCBD/ACTR. Note that KD only weakly depends on temperature
for p53-TAD1/TAZ2 (doubled when the temperature is increased from 288K to 308K277).
c. Numbers of charged residues and the net charges (in parentheses) of the IDP, its binding site,
and the vicinity of the binding site. Residues at the IDP binding interface are identified as those
with greater than 1.0 A˚2 solvent accessible surface area changes upon complex formation. Surface
residues are identified as those with >5% solvent accessibility. All surface residues within 15
A˚ Cα-Cα distance from the bound IDP but not directly involved in intermolecular contacts are
considered to be within the vicinity of the IDP binding site.
d. Estimated based on the association rate constant of p53-TAD2/TAZ2 ( 1010 M−1s−1 265),
assuming that TAD1 and TAD2 have similar off rates. TAD2 binds to the TAZ2 primary site with
KD 32 nM265, about two orders of magnitude stronger than TAD1.
competent) encounter complexes. The NCBD/ACTR complex involves synergistic folding of
two IDPs and thus offers a particularly interesting opportunity to understand whether and how
electrostatic interactions may modulate the formation of nontrivial folded topologies. Amazingly,
all three complexes associate with on-rates in excess of 107 M−1s−1 (see Table 4.1), a regime
that is typically considered “diffusion-limited” and can only be accessed in the limit of ultrafast
conformational transitions209.
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Figure 4.1: Structures and surface electrostatic potentials of three complexes. (A) p53-TAD1/TAZ2, (B)
NCBD/ACTR, and (C) HIF-1α/TAZ1. TAZ2, NCBD and TAZ1 are shown in molecular surface and
colored based on the surface electrostatic potential calculated using PBEQ module of CHARMM281,282.
Red indicates negative and blue indicate positive charge. p53-TAD1, ACTR and HIF-1α are shown in
cartoons, with charged side chains shown in stick. Figure (A) and (C) are prepared by DG.
4.2 Results
4.2.1 Topology-based modeling of IDP coupled binding and folding
Series of topology-based coarse-grained models were first derived based on the complex struc-
tures to allow direct simulation of reversible binding and folding with tractable computational
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cost. Topology-based modeling is based on the theoretical framework of minimally frustrated
energy landscapes for natural proteins98, and has been highly successful in predicting essential
features of protein folding mechanisms97,98,283. Formation of stable IDP complexes such as those
studied in this work should also satisfy minimal frustration, and thus topology-based modeling is
applicable. Indeed, it has been successfully applied to several IDP complexes33,92,93,163,165, with
many key predictions substantiated by independent experimental studies. Nonetheless, important
differences do exist between IDPs and structured proteins in sequence compositions and binding
interface characteristics21. We have previously demonstrated that traditional topology-based mod-
els need to be carefully calibrated to ensure proper balance among competing intramolecular and
intermolecular interactions (see Methods for detail on the calibration protocol)62. We note that
the importance of model calibration was also illustrated in a recent study of the HIF-1α/TAZ1
complex92.
Table 4.2 summarizes the final calibrated models for all three complexes. The calculated resid-
ual helicity distributions of the unbound states are show in Figure S4.1. Three independent
models were constructed for each complex: one without explicit charges (mimicking high salt
concentration with fully screened long-range electrostatic interactions), one with explicit charges
(mimicking low salt concentration with unscreened long-range electrostatic interactions), and a
third one with explicit charges and 0.05 M salt (mimicking physiological conditions). All models
reproduce the experimental KD to the same order of magnitude, except that the no charge model
for HIF-1α/TAZ1 yields a KD value about one order of magnitude too large. We note that
calculated KD values can be very sensitive to small changes of in the scaling of intermolecu-
lar interactions during model calibration (see Methods). It is computationally expensive to use
REX simulations to systematically search for the parameter space, especially for models without
explicit charges due to slower transitions. Nonetheless, by performing production simulations
at the corresponding melting temperatures, remaining imperfections in the balance of various
interactions should be further suppressed, allowing reliable comparative studies of the mechanistic
roles of electrostatic interactions in coupled binding and folding.
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Table 4.2: Dissociation constants, melting temperatures, average reversible coupled binding and folding
transition rates calculated using various coarse-grained models with and without explicit charges and/or
0.05 M salt.
Models Calc. KD Tm kTS kcap kesc kevo
(K) (ms−1) (ns−1) (ns−1) (ns−1)
TAD1/TAZ2
No charge 1.4 ± 2.0 µM 327 4.3 ±1.5 1.4 8 0.049
Charged, 0.05M salt 1.6 ± 1.6 µM 340 14.5 ± 1.1 3.2 4.1 0.08
Explicit charges 4.9 ± 3.2 µM 335 27.0 ± 0.2 32.1 0.1 0.16
HIF-1α/TAZ1
No charge 64 ± 64 nM 327 6.1 ± 0.5 2.8 6.3 0.022
Charged, 0.05M salt 9.4 ± 9.6 nM 340 10.2 ± 1.8 3.4 5.6 0.039
Explicit charges 1.3 ± 1.6 nM 345 29.4 ± 3.7 5 0.69 0.048
NCBD/ACTR
No charge 67 ± 99 nM 318 0.53 ± 0.2 0.13 0.61 0.0043
Charged, 0.05M salt 96 ± 92 nM 315 1.7 ± 0.1 0.29 0.31 0.0074
Explicit charges 39 ± 14 nM 322 5.2 ± 0.7 0.79 0.02 0.012
KD was calculated from REX simulations at 300 K(see Table 4.1 for the experimental values);
kTS was calculated from the production Langevin simulations at the corresponding Tm, as kTS =
NTS/ttot, where NTS is the number of reversible binding and folding transitions observed during
the total simulation time span ttot. As all simulations were performed at Tm, kTS as defined
is half of the binding and unbinding rates. kcap, kesc and kevo are defined in Equation 4.1-4.4.
The effective concentrations of these simulations are 1.66 mM, 1.66 mM and 1.43 mM for p53-
TAD1/TAZ2, HIF-1α/TAZ1 and NCBD/ACTR, respectively. All uncertainties were estimated as
the differences between results calculated from the first and second halves of the data. Data of
p53-TAD1/TAZ2 and HIF-1α/TAZ1 are obtained by DG.
97
4.2.2 Baseline mechanisms of coupled binding and folding: effects of electrostatic forces
Free energy surfaces were constructed using various combinations of folding and binding order
parameters to understand the baseline mechanisms of coupled binding and folding and to dissect
the effects of long-range electrostatic forces. In particular, the fractions of native contacts formed
have been shown to provide natural reaction coordinates for such mechanistic analysis237. Figure
4.2 compares the free energy surfaces as a function of intra- and inter-molecular native contact
factions for all three complexes, calculated using calibrated Go¯-like models with and without
explicit charges and/or salt (see Table 4.2). Both p53-TAD1 and HIF-1α recognitions follow
induced folding-like mechanisms, where the peptides only gain structures after forming significant
numbers of native intermolecular contacts. For example, Figure 4.2A shows that p53-TAD1 does
not start to fold until Qinter reaches ∼0.5. Free NCBD is a molten globule with folded-like sec-
ondary structures199, and its synergistic folding with ACTR has been previously shown to involve
multiple stages of selection and induced folding34,163, reminiscent of the “extended conformational
selection” mechanism205. Nonetheless, neither protein gains significant secondary (for ACTR) or
tertiary (for NCBD) structures until over 20% of native intermolecular contacts are formed (Figure
4.2 G and J).
Interestingly, formation of all three complexes involves intermediates, even though the inter-
mediate in p53-TAD/TAZ2 interaction only become pronounced in the presence of nonspecific
electrostatic forces (see Figure 4.2 A vs. C). Detailed examination of the simulation trajectories
and various free energy surfaces using fractions of native contacts formed by different IDP seg-
ments (e.g., see Figure S4.2-S4.4) revealed the existence of multiple parallel pathways for forming
HIF-1α/TAZ1 and NCBD/ACTR. While these mechanistic details are not the focus of the current
work, they appear to be highly consistent with previous experimental and computational studies.
For example, as shown in Figure S4.2, both the first and third helices of HIF-1α could initiate
recognition, with the pathway initiated by the third helix binding being much more prevalent.
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Similar observations were also made in a separate computational study92. Specific recognition of
NCBD/ACTR appears to be primarily initiated by the C-terminal segments of these two peptides
(Figure S4.3-S4.4), which forms a key intermediate that was also suggested by an H/D exchange
mass spectrometry study58. Kinetic data from a recent stop-flow study of the NCBD/ACTR
interaction280 are consistent with the prediction of induced folding as a baseline mechanism and
have further confirmed the existence of parallel pathways and multiple folding intermediates.
Representative snapshots along the dominant binding and folding pathways of p53-TAD1/TAZ2
and HIF-1α/TAZ1 are shown in Figure S4.5-S4.6.
Explicit inclusion of charges does not significantly perturb the baseline mechanisms of coupled
binding and folding. As shown in Figure 4.2 and Figure S4.2-S4.4, long-range electrostatic forces
do not lead to fundamental changes in any of the free energy surfaces examined. The baseline
mechanisms for the formation of all three complexes remain induced folding-like. Furthermore,
nonspecific electrostatic interactions do not change the relative prevalence of the parallel pathways
that exist. For example, HIF-1α still initiates binding mainly through the third helix (Figure
S4.2); synergistic folding NCBD and ACTR is still mainly initiated through their C-terminal
segments (Figure S4.3-S4.4). The key effect of electrostatic forces appears to be substantial
reductions in the free energy barriers that separate various basins. That is, even under the no
salt condition, strong nonspecific electrostatic interactions do not appear to add to the ruggedness
of coupled binding and folding free energy surfaces. An implication is that there exists a level of
self-consistency between the charge distribution and folded topology in the bound states, despite
a lack of apparent complementary between folding topologies and surface electrostatic potentials
for these IDP complexes (see Figure 4.1).
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4.2.3 Kinetic effects of long-range and nonspecific electrostatic forces
Kinetics of coupled binding and folding was derived directly from production Langevin dy-
namics simulations performed using the calibrated Go¯-like models at their corresponding Tm.
The results, summarized in Table 4.2, show that long-range electrostatic forces accelerate the
reversible binding/unbinding transition rates for all three complexes. The overall electrostatic
acceleration, estimated by comparing the average transition rates (kTS) calculated using models
with and without explicit charges, ranges from ∼5 fold for HIF-1α to 10 fold for NCBD/ACTR.
The magnitude of acceleration is similar to what was previously measured for other IDPs including
p27261 and PUMA267 (both ∼10 fold). The presence of 0.05 M salt significantly attenuates the
predicted electrostatic acceleration, to only about two fold. However, the effect of salt screening
on electrostatic acceleration is likely over-predicted261, which is due to the Cα-only model used in
this work and may be corrected with more detailed protein models99. Consistent with the kinetic
analysis, there are significant reductions in the free energy barriers along Qinter (see Figure 4.3),
which has been shown to be a good binding reaction coordinate62. In addition, the magnitude
of barrier reduction correlates well with the degree of rate acceleration calculated directly from
Langevin dynamics simulations, with the largest barrier reduction observed for NCBD/ACTR and
the smallest reduction observed from HIF-1α/TAZ1.
To further analyze the effects of electrostatic interactions on different stages of coupled binding
and folding, the recognition process was divided into two generic steps, including an encounter
step followed by an evolving (folding) step to final bound and folded state (Equation 4.1 in
Methods). Such generic decomposition ignores the details of IDP-specific folding pathways, to
allow on to focus on the net effects of electrostatic forces on the overall efficiency of IDP folding
upon encounter. For this, three general states were identified during production simulations,
including the unbound (U), collision complex (CC), and bound (B) states (see Methods for specific
criteria for state assignment). The mean first passage times (MFPT) and numbers of transitions
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(Ntrans) among these states were then calculated. The results, summarized in Table S4.1-S4.3,
show that long-range electrostatic forces greatly reduce the average encounter time, from 0.72 to
0.03 ns for p53-TAD, from 0.37 to 0.20 ns for HIF-1α, and from 7.71 to 1.26 ns for NCBD. At the
same time, long-range electrostatic forces also significantly enhance the efficiency of IDP folding
upon encounter, allowing much larger fractions of the encounter complexes to eventually evolve to
the bound states. For example, for NCBD/ACTR, only 16 out ∼2300 encounter events evolved to
the bound state in absence of long-range electrostatic forces (0.7%); whereas with explicit charges,
there was ∼37% probability (108 out of 288) of forming the specific complex once the proteins
were captured into the collision complex state (Table S4.3). For the HIF-1α/TAZ1 complex, the
percentages of collision to specific complex transition are 0.4% without and 7% with explicit
charges (Table S4.2); for p53-TAD1/TAZ2, the production percentages are 0.6% without and 60%
with explicit charges (Table S4.1). It should be emphasized that nonspecific electrostatic interac-
tions significantly stabilize the collision complexes, due to large and complementary net charges
of the interacting proteins (see Table 4.1). As such, much fewer fully unbinding events were
observed during production simulations using the charged models. This effect also led to more
reversible transitions between the bound and collision complex states and thus an overestimation
of the true folding efficiency of IDPs upon collision as estimated above. We also note that the
collision complexes as defined in our analysis were not intended to represent so-called “encounter
complexes” that have been often considered key intermediates of protein-protein association284,
although encounter complexes are also believed to be mainly stabilized by nonspecific electrostatic
interactions.
The enhanced apparent efficiency of folding upon encounter appears to be frequently achieved
at the cost of longer folding times. For example, the MFPTs of transitions from the collision
complexes to the bound states increase from 0.26 to 3.94 ns for the p53-TAD1/TAZ2 complex
(Table S4.1) and from 8.14 to 44.56 ns for the NCBD/ACTR complex (Table S4.3). The net effects
on the kinetics of encounter and folding stages can be quantified by calculating three effective rate
constants as defined in Equation 4.2-4.4 (see Methods)172. The results, summarized in Table 4.2
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and plotted in Figure 4.4, clearly demonstrate that nonspecific electrostatic interaction enhance the
encounter rates and reduce the escape rates of the collision complexes. Importantly, the effective
evolution rates are always faster, by about three fold, in the presence of long-range electrostatic
forces, despite longer MFPTs for the transitions from the collision complexes to the bound state
observed for the p53-TAD1/TAZ2 and NCBD/ACTR complexes. The magnitude of electrostatic
acceleration of folding upon encounter is similar to what was previously observed for folding and
binding of p27 to the Cdk2/cyclin A complex261.
4.2.4 Mechanism of electrostatically accelerated folding upon encounter
Inspection of the conformational properties of the collision complexes provides further insights
into the molecular basis for enhanced efficiency of IDP folding upon encounter due to long-range
electrostatic forces. As shown in Figure 4.5, without nonspecific electrostatic interactions (models
without explicit charges), the initial contacts between two binding partners are largely random, and
the distributions of IDP initial contact points on the substrate surface in the collision complexes
are relatively uniform (left column). In contrast, with the inclusion of explicit charges, the
probabilities of IDP encountering near the native binding interface are dramatically increased.
Coupled with reduced escape rates, this allows much higher efficiency of IDP folding upon en-
counter to achieve higher overall association rate constants (Table 4.2). The ability of long-range
electrostatic forces to guide the recognition process is also reflected in the free energy surfaces
as a function of binding RMSD of the IDP and center of mass separation between two peptides.
As shown in Figure 4.6, long-range electrostatic forces generate a strong free energy gradient
that extends over 10-15 A˚ away from the native bound positions, without creating over-stabilized
misfolded states at short separation distances. It is intriguing that, even though both NCBD and
ACTR are disordered in the unbound state, nonspecific long-range electrostatic forces between
complementary charges on these two proteins can still manage to promote native-like topologies
in the collision complexes. In particular, there is a much higher probability of NCBD and ACTR
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initiating contacts via the C-terminal helix of NCBD and the second helix of ACTR (Figure 4.5
E-F). This is part of a key pathway of synergistic folding inherent to the NCBD/ACTR complex
that was predicted by coarse-grained and atomistic simulations34,163 and later substantiated by
H/D exchange mass spectrometry58. Therefore, nonspecific electrostatic interactions appear to
mainly augment existing folding pathways inherent to the folded topologies to facilitate efficient
folding of IDPs upon encounter. Coupled with the previous observation that the vicinity of the
IDP binding site tends to be enriched with charges to complement those on IDPs261, the current
results suggest that there is likely a co-evolution of IDP folded topology, charge characteristics,
and coupled binding and folding mechanisms. Furthermore, the co-evolution is likely driven by
the important need to achieve facile IDP recognition for cellular signaling and regulation.
4.3 Discussion
While fulfilling important functional constraints such as structural plasticity for binding numerous
specific targets, protein intrinsic disorder can lead to potential kinetic bottlenecks to be viable in
cellular signaling and regulation. Our previous work on the p27/Cdk2/cyclin A complex has
revealed a mechanism where nonspecific electrostatic interactions not only enhance the protein-
protein encounter kinetics but also promote folding-competent encounter topologies to increase
the efficiency of IDP folding upon encounter261. Using carefully calibrated topology-based coarse-
grained models, we have now further demonstrated that similar electrostatically accelerated en-
counter and folding mechanisms also underlie the formation of three IDP complexes with more
complexed folded structures, namely, p53-TAD1/TAZ2, HIF-1α/TAZ1, and NCBD/ACTR. Im-
portantly, these complexes lack apparent features on the electrostatic surface potentials to directly
suggest the ability of nonspecific long-range electrostatic forces to promote native-like encounter
topologies to enhance the IDP folding efficiency upon encounter. Nonetheless, there seems to exist
a sufficient level of self-consistency between the charge distributions and folded topologies in the
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bound state to allow accelerated recognition in presence of nonspecific electrostatic interactions.
Therefore, enriched charges on IDPs not only play key roles in modulating the conformational
properties of the unbound state, but also likely play general and important roles in regulating
efficient interactions of IDPs with specific partners. We note that IDPs are frequently regulated by
post-translational modifications that add or remove charges. Improved mechanistic understanding
of electrostatic forces in IDP recognition derived from the current work will thus help to dissect
the profound impacts of post-translational modifications and disease-related mutations on IDP
structure and interaction.
4.4 Methods
4.4.1 Calibration of topology-based coarse-grained models with and without explicit charges
Cα-only sequence-flavored Go¯-like models232 were first derived from the complex structures of
p53-TAD1/TAZ2, HIF1-α/TAZ1 and NCBD/ACTR (see Table 4.1) using the Multiscale Modeling
Tools for Structural Biology (MMTSB) Go¯-Model Builder (http://www.mmtsb.org)215. The 3
zinc ions bound to TAZ1 in the HIF1-α/TAZ1 complex were modeled explicitly with distance
restraints to the coordinating residues. All three models were then calibrated to balance the
intrinsic folding propensity and the strength of intermolecular interactions using a previously
described protocol62. Briefly, the strengths of intra-molecular native contact were uniformly
scaled to reproduce the experimentally measured residual helicity of unbound IDPs, which are
mainly based on NMR secondary chemical shift and/or circular dichroism analysis (p53-TAD1285,
NCBD/ACTR199, and HIF1-α278). The residual helicity distributions calculated using the final
models listed in Table 4.2 are provided in Figure S4.1. Then, the strengths of intermolecular
contacts were adjusted, such that binding affinities calculated from replica exchange molecular
dynamics (REX-MD) simulations approximately match the experimental values (see Table 4.1).
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Following the previously described procedure261, the calibrated sequence-flavored Go¯-like models
were then further modified by assigning proper explicit charges to all charged residues (Lys, Arg,
Glu and Asp) as well as zinc ions in the HIF1-α/TAZ1 complex. The charged models were then
re-calibrated to reproduce the experimental residual structure level (Figure S4.1) and binding
affinity (Table 4.2). Such calibration is critical to avoid inherent bias for particular types of
interactions, e.g., intra- vs. inter-molecular or native vs. nonspecific electrostatic. Nonspecific
electrostatic interactions were modeled using the Debye-Hu¨ckel potential to account for ionic
screening. The dielectric constant was set at 80.
4.4.2 Simulation protocols
The complexes were simulated in cubic boxes with periodic boundary conditions imposed in
CHARMM63,216. The box sizes are 100, 100 and 105 A˚ for p53-TAD1/TAZ2, HIF-1α/TAZ1
and NCBD/ACTR, respectively. Langevin dynamics was performed with 15 fs time steps and a
friction coefficient of 0.1 ps−1. SHAKE was used to fix all virtual bond lengths217. Non-bonded
interactions were cut off at 25 A˚. Unbound IDPs were simulated at 300 K for 750 ns to calibrate the
intramolecular interactions. REX-MD was performed using the MMTSB Toolset215 for calibration
of the intermolecular interactions. For this, eight replicas spanning 270 to 400 K were used. The
lengths of REX calibration simulations ranged from 1.05 µs (for p53-TAD1/TAZ2) up to 10 µs (for
NCBD/ACTR), as needed for achieving sufficient convergence. Temperature weighted histogram
analysis method (WHAM)286 was used to compute the heat capacity (CV ) curves and generate
unbiased probability distributions for free energy and thermodynamic analysis. In particular, the
dissociation constants (KD) were calculated from the bound and unbound probabilities at 300
K62, where the unbound state was defined as the state without any native intermolecular contacts
formed. For NCBD/ACTR complex, the 1D free energy profile lack significant barriers between
the unbound and partially bound intermediate states (Figure 4.3C, red trace). Therefore, the
unbound probability was calculated as 1 - Pbound, where Pbound is the bound probability (see below
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for the specific criteria of state assignments). Once calibrated, production simulations of 30-40 µs
in lengths were performed using all models at the corresponding Tms (see Table 4.2). The Tm value
was first identified based on the CV curve and then fine tuned to ensure that similar probabilities
of sampling the bound and unbound states were observed in the production simulation.
4.4.3 Free energy and kinetic analysis
All free energy profiles were calculated from the REX simulations and the kinetic analysis was
performed based on the production simulations, unless otherwise stated. For calculation of contact
fractions, a given native contact was considered as formed if the inter-Cα distance was within
1.0 A˚ of the distance in the native complex. Nonspecific intermolecular contacts are considered
as formed when the inter-Cα distance is within 10 A˚ cutoff. Three general conformational
states were defined for each complex, including the unbound (U), collision complex (CC) and
bound (B) states, to understand the effects of electrostatic forces on protein-protein encounter and
subsequent folding upon encounter. The unbound state includes conformations with no specific or
nonspecific contacts formed between IDP and substrate, and the collision complex state includes
conformations with at least one nonspecific but no specific intermolecular contact formed. The
bound states are defined as following: 1) for p53-TAD1/TAZ2: Ninter ≥ 11; 2) for HIF-1α/TAZ1:
Ninter ≥ 26 for the no charge model, Ninter ≥ 23 for the charged model, and Ninter ≥ 24 for the
charged model with 0.05 M salt; 3) for ACTR/NCBD: Ninter ≥ 30. Ninter is the total number
of native intermolecular contacts formed. Note that slightly different criteria were used to define
the bound state of HIF-1α/TAZ1 due to small shifts of the bound free energy basins calculated
using different models (see Figure 4.3). 15-ps running averages were used for assigning states,
to avoid including fictitious transitions due to rapid small fluctuations in the calculated contact
counts (especially between the U and CC states). MFPTs and numbers of transitions among
all three states were derived from the production simulation trajectories, and various rates were
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calculated as defined in Equation 4.2-4.4.
U
kcap/kesc←−−−−→ CC kevo−−→ B (4.1)
kcap = MFPT
−1
cap (4.2)
kesc = (
MFPTesc ×Nesc +MFPTevo ×Neov
Nesc +Nevo
)−1 × Nesc
Nesc +Nevo
(4.3)
kevo = (
MFPTesc ×Nesc +MFPTevo ×Neov
Nesc +Nevo
)−1 × Nevo
Nesc +Nevo
(4.4)
Here, kcap, kesc, and kevo are the capture, escape (to the unbound state) and evolution (to the
bound state) rates of the collision complex, respectively; Nesc and Nevo are the numbers of
escape and evolution transitions. Note that the MFPTs calculated correspond to the average
times spent in an initial state before a transition to the final state. Ideally, the average lifetime
of CC should be independent of whether the trajectory ends up in either the U or B state for a
true three-state model as shown in Equation 4.1. However, The actual transitions between the
CC and B states involve several intermediates that are not represented in Equation 4.1, and the
effective MFPTs as calculated thus depend on both the initial and final states (e.g., see Table
S4.1-S4.3). Analytical expressions on similar MFPTs involved in amyloid fibril templating can
be found a recent theoretical analysis by Schmit287. All molecular visualizations were prepared
using VMD219.
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Figure 4.2: Free-energy surfaces at Tm as a function of the fractions of intra- and intermolecular contacts
formed, computed using various Go¯-like models with and without explicit charges and/or 50 mM salt
(see Table 4.2). Rows A-C, D-F and G-L are for the p53-TAD1/TAZ2, HIF-1α/TAZ1 and NCBD/ACTR
complexes, respectively. Qinter is the fraction of intermolecular contacts formed; Qp53, QHIF−1α and
QACTR are the fractions of intramolecular contacts formed by p53-TAD1, HIF-1α and ACTR, respectively;
QNCBD−tert is the fraction of tertiary intramolecular contacts formed by NCBD (the helical content of
NCBD remain similar during coupled binding and folding). Contours are drawn every kT, where k is
Boltzmann constant and T is the absolute temperature. Figure (A)-(F) are prepared by DG.
108
Figure 4.3: Free energy as a function intermolecular contact fraction at Tm, calculated from the REX
simulations using WHAM, for (A) TAD1/TAZ2, (B) HIF-1α/TAZ1 and (C) NCBD/ACTR. Figure (A) and
(B) are prepared by DG.
Figure 4.4: Effective rate constants for transitions between the unbound, collision complex and bound
states, calculated using models with and without explicit charges and/or 50mM salt, for (A) TAD1/TAZ2,
(B) HIF-1α/TAZ1 and (C) NCBD/ACTR. These rates were defined in Methods, Equation 4.1-4.4. The
results demonstrate that long-range electrostatic forces increase both the capture and evolution rates and at
the same time reduce the escape rates. Figure (A) and (B) are prepared by DG.
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Figure 4.5: Distributions of IDPs on the substrate surfaces in the collision complexes derived from
simulations using models with and without explicit charges. For the p53-TAD1/TAZ2 (A)-(B) and
HIF-1α/TAZ1 (C)-(D) complexes, TAZ2 and TAZ1 are colored based on the probability of each residue in
contact with the IDPs in the collision complex ensembles, and p53-TAD1 and HIF-1α are shown only in
the fold and bound conformations (yellow cartoon) for reference. For the NCBD/ACTR complex (E)-(F),
both IDPs are shown in the bound and folded conformations and colored based on the probability of each
residue involved (nonspecific) intermolecular contacts in the collision complex ensemble. Figure (A)-(D)
are prepared by DG.
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Figure 4.6: Free-energy surfaces at Tm as a function of binding RMSD of the IDP and center of mass
separation between two peptides (RCM ), computed using various Go¯-like models with and without explicit
charges and/or 50 mM salt (see Table 4.2). The binding RMSD (of the IDP) was calculated by first aligning
the snapshot with respect to the folded structure using only the folded substrate. For NCBD/ACTR, both
proteins are IDPs and the (regular) RMSD was calculated using the whole complex. Rows (A)-(C), (D)-
(F) and (G)-(I) are for the p53-TAD1/TAZ2, HIF-1α/TAZ1 and NCBD/ACTR complexes, respectively.
Contours are drawn every kT. Figure (A)-(F) are prepared by DG.
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4.5 Supplemental Materials
4.5.1 Sequences of IDPs
Charged residues are highlighted in red/blue fonts, and the folded segments in the complexes are
underlined. Sequence plots of p53-TAD1 and HIF-1α are prepared by DG.
p53-TAD1:
MET GLU GLU PRO GLN SER ASP PRO SER VAL GLU PRO PRO LEU SER GLN GLU THR
PHE SER ASP LEU TRP LYS LEU LEU PRO GLU ASN ASN VAL LEU SER PRO LEU PRO
SER GLN ALA
HIF-1α:
SER ASP LEU ALA CYS ARG LEU LEU GLY GLN SER MET ASP GLU SER GLY LEU PRO
GLN LEU THR SER TYR ASP CYS GLU VAL ASN ALA PRO ILE GLN GLY SER ARG ASN
LEU LEU GLN GLY GLU GLU LEU LEU ARG ALA LEU ASP GLN VAL ASN
NCBD:
PRO ASN ARG SER ILE SER PRO SER ALA LEU GLN ASP LEU LEU ARG THR LEU
LYS SER PRO SER SER PRO GLN GLN GLN GLN GLN VAL LEU ASN ILE LEU LYS SER
ASN PRO GLN LEU MET ALA ALA PHE ILE LYS GLN ARG THR ALA LYS TYR VAL ALA
ASN GLN PRO GLY MET GLN
ACTR:
GLU GLY GLN SER ASP GLU ARG ALA LEU LEU ASP GLN LEU HIS THR LEU LEU
SER ASN THR ASP ALA THR GLY LEU GLU GLU ILE ASP ARG ALA LEU GLY ILE PRO
GLU LEU VAL ASN GLN GLY GLN ALA LEU GLU PRO LYS
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Figure S4.1: Residual helicities of (a) p53-TAD1, (b) HIf-1α, and (c) ACTR in the unbound states
calculated using different Go¯-like models. The solid traces correspond to models without explicit charges
and the dashed traces are from the charged models. The black traces were computed from models
with no adjustment of the intramolecular interaction strengths (i.e., scale = 1.0), which significantly
over-stabilized the helices. The red traces were calculated using the final calibrated models with optimal
scaling of intramolecular interactions (see Table 4.2 of the main text). The residual helicity showed
minimal dependence on the salt concentration for all peptides and the corresponding profiles are thus not
shown. Free NCBD has helical content similar to the bound state, and no further calibration to the original
sequence-flavored Go¯-like model appears necessary (see Chapter 3 for additional details). The helicity
distribution of NCBD is thus not shown. Figure (a) and (b) are prepared by DG.
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Table S4.1: Mean-first-passage-times (MFPTs) and numbers of transitions (in parenthesis) between
conformational sub-states of the p53-TAD1/TAZ2 complex computed from the production Langevin
simulations. The state assignment criteria are provided in the main text, and the transitions shown are
from the one in the row to that in the column. All MFPTs are in ns. Table is prepared by DG.
w/o charge
w/charge+0.05M salt U CC B
w/ charge
0.72 (10026)
U 0.31 (13735)
0.03 (1098)
0.12 (10026) 0.26 (60)
CC 0.24 (13735) 0.43 (256)
3.47 (1098) 3.94 (1694)
109.02 (60)
B 28.86 (256)
2.63 (1695)
Table S4.2: Mean-first-passage-times (MFPTs) and numbers of transitions (in parenthesis) between
conformational sub-states of the HIF-1α/TAZ1 complex computed from the production Langevin
simulations. The state assignment criteria are provided in the main text, and the transitions shown are
from the one in the row to that in the column. All MFPTs are in ns. Table is prepared by DG.
w/o charge
w/charge+0.05M salt U CC B
w/ charge
0.37 (19428)
U 0.29 (19091)
0.2 (5932)
0.14 (19428) 14.33 (67)
CC 0.16 (19091) 3.26 (133)
1.20 (5932) 3.65 (416)
137.41 (68)
B 45.14 (133)
12.45 (417)
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Table S4.3: Mean-first-passage-times (MFPTs) and numbers of transitions (in parenthesis) between
conformational sub-states of the NCBD/ACTR complex computed from the production Langevin
simulations. The state assignment criteria are provided in the main text, and the transitions shown are
from the one in the row to that in the column. All MFPTs are in ns.
w/o charge
w/charge+0.05M salt U CC B
w/ charge
7.71 (2282) 11.06 (5)
U 3.50 (2161) 27.20 (2)
1.26 (181) 22.60 (1)
1.57 (2287) 8.14 (16)
CC 2.95 (2160) 13.13 (52)
22.10 (180) 44.56 (108)
1420.5 (1) 818.89 (21)
B 368.77 (3) 274.24 (51)
165.00 (2) 190.80 (108)
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Figure S4.2: 2D free energy surfaces at Tm calculated using models with and without explicit charges (see
Table 4.2 of the main text). QHIF−1αAinter and Q
HIF−1αC
inter are the fractions of native intermolecular contacts
formed by the first and third helices of HIF-1α, respectively. RCM is the distance between the centers of
mass of HIF-1α and TAZ1. Contours are drawn every kT. Figures are prepared by DG.
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Figure S4.3: 2D free energy surfaces at Tm calculated using models with and without explicit charges
(see Table 4.2 of the main text). QACTR−H1inter , Q
ACTR−H2
inter and Q
ACTR−H3
inter are the fractions of native
intermolecular contacts formed by the first, second and third helices of ACTR, respectively. Contours are
drawn every kT.
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Figure S4.4: 2D free energy surfaces at Tm calculated using models with and without explicit charges
(see Table 4.2 of the main text). QNCBD−H1inter , Q
NCBD−H2
inter and Q
NCBD−H3
inter are the fractions of native
intermolecular contacts formed by the first, second and third helices of NCBD, respectively. Contours are
drawn every kT.
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Figure S4.5: Representative snapshots along the binding and folding pathways of p53-TAD1/TAZ2. Figure
is prepared by DG.
Figure S4.6: Representative snapshots along the binding and folding pathways for HIF-1α/TAZ1. Figure
is prepared by DG.
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Chapter 5
Efficiency of Adaptive Temperature-based Replica
Exchange for Sampling Large-scale Protein
Conformational Transitions∗
Abstract
Temperature-based replica exchange (RE) is now considered a principal technique for enhanced
sampling of protein conformations. It is also recognized that existence of sharp cooperative
transitions (such as protein folding/unfolding) can lead to temperature exchange bottlenecks and
significantly reduce the sampling efficiency. Here, we revisit two adaptive temperature-based
RE protocols, namely, exchange equalization (EE) and current maximization (CM), that were
previously examined using atomistic simulations (Lee and Olson, J. Chem. Physics, 134, 24111
(2011)). Both protocols aim to overcome exchange bottlenecks by adaptively adjusting the sim-
ulation temperatures, either to achieve uniform exchange rates (in EE) or to maximize tem-
perature diffusion (CM). By designing a realistic yet computationally tractable coarse-grained
protein model, one can sample many reversible folding/unfolding transitions using conventional
constant temperature molecular dynamics (MD), standard REMD, EE-REMD, and CM-REMD.
This allows rigorous evaluation of the sampling efficiency, by directly comparing the rates of
folding/unfolding transitions and convergence of various thermodynamic properties of interest.
The results demonstrate that both EE and CM can indeed enhance temperature diffusion com-
∗Reprinted (adapted) with permission from W. Zhang and J. Chen (2013), “Efficiency of adaptive
temperature-based replica exchange for sampling large-scale protein conformational transitions”, J. Chem. Theory
Comput. 9, 2849-2856. Copyright (2013), American Chemical Society.
Author Contributions: Conceived and designed the experiments: JC WZ. Performed the experiments: WZ JC.
Analyzed the data: WZ JC. Contributed reagents/materials/analysis tools: WZ JC. Wrote the paper: WZ JC.
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pared to standard RE, by ∼3- and over 10-fold, respectively. Surprisingly, the rates of reversible
folding/unfolding transitions are similar in all three RE protocols. The convergence rates of several
key thermodynamic properties, including the folding stability and various 1D and 2D free energy
surfaces, are also similar. Therefore, the efficiency of RE protocols does not appear to be limited
by temperature diffusion, but by the inherent rates of spontaneous large-scale conformational
re-arrangements. This is particularly true considering that virtually all RE simulations of proteins
in practice involve exchange attempt frequencies (∼ps−1) that are several orders of magnitude
faster than the slowest protein motions (∼µs−1). Our results also suggest that the efficiency of
RE will not likely be improved by other protocols that aim to accelerate exchange or temperature
diffusion. Instead, protocols with some types of guided tempering will likely be necessary to drive
faster large-scale conformational transitions.
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5.1 Introduction
Successful computer simulations of protein conformational equilibrium and transitions not only
require accurate description of protein energetics in complex heterogeneous environments, but
also require sufficient sampling of the relevant conformational space. At present, generating
atomistic structure ensembles that are statistically representative of the accessible conformations
of a protein under a given set of thermodynamic conditions remains a challenging problem100. The
difficulty arises not only because of the large and complex conformational space of biomolecules,
but also due to significant energy barriers that might separate different conformational subspaces.
The efficiency of conventional Monte Carlo (MC) or molecular dynamics (MD) is limited due
to frequent trapping of protein in numerous local energy minima. The replica exchange (RE)
method103–105,178, also known as parallel tempering, has emerged as a relatively straightforward
but powerful approach for enhanced conformational sampling. The basic idea is to simulate
multiple replicas of the system at different temperatures independently using either MC or MD.
Periodically, replicas attempt to exchange simulation temperatures according to a Metropolis
criterion that preserves the detailed balance and ensures canonical distributions at all tempera-
tures. The resulting random walk in the temperature space helps the system to escape states of
local energy minima and thus facilitate conformational sampling. Replica exchange molecular
dynamics (REMD) in particular has been widely applied to and shown to be successful in protein
simulations106–110. Nonetheless, questions remain regarding the true efficiency of RE in sampling
large-scale (protein) conformational transitions and its dependence on the properties of the system
and key RE parameters, such as the number of replicas, exchange attempt frequency, and choice
of simulation temperatures, etc.
The key parameters of REMD of protein simulations has been a subject of substantial research
interest in recent years, examined both based on theoretical considerations111–116 and through
actual simulations of small peptides110,117–119. These studies generally confirm that RE can en-
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hance the conformational sampling as long as the activation enthalpies are positive. In particular,
recent theoretical analysis112 and kinetic network models114,115 of RE for two-state systems have
emphasized the importance of choosing a maximum temperature slightly above the temperature
where the folding rate is maximal because of the anti-Arrhenius behavior of protein folding at
high temperatures. Once the maximum temperature is chosen, other REMD parameters can be set
to achieve effective diffusion of replicas across the temperature ladder, arguably with the smallest
possible number of replicas. Many strategies have been previously proposed for the later purpose,
such as more frequent exchange attempts119, global energy reassignment78, and non-equilibrium
switches123. More aggressive approaches attempt to reduce to number of replicas required for
effective temperature diffusion by directly reducing the number of particles that participate in
temperature exchanges124–126, but sometimes with undesirable consequences127.
It is typically assumed that REMD will provide the highest sampling efficiency if all the replicas
spend equal amount of time at each temperature. As proposed by Sugita and Yokomoto104 and
Kofke129, this may be achieved through optimizing the allocation of simulation temperatures to
provide efficient and uniform exchanges. Nonetheless, it is not clear whether consideration of
exchange efficiency alone is sufficient to optimize the sampling efficiency, which is more directly
measured by the frequency of conformational transitions, and ultimately by the convergence of
various thermodynamic properties of interest. For example, REMD simulations were previously
performed in the GBSW implicit solvent to examine the conformational equilibrium of a β-hairpin
derived from protein GB1 domain (GB1p; residues 41-56)77. The exchange (acceptance) rates of
both folding and control REMD simulations were very uniform and >60% for all pairs (Figure
5.1A). Nonetheless, there was an apparent segregation of replicas in the temperature space: a few
of replicas dominated the lowest temperature and had much lower averaged temperatures (e.g.,
replicas 2, 6 and 10; see Figure 5.1B). Closer examination suggests that the observed temperature
trapping reflects a lack of reversible folding and unfolding transitions during these simulations.
The few replicas that happened to fold first during the folding run (or those did not unfold at first
during the control run) remained folded throughout the simulation timespan and thus had much
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higher tendency to visit the lower temperature windows (e.g. replicas 2 and 10; the black and red
traces in Figure 5.1C). Even though the folded replicas did visit higher temperatures frequently,
they did not spend sufficient time to unfold spontaneously and thus quickly reversed back to lower
temperatures. Vice versa was true for the unfolded replicas. As a result, there was rapid mixing of
the replicas due to uniform and high exchange rates, but all replicas remained trapped in various
free energy basins. Similar observations have also been made by Periole and Mark117.
Figure 5.1: REMD simulations of GB1p β-hairpin. (A) Exchange acceptance rates between neighboring
temperatures for the control (initiated from the native structure) and folding (from a fully extended structure)
REMD simulations. Condition numbers correspond to different simulation temperatures. (B) Average
temperatures and percentages of occupancy at the lowest temperature (260 K) of all replicas in the folding
REMD simulation. (C) 50-ps running averages of the temperature history of four representative replicas (2:
black, 10: red, 12: blue, 16: green) during the folding REMD simulation. The grey traces in the background
are the raw time traces. Details of these simulations were described in Reference77.
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In light of the inadequacy if uniform exchange to promote folding/unfolding transitions, the recent
proposed current maximization (CM) protocol130 is very attractive. CM aims to systematically
optimize temperature diffusion such that the number of “round trips” in the temperature space of
each replica is maximized. Arguably the number of “round trips” is more directly related to the
ability of RE to drive conformational transitions, and thus CM could substantially improve the
sampling efficiency130. Lee and Olson recently compared the sampling efficiency of CM and an-
other adaptive temperature-based REMD protocol, namely, exchange equalization (EE)128, using
the 57-residue SH3 domain of α-spectrin in implicit solvent as a model system. However, due
to the system size and associated computational cost, no reversible folding/unfolding transitions
were sampled. As a result, how effectively the improved temperature diffusion in CM can translate
into sampling efficiency remains to be established.
Identification of appropriate protein model systems for rigorous benchmarking of sampling effi-
ciency has actually been difficult. Due to the computational cost constraint, small peptides have
been mainly used as model systems110,117,119. REMD simulations of the 21-residue Fs-21 peptide
in implicit solvent demonstrated that REMD could enhance the sampling efficiency by 14 to 72
times at different temperatures compare to conventional MD based on examination of helicity
auto-correlation functions110. Periole and Mark simulated a β-heptapeptide in explicit solvent to
examine the convergence and sampling efficiency, which suggested REMD to be at least one order
of magnitude more efficient than MD117. While these studies have provided important insights into
the efficacy of REMD, small model peptides lack long-range ordering that exist in actual globular
proteins, and, more importantly, do not fully reflect globular proteins where folding/unfolding
transitions often occur at much longer timescales compare to local conformational fluctuations.
Our previous simulations of small proteins1,35,74 (also see Figure 5.1) have suggested that the
ability to drive slow global conformational transitions is a key bottleneck in REMD sampling.
Therefore, there is a need to develop realistic yet computationally tractable protein models for
more rigorous benchmarking of REMD sampling efficiency.
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In this work, we first construct a protein model derived from coarse-grained topology-based
models98, which are based on the principle of minimal frustration for evolved proteins and allow
direct simulations of folding and unfolding transitions to characterize folding mechanisms. In
particular, impressive correspondence has been demonstrated between experiment and theory
for many proteins98,229, supporting the notion that topology-based models capture the essence
of folding behaviors of globular proteins. Specifically, the original sequence-flavored Go¯-like
model232 was modified to include non-specific hydrophobic interactions to mimic the presence of
non-native interactions in real proteins. Inclusion of non-specific interactions also increases the
complexity of the energy landscape, and thus the sampling challenge. Such a model arguably
provides a reasonable balance between the level of realisticity and computational tractability
for more rigorous benchmarking of how the above-discussed adaptive temperature-based REMD
protocols enhance sampling of protein conformations.
5.2 Methods
5.2.1 Adaptive temperature-based REMD protocols
A typical REMD involves multiple replicas simulated simultaneously at different temperatures.
For given choices of the number of replicas N, the minimum temperature, Tmin, and the maximum
temperature, Tmax, the temperature distribution is usually assigned as:
T1 = Tmin, Ti+1 = Ti(
Tmax
Tmin
)[
1
N−1 ]. (5.1)
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Exchange of simulation temperatures are attempted periodically and accepted according to a
Metropolis criterion that maintains the detailed balance104.
p(i↔ j) = min[1, e(βj−βi)(Ej−Ei)] (5.2)
where βi = 1/kBTi, kB is Boltzmann’s constant, and Ti and Ei are the temperature and potential
energy of replica i. After a successful exchange of simulation temperatures, the velocities of
swapped replicas are rescaled according to,
P (Tj) =
√
Tj
Ti
P (Ti), P (Ti) =
√
Ti
Tj
P (Tj). (5.3)
Exchange rate equalization (EE)
For systems displaying strong phase transitions such as protein folding and unfolding, the standard
REMD can suffer from depressed exchange rate near the transition temperature, Tm. One approach
to resolve this limitation is to dynamically adapt the temperature spacing and populate more
simulation windows near Tm. This may be achieved by equalizing the exchange rates through
out the REMD temperature range. Briefly, as described by Lee and Olson288, the simulation
temperatures, {Ti}, can be updated periodically during REMD to maximize the sum of exchange
acceptance rates, Si→i+1 , raised to a properly chosen negative power, r,
Ω = max[
N−1∑
i=1
(si→i+1)r] (5.4)
In the limit of r → ∞, the exchange rates would be uniform with maximized Ω. The value of
r was assigned to be -4 in the current work as suggested by Lee and Olson288. Assuming that
the energy distributions at all temperatures are Gaussian, the exchange rates can be estimated
by integrating the acceptance probability over the energy distributions128. This allows numerical
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optimization of {Ti} according to Equation 5.4 to achieve approximate equalization of exchange
rates between all neighboring replica pairs.
Current maximization (CM)
The CM method aims to maximize the number of round trips that the replicas travel between
the lowest and highest simulation temperatures130. For this, a replica is marked as cold or hot
depending on its last visit to either temperature extremes. The cold fraction can be then calculated
for each temperature as
f(T ) =
ncold(T )
ncold(T ) + nhot(T )
(5.5)
where ncold(T ) and nhot(T ) are the number of cold and hot replicas at temperature T . It has been
shown that the current of temperature diffusion can be maximized by adjusting the temperatures,
Ti, such that f(T ) increases linearly as a function of the temperature index, i289. This can be
achieved by first interpolating a continuous f(T ) from the computed values of f at the current set of
temperatures and then using it to search for new temperatures within the pre-specified temperature
ranges where f(T ) = i/(N−1). To avoid crowding of replicas near Tm, a constraint is introduced
such that no neighboring temperatures can be more than two geometric spacing units apart128
Ti+1
Ti
≤ (Tmax
Tmin
)
2
N−1 (5.6)
5.2.2 A topology-based coarse-grained protein model with rugged energy landscape
The sequence-flavored Go¯-like model232 is an advanced topology-based model that exploits the
idea that sequence can provide differing statistical weights to alternative folding pathways. By
including knowledge-based pseudo-torsional potentials and using the Miyazawa-Jernigan (MJ)
statistical potentials234 for residue-specific Cα-based native interactions, the model can recapitu-
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late subtle differences in folding mechanisms that arise from sequence differences in topologically
analogous proteins235,236. In this work, we further extend this model to include nonspecific
hydrophobic interactions. Specifically, an initial model was first generated for the B1 domain
of streptococcal protein G (GB1) (PDB: 3gb1)290 (see Figure 5.2) using the Multiscale Modeling
Tools for Structural Biology (MMTSB) Go¯-Model Builder (http://www.mmtsb.org)215. We then
recalibrated the model to have Tm ∼ 350K by uniformly adjusting the strength of all native
contacts. Non-specific van der Waals (vdW) interactions were then introduced between all Cα
beads with strengths similar to those of the native contacts. Specifically, the well depth was
empirically set to ε = -1.1 kcal/mol, which appeared to provide a reasonable compromise between
retaining fast folding rates and increasing energy landscape complexity based on pilot REMD
simulations. The pilot simulations also suggested that non-specific 1-4 vdW interactions as well
as those in two short loops (see Figure 5.2) needed to be turned off to avoid steric restriction of
rotation around Cα-Cα bonds and facilitate chain diffusion. The final model retains a sharp folding
transition (Figure 5.3A), but displays more complex energy landscape with multiple intermediate
states (Figure 5.3B; also see Section 3.4). Compared to the original sequence-flavored Go¯-like
model, the folding and unfolding rates are about 15 times slower at corresponding Tm’s.
5.2.3 Simulation protocols and analysis
All the REMD simulations were performed using the MMTSB Toolset215 with 8 replicas spanning
300 to 400K. For each replica, Langevin dynamics simulation was performed using CHARMM63,216
with a dynamic time step of 10 fs and a friction coefficient of 0.1 ps−1. The SHAKE algorithm217
was applied to constrain all virtual bond lengths. Replica exchanges were attempted between
neighboring replicas every 5000 MD steps (50 ps). The geometrically spaced distribution (Equa-
tion 5.1) was used as the initial temperature profile. Pilot runs were first performed to obtain
the optimized temperature distributions according to either EE or CM protocol. Specifically,
multiple cycles of 1-µs REMD were performed, each followed by optimization of the temperature
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Figure 5.2: The structure of B1 domain of streptococcal protein G (PDB ID: 3gb1)290. The center helix is
colored in violet, β-strands in yellow, and loops in cyan.
distributions using the EE and CM methods until the whole profile stabilized. Additional 5-µs
REMD simulations were then performed verify that the EE and CM temperature distributions were
stable (for the given protein model). Finally, the converged EE and CM temperature profiles were
used for independent production REMD simulations, initiated from the native structure (control
run) and a fully extended structure (folding run), respectively. The length of all REMD simulations
was 100 µs. The parallel control and folding runs allow additional diagnosis of convergence. For
control, standard REMD and constant-temperature MD simulations (at 300 K and Tm ≈ 354K)
were also performed (initiated from the native structure). These simulations are summarized in
Table 5.1. We note that Tm calculated from the production simulations are slightly different from
the value estimated using the pilot run (∼354K).
The sampling efficiencies of various simulation protocols are judged mainly based on: the number
of folding/unfolding transitions NTS , average time of conformational transitions, τTS , and conver-
gence of the calculated folding free energy, ∆G, and several 1D and 2D potential of mean forces
(PMFs). In the context of topology-based modeling, the fractions of native contacts provide natu-
ral reaction coordinates for describing folding and unfolding transitions237. The model for protein
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Table 5.1: Summary of production REMD and MD simulations.
Method Initial State Length (µs) Tm(K) NTR NTS τTS (µs)
EE
Folded 100 351 4423 28 28.6
Extended 100 352 4003 24 33.3
CM
Folded 100 354 18533 18 44.4
Extended 100 352 19570 23 34.8
Standard Folded 100 352 1411 21 38.1
MD @ 354K Folded 200 - - 14 14.3
MD @ 300K Folded 100 - - 0 Undef
Tm values shown were estimated based on the peak of the final calculated CV curves. NTR is the
total number of round trips that all replicas travel between temperature extremes.
GB1 includes 75 native contacts. Based on the 1D PMF as a function of native contact fraction (see
Figure 5.3B), conformations with <25 native contacts were assigned to be in the unfolded state,
and those with>55 native contacts to the folded state. These definitions of the folded and unfolded
states were then used to calculate the number of folding and unfolding transitions sampled in MD
or by all replicas in REMD simulations (see Table 5.1). We further divided the native contacts into
those involving the N-terminal residues 1-20 (Q-nt), the C-terminal residues 42-55 (Q-ct), or the
central α-helical residues 23-36 (Q-h), and calculated 2D various PMFs. Achieving convergence
on these 2D PMFs should be more challenging than converging on folding stability alone or 1D
PMF. Thus, it provides a more stringent test on various REMD protocols’ ability to enhance
sampling. The weighted histogram analysis method (WHAM) was used to combine information
from all temperatures to compute either the CV curves or various unbiased 1D and 2D probability
distributions142. All the analysis was performed using a combination of the MMTSB toolset,
CHARMM and in-house scripts. The numbers of temperature round trips in REX simulations
were calculated between the lowest two temperature and highest two temperatures.
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Figure 5.3: (A) The heat capacity, CV , as a function of temperature and (B) free energy as a function of
the native contact fraction (Q) at Tm = 354 K, calculated from various 100-µs EE- and CM-REMD and
standard REMD simulations. The PMF derived from a 200-µs constant temperature MD at Tm = 354K is
also shown (green trace in panel B).
5.3 Results and Discussion
5.3.1 Convergence of the EE- and CM-optimized temperature distributions
For given temperature range and number of replicas, the EE- or CM-optimized temperature dis-
tributions should depend solely on the nature of the system (e.g., the density of state distribution).
Indeed, as shown in Figure 5.4, both EE- and CM-optimized temperature distributions quickly
deviated from the initial geometrically spaced profile (black traces), but started to stabilize by
the fourth 1-µs cycles of iterative REMD runs. In the next couple 1-µs cycles, the temperature
profiles varied only slightly between cycles (<5 K), which appears to arise mainly due to the
finite length of the pilot REMD cycles. Additional 5-µs pilot REMD runs further validate that the
final EE- and CM-optimized temperature profiles are well converged. As previously observed128,
the EE-optimized temperature distribution sets large intervals at lower temperatures and closely
places simulation windows at higher temperatures; whereas CM optimization tends to place dense
windows near the melting temperature of the protein. The final EE- and CM-optimized tempera-
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ture distributions (red traces in Figure 5.4) were used in the 100-µs control and folding production
REMD simulations.
Figure 5.4: Temperature distributions optimized by (A) EE and (B) CM at the end of multiple cycles of
1-µs and 5-µs pilot REMD runs (see Methods).
5.3.2 Exchange acceptance rates and numbers of round trips in the temperature space
As a first step towards examining the efficiency of EE and CM, key REMD metrics, including
exchange acceptance rates and numbers of temperature round trips, were calculated to ensure that
the adaptive temperature distributions achieved the goals of EE and CM. As shown in Figure
5.5, the exchange acceptance rates are indeed approximately equalized (∼60%) in both control
and folding EE-REMD production simulations. Note that the exchange acceptance rates between
control and folding simulations are similar, indicating that simulations were well converged. In
contrast, the geometrically spaced temperature distribution used in standard REMD leads to an
exchange bottleneck near Tm, albeit less pronounced compared to what was observed in atomistic
simulations128. CM-REMD yielded higher exchange acceptance rates near Tm (>80%), which is
consistent of denser windows in this region. The exchange acceptance rates in CM are lower at
both low and high temperature extremes, which is also similar to the previous study using atomistic
model with more replicas128. The numbers of round trips in the temperature space are summarized
in Table 5.1. The results show that the CM-optimized temperature distribution does enhance the
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diffusion in the temperature space, about 13-fold compared to the standard REMD. In comparison,
equalizing the exchange rates also enhances temperature diffusion, but only about 3-fold compared
to standard REMD. In the following, we further examine whether such equalized exchange rates
and enhanced temperature diffusion can effectively translate into more conformational transitions
and faster convergence in various thermodynamic properties.
Figure 5.5: Exchange acceptance rates extracted from the 100-µs production REMD simulations. Solid
and dash lines correspond to results from the control and folding simulations, respectively.
5.3.3 Number of folding and unfolding transitions
The sampling efficiency of REMD is arguably more directly related to the number of major
conformational transitions sampled, such as between folded and unfolded states. As summarized
in Table 5.1, 28 and 24 folding-unfolding transitions were observed during the control and folding
EE-REMD runs, respectively. Interestingly, despite enhanced temperature diffusion, the numbers
of conformational transitions sampled by CM-REMD simulations are actually smaller, 23 in the
folding run and only 18 in the control run. Using the differences between the control and folding
runs as rough estimates of the uncertainties, EE- and CM-REMD generated 26 ± 4 and 20.5 ± 5
reversible folding/unfolding transitions in an aggregated length of 800 µs. These numbers are not
significantly higher than a total of 21 reversible folding/unfolding events sampled in the standard
REMD simulation. Therefore, enhanced temperature diffusion, using either EE or CM, does not
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appear to accelerate large-scale conformational transitions. The implication is that temperature
diffusion is not limiting in driving large-scale conformational transitions even with the standard
REMD. We note that similar observations have also been made by Kouza and Hansmann in their
recent study of so-called rejection free replica exchange simulations291.
Theoretical studies based on two-state model systems have predicted that REMD cannot drive
transitions faster than the maximal rates at all the temperatures sampled (which should occur at
slightly above Tm for actual proteins)114. Indeed, the average time per conformational transition,
τTS , is ∼30 µs or more in all REMD simulations, which over twice longer than τTS of ∼14.3 µs
observed in regular MD at Tm (see Table 5.1). We note that a key advantage of REMD, however,
is the ability to generate correct thermodynamic dynamic ensembles at all temperatures, such that
conformations sampled at all temperatures can be combined together using WHAM286 to calculate
thermodynamic properties any temperature of interest (e.g., the lowest temperature sampled). In
contrast, recovering thermodynamic properties at the room temperature using a single simulation
at Tm is generally unreliable. Therefore, slower average τTS in REMD compared to MD at Tm
does not suggest that REMD is less efficient than regular MD (the contrary has been shown to be
true extensively by previous works as discussed in Introduction). We also note that at 300 K no
reversible folding and unfolding transition was sampled in multiple 100-µs MD runs and REMD
is thus necessary for efficient generation of converged ensembles.
5.3.4 Convergence of thermodynamic properties
Arguably, the ultimate goal of REMD simulations is to generate statistically representative struc-
ture ensembles such that well-converged thermodynamic properties can be derived. Here, we
focus on several typical thermodynamic properties frequently involved in protein folding studies,
including Tm, CV, folding stability (∆Gfold, “zero-dimensional” free energy), 1D PMF, and
several 2D PMFs. Importantly, both CV and 1D PMF as a function of the total native contact
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fraction (Q) are well-converged among all REMD simulations (e.g., see Figure 5.3). ∆Gfold
values at Tm ≈ 354K derived from all REMD and MD simulations are within 0.25 kT from each
other (except the CM-REMD control run, which deviates by∼0.5 kT from other runs). Sample 2D
PMFs, calculated from the control EE-REMD run, are shown in Figure 5.6. We note that inclusion
of non-specific hydrophobic interactions does not change the fundamental features of these free
energy surfaces compared to the original sequence-flavored model232. For example, the folding of
the C-terminal hairpin precedes that of the N-terminal hairpin (see Figure 5.6D). However, all the
free energy surfaces are significantly more rugged with several local minima that are not present
in the surfaces derived from the original model (e.g., see Figure 5.6B).
Figure 5.6: 2D free energy surfaces of folding of protein GB1 along various order parameters at Tm
calculated from control EE-REMD simulations. Q, Q-nt, Q-ct and Q-h are fraction of native contacts of the
whole protein, the N-terminal hairpin, the C-terminal hairpin and central helix respectively.
Figure 5.7 compares the self-convergence of 1D PMF and a representative 2D free energy (Q vs.
Q-nt) as a function of simulation time, measured using the root mean square deviation (RMSD)
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from the final profiles calculated using all 100 µs data. A few observations can be made. First,
among all three simulations initiated from the folded state (EE control, CM control and standard
REMD), both EE- and CM-REMD runs appear to converge faster compared to the standard
REMD. For example, the 1D PMF quickly converged within about 5 µs in both EE- and CM-
REMD control runs while it took∼15 µs to achieve a similar level of convergence for the standard
REMD (Figure 5.7A). Similar observations were also made in 2D PMFs (e.g., see Figure 5.7B).
Importantly, the apparent faster convergence of EE- and CM-REMD control simulations within
short timescales does not appear to arise from more efficient conformational sampling. Instead,
it is mainly attributed to faster mixing of conformation states sampled at different temperatures
due to more efficient temperature diffusion in EE- and CM-REMD. Second, comparing the results
of the control and folding runs suggests that the true convergence of thermodynamic properties
is much slower than the apparent rates of self-convergence in the control runs. Interestingly,
EE-REMD appears to be slightly more efficient than CM-REMD despite less efficient temperature
diffusion, which is consistent with the larger number of folding/unfolding transitions sampled.
Third, the convergence of higher dimensional PMFs expectedly is much slower. All three REMD
protocols perform very similarly, with the RMSD from the final profiles gradually decreasing
throughout the 100 µs simulation span.
To further investigate how the number of actual conformational transitions sampled affects the
accuracy of calculated thermodynamic properties, we divided both EE and CM control simulations
into uniform fragments of various lengths and calculated the average numbers of conformational
transitions and standard deviations of calculated ∆Gfold. The results are summarized in Figure
5.8. It shows a clear inverse correlation of the standard deviation of ∆Gfold and the number of
conformational transitions sampled. Importantly, due to rapid mixing of conformations sampled at
different temperatures (as noted above), reasonable estimates of ∆Gfold, with ∼1 kT uncertainty,
appear feasible even with “ultra-short” REMD simulations on the order of 100 ns (which is
actually the typical length of atomistic REMD simulations), even though virtually no reversible
transitions could be sampled in such a short simulation timespan. In addition, the uncertainty in
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Figure 5.7: Self-convergence of (A) 1D PMF (as a function of Q), and (B) a representative 2D free energy
surface (as a function of Q and Q-nt) during various 100-µs REMD simulations. The RMSD values shown
were calculated with reference to the final 1D or 2D free energy profiles extracted using all 100 µs data of
corresponding REMD runs.
the calculated ∆Gfold does not decrease significantly with longer simulations, until significant
numbers of reversible folding/unfolding transitions are sampled. The later requires simulation
timescales a few fold of the inherent folding/unfolding time, which is >20 µs for the current
protein model. Along this line, it appears that equalized exchange achieved by EE-REMD is
slightly advantageous (e.g., compare the black vs. red traces in Figure 5.8), in allowing more rapid
mixing of different temperatures to achieve better convergence with simulations much shorter than
the folding/unfolding timescales (which is the case for most atomistic simulations).
5.4 Conclusions
Existence of sharp cooperative transitions in proteins can lead to temperature exchange bottleneck
and subsequently limit the sampling efficiency of the popular REMD method. Several approaches
have been proposed to address this bottleneck, including two adaptive temperature REMD pro-
tocols previously examined by Lee and Olson128. In this work, we constructed a reasonably
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Figure 5.8: Standard deviation of calculated folding free energy (σ∆G) and average number of
conformational transitions (<NTS>) calculated using various length of EE- and CM-REMD control
simulations.
realistic yet computationally tractable protein model to re-evaluate how effective equalizing the
exchange rates or maximizing the current of temperature diffusion can enhance the sampling of
large-scale protein conformational transitions. The results demonstrate that, despite substantially
enhanced temperature diffusion, neither EE- nor CM-REMD could generate significantly more
folding/unfolding transitions. As the result, the convergence of key thermodynamic properties
is similar with EE-, CM- or standard REMD, except for very short simulations. In the later
case, the apparent convergence can be mainly attributed to mixing of conformations sampled
at different temperatures and thus can benefit from enhanced temperature diffusion from either
EE- or CM-REMD. We note that typical atomistic REMD simulations are on the order of 100 ns
and thus do fall into the “very short” category. A key lesson from the current work is also that,
with exchange attempt frequency (∼ps−1) several orders of magnitude faster than the inherent
timescale of slowest protein motions (∼µs−1), temperature diffusion does not appear to be limiting
in the ability of REMD to drive large-scale conformational transitions. Therefore, it is unlikely
that any protocol that aims to accelerate temperature exchange or temperature diffusion will lead
to substantial enhancement in true sampling efficiency of REMD protein simulations. One will
139
likely need to explore protocols that involve some types of guided tempering to allow the protein
to take advantage of faster unfolding at high temperatures simultaneously with rapid folding near
the transition temperature.
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5.5 Supplemental Materials
Figure S5.1: Time series of the temperature (condition number), total energy, RMSD and the numbers of
native and total (nonspecific) contacts for a single replica (replica 1 from the EE control run; see main text).
Nonspecific contacts are considered formed whenever the Cα-Cα distance is below 10 A˚.
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Chapter 6
Replica Exchange with Guided Annealing for
Accelerated Sampling of Disordered Protein
Conformations ∗
Abstract
We critically examine a recently proposed convective replica exchange (cRE) method for enhanced
sampling of protein conformation based on theoretical and numerical analysis. The results demon-
strate that cRE and related replica change with guided annealing (RE-GA) schemes lead to unbal-
anced exchange attempt probabilities and break detailed balance whenever the system undergoes
slow conformational transitions (relative to the temperature diffusion timescale). Nonetheless,
numerical simulations suggest that approximate canonical ensembles can be generated for systems
with small conformational transition barriers. This suggests that RE-GA maybe uniquely suitable
for simulating intrinsically disordered proteins (IDPs), an important class of newly recognized
functional proteins. The efficacy of RE-GA is demonstrated by calculating the conformational
ensembles of intrinsically disordered KID protein. The results show that RE-GA helps the pro-
tein to escape nonspecific compact states more efficiently and provides several fold speedups in
generating correct and converged ensembles compared to the standard temperature RE.
∗Accepted by Journal of Computational Chemistry as a full paper.
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6.1 Introduction
Temperature-based replica exchange (RE) is now widely accepted as a premier method for en-
hanced sampling of biomolecular conformation104,105,292. In RE, multiple replicas of the system
are simulated independently at different temperatures, and they periodically attempt to exchange
simulation temperatures according to a Metropolis criterion that preserves detailed balance and
ensures proper canonical ensembles at all temperatures. The resulting random walk in the tem-
perature space could help each replica to escape local energy minima and thus facilitate con-
formational sampling. Extensive theoretical analysis111–116 and simulation studies110,117–119 have
established that RE can accelerate sampling as long as the activation enthalpies of conformational
transitions are positive. At the same time, it has also been recognized that temperature RE can be
severely limited by the presence of sharp, cooperative conformational transitions such as protein
folding111,120. In such cases, replicas often segregate into distinct conformational subspaces (e.g.,
folded/compact and unfolded), and the segregation may often be accompanied with apparent
temperature exchange bottlenecks121. Importantly, so-called adaptive RE methods can effectively
reduce or eliminate exchange bottlenecks, by adjusting the RE temperature distribution to either
equalize exchange success rates129 or maximize temperature diffusion current128,130. However,
improved temperature distributions were found to be limited in improving actual sampling293–295.
In particular, a recent benchmark study using coarse-grained protein models directly demonstrated
that improved temperature exchange did not always lead to better sampling of major conforma-
tional transitions, judged by rates of global folding transitions as well as the convergence of various
key thermodynamic properties of interest254.
A common symptom of RE in the challenging case of simulating cooperative transitions is that a
few replicas occupy the lowest temperatures for extensive period of time, if not for the entire span
of RE after initial relaxation (e.g., see Figure 1 of Ref.121). These low temperature replicas always
occupy conformational states that are enthalpically much more stable than other states sampled at
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higher temperatures. Even though the trapped replicas do visit higher temperatures occasionally,
especially with adaptive RE schemes, they usually exchange back to lower temperatures very
rapidly and thus can not take sufficient advantage of higher temperatures to escape the stable
energy minima. This observation has led us to suggest that an effective way to overcome the
apparent conformational/temperature trapping may be to design temperature exchange schemes
that would guide the trapped replicas to visit higher temperatures more frequently121. Such
schemes may be generally referred to as RE with guided annealing (RE-GA). A similar idea is the
recently described convective RE method (cRE)131, where the replicas take turns to steadily raise
or lower their temperatures in “convective” cycles. We have also been independently exploring
several alternative RE-GA schemes. For example, one could first detect trapped replicas such as by
examining the average temperatures and then guide the identified trapped replicas to steadily raise
temperature by modifying the exchange attempt patterns. Alternatively, one can periodically chose
the lower-temperature replica and subject it to guided annealing. Since these RE-GA schemes
only modify the exchange attempt patterns and retain the use of Metropolis criteria for accepting
exchange attempts, it appears that detailed balance should be maintained and correct canonical
ensemble generated. In fact, a formal proof of detailed balance was offered by Spill et al. in their
description of the cRE method131.
In this work, we rigorously evaluate the correctness and effectiveness of RE-GA schemes in-
cluding cRE, based on theoretical analysis, numerical simulations, and proteins simulations at
coarse-grained and atomistic levels. The results reveal that all RE-GA schemes inevitably lead
to unbalanced exchanged attempt probabilities and do not rigorously maintain detailed balance
in cases of slow conformational transitions. Nonetheless, numerical simulations suggest that the
systematic bias induced by GA cycles is minimal when the activation enthalpy of conformational
transitions is small (e.g., < a few kcal/mol). Therefore, RE-GA appears to be suitable for ac-
celerated sampling of disordered protein states using atomistic force fields. It is particularly
effective in assisting the system to escape numerous nonspecific compact conformational states
that are present in the current atomistic force fields, which in turn allow more efficient sampling
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of transient local protein conformations. Application to the simulation of the disordered ensemble
of a 28-residue intrinsically disordered protein (IDP) demonstrates that RE-GA is several fold
more efficient compared to the standard temperature RE.
6.2 Methods
6.2.1 Theory of replica exchange with guided annealing (RE-GA)
In temperature RE simulations, N replicas of the system are simulated in parallel at different
temperatures distributed between two pre-selected values, Tmin, which is often the temperature of
interest, and Tmax, which should be slightly above the temperature of maximal reversible transition
kinetics114. Periodically, replicas attempt to exchange simulation temperatures with an acceptance
probability given by the Metropolis criterion,
p(i↔ j) = min[1, e(βj−βi)(Ej−Ei)] (6.1)
where βi = 1/kBTi, kB is Boltzmann’s constant, and Ti and Ei are the current temperature
and total potential energy of replica i, respectively. Most standard RE implementations only
involve exchange attempts between replicas occupying neighboring temperatures, even though
several more aggressive global exchange schemes have been proposed122,296. Importantly, the
exchange attempts alternate between even and odd neighboring pairs, such that all replicas have
equal probabilities to attempt to exchange to either higher or lower temperatures except when
they are occupying Tmin or Tmax. The balanced exchange attempt probabilities together with the
Metropolis exchange acceptance criterion (Equation 6.1) allow proper canonical ensembles to be
generated at all temperatures during RE simulations. It should also be emphasized that Equation
6.1 is valid only when all replicas are fully relaxed and their conformational states satisfy the
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canonical distributions prior to exchange attempts. Some aggressive exchange schemes such as the
rejection-free RE291, while formally correct, do not allow sufficient importance sampling between
exchanges and will fail to generate canonical ensembles. This principle was thoroughly discussed
by Kouza and Hansmann291.
Given the Metropolis criterion of Equation 6.1, replicas that sample lower energy states naturally
tend to occupy lower temperatures, and those sampling higher energy states tend to occupy high
temperatures. For systems with sharp cooperative transitions, the low energy replicas will re-
main at low temperatures until spontaneous large-scale conformational transitions occur between
folded/compact and unfolded states. This can lead to apparent segregation of replicas in the
temperature space. The conformational transitions that allow replicas to escape trapping (at either
low or high temperature regions) will involve either spontaneous unfolding of folded/compact
states at low temperature or folding of disordered states at high temperature. Both transitions
are rare events and this further worsens the replica segregation problem as frequently observed in
protein RE simulations111,117,121,297,298. Arguably, this may be considered a fundamental limitation
of temperature RE, and one may have to consider Hamiltonian RE to overcome this limita-
tion135,299,300. Alternatively, RE-GA attempts to directly address the apparent replica segregation
through GA cycles, which modify the exchange attempt patterns to guide the folded/compact
replicas to visit higher temperatures more frequently and accelerate unfolding and/or to guide the
unfolded replicas towards lower temperatures to encourage folding transitions.
In this work, we mainly focus on three GA schemes. The first scheme is the cRE method
previously described by Spill et al.131, where replicas take turn to be the “stick replica” and
undergo convective annealing cycles. For that, the exchange attempts are chosen such that the
stick replica will first only try to exchange to higher temperatures until reaching Tmax. Then, the
stick replica will only attempt to exchange to lower temperatures. When the stick replica reaches
Tmin, the direction of exchange attempts is reversed again until the stick replica returns to its
original temperature. In this work, the cRE algorithm was slightly modified to include a convective
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annealing frequency, which specifies the number of regular RE steps between convective annealing
cycles. The original algorithm131 corresponds to the limit of annealing frequency zero. In the
second scheme, referred to as RE with selective annealing (RE-SA) hereafter, we periodically
select the lowest temperature replica and subject it to a GA cycle where only exchanges to
higher temperatures are attempted until the selected replica reach Tmax. The main difference
between RE-SA and cRE is that the replica is not guided to exchange toward Tmin right after
reaching Tmax, which allows the replica to spend more time at higher temperatures to escape
the stable energy minima. An alternative implementation of RE-SA is first to detect so-called
trapped replicas, whose average temperatures during last Ntrap RE cycles are below a preselected
threshold, and then periodically selected the trapped replica occupying the lowest temperature to
undergo GA cycles. These two implementations appear to be equivalent in practice, and we only
present the results for the implementation without explicit detection of temperature trapping. The
third scheme, denoted RE with random annealing (RE-RA), periodically selects a random replica,
regardless of its temperature, and subjects it to a GA cycle that guides it to reach Tmax before
being released. All RE-GA schemes have been implemented in MMTSB301.
Spill et al. have previously offered a formal proof of detailed balance for cRE131. The key
conclusion from the proof is that an algorithm driving the stick replica through complete round
trips in the temperature space should guarantee detailed balance. However, the proof contains
an error in reordering the double summation in Equation 5 of Ref.131. The reordering is only
correct if the numbers of actual exchange attempts required for successful exchange to higher and
lower temperatures are the same. However, in the presence of slow cooperative conformational
transitions, it will takes many more attempts for replicas occupying low energy states to exchange
to higher temperatures than returning to lower temperatures, and vice versa for replicas occupying
high energy states. As such, the net drift in the stationary distributions, B, as defined in Ref.131,
will be non-zero whenever spontaneous conformational transitions significantly lag (convective)
temperature cycles. In other words, cRE (and other RE-GA schemes) lead to unbalanced exchange
attempt probabilities and break the detailed balance condition when the conformational transitions
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are slow compared to the temperature diffusion timescales. The theoretical analysis will be
validated using both numerical and coarse-grained protein simulations.
6.2.2 Numerical RE simulations using a kinetic network model
Numerical simulations based on a two-state kinetic network model were performed to characterize
the properties of various RE-GA schemes and study the dependence of their performance on in-
herent conformational dynamics of the system. The system is assumed to undergo ideal two-state
transition between folded and unfolded states. As summarized in Table S6.1, four models with
different folding and unfolding activation enthalpy and entropy, denoted as ∆H†f , ∆H
†
u, ∆S
†
f and
∆S†u, respectively, are constructed. Given the folding and unfolding rates at different temperatures,
kf (T ) = e
−(∆H†f−T∆S†f )/kBT ,
ku(T ) = e
−(∆H†u−T∆S†u)/kBT ,
(6.2)
the probability of spontaneous conformational transitions during between replica exchange at-
tempts can be calculated as,
pf→u(T ) = 1− e−
∆t
τu(T ) ,
pu→f (T ) = 1− e−
∆t
τf (T ) ,
(6.3)
where ∆t is the time between exchange attempts, and τ = 1/k. The fifth model was design to
mimic the anti-Arrhenius behavior of protein folding114, where the folding activation enthalpy and
entropy vary linearly with respect to the temperature and its logarithm, respectively:
∆H†f (T ) = ∆H
†
f (T0) + (T − T0)∆C†p,
∆S†f (T ) = ∆S
†
f (T0) + ln(
T
T0
)∆C†p.
(6.4)
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When the activation heat capacity, ∆C†p, is negative, the activation enthalpy becomes negative and
the folding rate decreases as a function of temperature above T = T0−∆H†f (T0)/∆C†p. Table S6.1
summarizes the key parameters including temperature dependence of folding and unfolding times
of all five models. Note the parameters for model 5 were designed to mimic the Go¯-like model of
protein G B1 domain, where the folding rate displays anti-Arrhenius behavior from 300 K (that is
∆H†f (T0=300K)<0). The numerical simulations involve 4 or 8 replicas distributed exponentially
between 300 and 450 K (see Table S6.1). Temperature exchanges were attempted every 10 ps, and
the total length of each numerical simulation is 1.0 ms (100 million RE cycles). For each model,
10 independent numerical simulations were performed to analyze the conformational transition
statistics and thermodynamic properties.
6.2.3 Coarse-grained and atomistic protein simulations
Both coarse-grained and atomistic protein simulations were performed to further evaluate the cor-
rectness and efficiency of various RE-GA schemes. Following our previous work121, a sequence-
flavored Go¯-like model was derived from the PDB structure of protein G B1 domain (PDB:
3gb1290; see Figure 6.1A), using the Multiscale Modeling Tools for Structural Biology (MMTSB)
Go¯-Model Builder (http://www.mmtsb.org)232,233. The model was recalibrated to to have Tm
∼ 350K by uniformly adjusting the strength of all contacts. Standard RE, cRE and RE-SA
simulations were carried out using 8 replicas spanning 300 to 400K. For each replica, Langevin
dynamics simulation was performed using CHARMM63,216 with a dynamic time step of 10 fs
and a friction coefficient of 0.1 ps−1. We note that the use of small friction coefficient expedites
conformational dynamics and that test simulations using higher friction coefficients of 1.0 and 5.0
ps−1 generated virtually identical conformational ensembles. The SHAKE algorithm217 was used
to constrain all virtual bond lengths. Exchanges were attempted between neighboring replicas
every 5000 dynamics steps (50 ps). For RE-SA, the replica occupying the lowest temperature
was selected for GA every 1000 RE cycles (50 ns) upon the completion of the previous annealing
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cycle. The lengths of all simulations were 10 µs per replica. An additional RE-SA simulation was
initiated from a fully extended conformation (referred to as “folding” run) to examine the level of
convergence.
Figure 6.1: Folded structures of (A) protein GB1, shown in Cα-only trace representation, and (B) KID
domain, shown in the cartoon representation. The helical, sheet and loop regions are colored purple, yellow
and cyan, respectively.
Atomistic simulations of intrinsically disordered kinase inducible domain (KID; residues 119-146,
TD SQKRR EILSR RPSYR KILND LSSDA P) of the transcription factor CREB were performed
in the GBSW implicit solvent protein force field75,77. The folded conformation of KID was
derived from the pKID/KIX complex structure (PDB ID: 1kdx302; see Figure 6.1B). We have
previous characterized the disordered ensembles of KID using two independent 200-ns standard
RE simulations169. In the current work, two independent RE-SA simulations (control and folding)
were carried out using 16 replicas spanning 270 to 500 K. Langevin simulations were performed
with a friction coefficient of 0.1 ps−1, and temperature exchanges were attempted every 2 ps. The
SHAKE algorithm217 was used to constrain the lengths all bonds involving hydrogen atoms and
the dynamic time step was 2 fs. The GA frequency is every 200 RE steps (0.4 ns). The lengths
of both control and folding simulations are 50 ns per replica. All analysis was performed using a
combination of the MMTSB toolset, CHARMM and in-house scripts.
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6.3 Results
6.3.1 Evaluation of RE-GA schemes based on coarse-grained protein simulations
We first utilized the sequence-flavored Go¯-like model of protein G B1 domain (Figure 6.1A), to
investigate if the introduction of GA cycles could indeed enhance the sampling efficiency and to
examine if RE-GA could generate correct canonical ensembles. Go¯-like models are based on the
principle of minimal frustration for evolved proteins98, and have been shown to be capable of
generating realistic reversible folding transitions229. These models thus provide a good balance
between the level of realisticity and computational tractability for rigorous evaluation of the
proposed RE-GA schemes. As illustrated in Figure 6.2A, introduction of GA cycles, in both
cRE and RE-SA schemes, dramatically accelerated folding and unfolding transitions compared
to the standard RE. Specifically, about 110 and 350 reversible folding transitions were observed
during the 10-µs cRE and RE-SA simulations, respectively, compared to only 8 such transitions
during the standard RE simulation. Therefore, GA cycles seem effective in overcoming the
apparent segregation of replicas in the temperature space and dramatically enhance conformational
sampling. Furthermore, not requiring the replica to return to low temperatures upon reaching
Tmax in RE-SA appears more efficient in driving sampling, generating over 3-fold more reversible
transitions compared to cRE.
Further analysis of the thermodynamic properties revealed systematic differences in the ensembles
derived from cRE and RE-SA simulations compared to the standard RE. For example, Figure
6.2B compares the free energy profiles as a function of the total native contact fraction. Even
though all free energy profiles are well converged (e.g., comparing RE-SA control vs. folding in
Figure 6.2B), both cRE and RE-SA significantly under-estimate the stability of the folded state
with respect to the unfolded state. The folding temperature, Tm, calculated from RE-SA is 17
K lower than the reference value calculated from RE. Similar observations can also be made
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Figure 6.2: (A) The time evolution of the native contact fraction for three representative replicas, selected
from the standard RE, RE-SA, and cRE control simulations of protein GB1, respectively. (B) Free energy
profiles as a function of the total native contact fraction of protein GB1 at 300 K, calculated from the last 8
µs of the 10-µs standard RE, cRE and RE-SA simulations.
when comparing various multi-dimensional free energy surfaces, which consistently show that
RE-SA over-estimates the unfolded population in the simulated ensembles (e.g., see Figure S6.1).
The observation that cRE and RE-SA, even though apparently effective in driving faster folding
transitions, lead to systematic biases in the simulated ensembles is consistent with the theoretical
analysis, which concludes that exchange attempt probabilities are not balanced with GA cycles
in the presence of slow cooperative conformational transitions (see Method). Spill et al.131 aslo
observed systematic over-representation of high-energy states in their cRE simulations (e.g., see
Table 1 of Ref.131), even though this was thought to merely reflect a natural consequence of more
extensive sampling of cRE.
6.3.2 Numerical simulations of RE-GA schemes
Numerical simulations were performed to further investigate how the systematic bias of various
RE-GA schemes depends on inherent conformational dynamics of the system and key GA param-
eters. As summarized in Table 6.1 and S6.1, four models with increasing folding enthalpy and
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Table 6.1: Summary of model parameters and key statistics of the numerical RE and RE-SA simulations.
Only results from RE-SA simulations with an annealing frequency of every 1000 RE cycles are shown.
Results using different GA frequencies and the additional RE-RA scheme are shown in the Supporting
Materials (Figure S6.2 and Figure S6.3). Full model parameters are shown in Table S6.1.
Model
∆Hf ∆Sf RE RE-SA
(kcal/mol) (kcal/mol) Keq NTS Keq/Keq0 Keq NTS Keq/Keq0
1 -1.5 -3.75 0.52±0.02 250.3±19 0.99 0.54±0.02 251.2±19 1.01
2 -6 -15 0.082±0.03 12.2±3.6 1.01 0.076±0.01 12.5±3.3 0.95
3 -9 -22.5 0.021±0.006 3.5±1.7 0.91 0.017±0.007 3.9±1.4 0.75
4 -12 -30 6.5±0.1×10−3 3.0±1.5 1.00 2.7±0.1×10−3 3.6±1.7 0.41
5 -38 -111 3.7±0.1×10−4 58.8±8.6 1.07 2.1±0.1×10−3 178.5±16 6.05
∆Hf and ∆Sf denote the folding enthalpy and entropy, respectively. The ideal unfolding
equilibrium constant is calculated as Keq0 = e[(∆Hf−T∆Sf )/RT ]. Simulated Keq values were
calculated directly from the statistics collected at T = 300 K.NTS denotes the number of reversible
transitions sampled per replica. The average and standard deviations from 10 independent
numerical simulations are shown.
entropy were designed to mimic ideal 2-state proteins of increasing size and stability. Model 1
has the lowest folding energy barrier and conformational transitions occur at fast ns timescales.
It represents highly flexible proteins with mostly local structural transitions, such as intrinsically
disordered proteins (IDPs)1,3,35. In contrast, model 4 has sizable folding enthalpy and entropy, and
the folding and unfolding transitions occur at µs to ms timescales. This model mimics moderately
sized proteins with slow corporative folding transitions. The results of numerical simulations of
the standard RE and three RE-GA schemes (cRE, RE-SA and RE-RA) using these four models are
summarized in Table 6.1 and Figure 6.3. More results are summarized in Figure S6.2 and S6.3.
The results confirm that all RE-GA schemes lead to systematic errors in calculated equilibrium
constants for models with slow conformational transitions (e.g., models 3 and 4; Figure S6.2 C-D).
The systematic errors decreases with lower folding/unfolding barriers and faster conformational
transitions, and become minimal for model 1. In contrast, the standard RE always generates
proper canonical ensembles and recovers the expected equilibrium constants for all models (also
see Table 6.1). Therefore, RE-GA does break detail balance and fails to generate proper canonical
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ensembles. As expected, all RE-GA schemes eventually recover the correct behavior of the
standard RE with less frequent annealing cycles.
Figure 6.3: Numerical simulations of RE-SA using (A) model 3 and (B) model 5. The specific model
parameters are provided in Table S6.1. The red traces plot the number of reversible transitions per replica
(NTS) and the black traces plot the calculated folding free energies. The dashed lines mark the ideal
folding free energies. Errors bars shown correspond to the deviations of 10 independent 1 ms numerical
simulations.
A surprising observation from the numerical simulations is that, as summarized in Figure 6.3A
and S6.3, introduction of GA cycles does not lead to any significant increase in the numbers of
conformation transitions sampled for models 1 through 4. The implication is that the standard RE
protocol is already as efficient as possible for enhanced sampling of systems that have positive
activation enthalpies and display Arrhenius temperature dependence. This observation apparently
contradicts the results from coarse-grained protein simulations (e.g., see Figure 6.2A). To rec-
oncile this discrepancy, we designed an ideal 2-state model with folding and unfolding barriers
similar to those derived from the Go¯-like model of protein G B1 domain (model 5 in Table 6.1).
Model 5 is anti-Arrhenius with a negative folding activation enthalpy and a large folding entropic
barrier. Numerical simulations showed that RE-SA did accelerate reversible transitions about
3-fold compared to RE, albeit at the same time over-estimating Keq about 6-fold (Table 6.1).
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6.3.3 Atomistic simulation of intrinsically disordered KID protein
The observation that RE-GA leads to minimal systematic errors for systems with small transition
free energy barriers suggests that RE-GA may be uniquely suitable for simulating disordered
ensembles of IDPs. In particular, we have previously observed that the tendency of current
implicit solvent protein force fields to over-stabilize nonspecific collapsed states severely limits
the ability to generate well-converged ensembles for moderately sized IDPs using the standard RE
protocol1,34. Here, we evaluate the applicability and efficiency of RE-SA for simulating the KID
domain in the GBSW implicit solvent77. Our previous work showed that it required over 160 ns for
the standard RE simulations to achieve satisfactory convergence in the simulated conformational
ensembles169 (also see Figure 6.4D-F). In contrast, RE-SA appears to achieve convergence well
within 50 ns. As shown in Figure 6.4, the residue helicity profiles from both the control and
folding RE-SA simulations fully stabilize within 40 ns (Panels A-B), while in RE simulations the
profiles continue to fluctuate up to the full simulation time span of 200 ns (especially in the control
run; Panels D-E). Comparing results derived from the converged segments of RE and RE-SA
simulations (last 40%), summarized in Panels C and F, shows that control and folding RE-SA runs
yielded essentially identical helicity profile with a root-mean-square difference (RMSD) of 0.022,
while substantial differences persist in the RE-derived profiles (RMSD = 0.088) despite four times
longer sampling time. Importantly, the final helicity profiles derived from RE and RE-SA are
similar, and both agree with previous NMR chemical shift analysis303. We have further examined
the distributions of helical substates in the simulated ensembles. The results, shown in Figure
6.5, demonstrate that the same states were sampled by RE-SA with similar probabilities (e.g.,
compared to Figure 5a of Ref.169), but much higher efficiency. In particular, the 2D distributions
derived from the control and folding runs are better converged with shorter RE-SA simulations
(RMSD = 0.0012) compared to those derived from longer RE simulations (RMSD = 0.0047;
Figure S1 of Ref.169). Therefore, RE-SA was able to generate apparently correct disordered
conformational ensembles of KID with several fold higher efficiency compared to RE.
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Figure 6.4: Convergence of calculated residue helicity profiles of KID using RE-SA (A)-(C) and RE (D)-
(F). Only conformations sampled at 285 K were considered in the analysis. Panel (C) compared results
from the last 20 ns of control and folding RE-SA simulations, and Panel (F) compared results from the last
80 ns of the control and folding RE simulations previously reported169.
Interestingly, the most important differences between the conformational ensembles generated by
RE and RE-SA are observed in the biopolymer properties. The end-to-end distance distributions
derived from RE and RE-SA simulations, shown in Figure 6.6, cover similar ranges between 5
to 25 A˚. However, RE-SA yields much smoother and more continuous distributions, while the
RE-derived distribution contains more features and is dominated by a few compact states with
small end-to-end distances. The interpretation, derived largely based on direct examination of
the temperature and conformational evolution of replicas as a function of simulation time, is that
KID were frequently trapped in nonspecific collapsed states during the RE simulation. While the
tapping did not appear to prevent the peptide to visit various local (helical) structures, it clearly
reduces the efficiency of local sampling in RE. In contrast, GA cycles appeared to be highly
effective in assisting the peptide to escape the collapse states, which allows the peptide to visit a
wide range of global configurations and facilitate the sampling of local structures in RE-SA. The
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Figure 6.5: Probability distributions of helical substates of KID derived from the last 20 ns of 50-ns RE-SA
control (A) and folding (B) simulations. The helical states are defined based on the helix starting position
and length. Contours are drawn at 0.002, 0.005, 0.01, 0.02, 0.04 and 0.06 levels.
caveat is that RE-SA may generate ensembles that are overly expanded.
6.4 Discussion
We have examined the ability of various RE-GA schemes including the recently developed cRE
method131 to enhance conformational sampling and generate proper canonical ensembles. The
introduction of GA cycles has been motivated by the observation that replicas in the standard RE
tend to segregate in the temperature space in the presence of sharp cooperative transitions such as
protein folding. Theoretical analysis argues that introduction of GA cycles results in unbalanced
exchange attempt probabilities and thus breaks the detailed balance condition whenever sponta-
neous conformational transitions lag temperature diffusion. This conclusion is validated by both
coarse-grained protein simulations and numerical RE simulations using 2-state kinetic models.
The numerical simulations further reveal that GA cycles only accelerate sampling for systems
that display anti-Arrhenius kinetics. For systems with positive folding activation enthalpies,
the standard RE appears to be already maximally efficient. Another key observation from the
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Figure 6.6: Distributions of the end-to-end distance of KID, calculated from (A) the last 80 ns of 200-ns
RE folding simulation169 and (B) the last 20 ns of the control and folding RE-SA simulations.
numerical simulations is that systematic errors introduced by GA cycles diminish for systems
with low transition barriers. This observation suggests that RE-GA may be uniquely suitable
for disordered protein states such as IDPs, an important class of recently recognized functional
proteins3,35. In particular, the peptide is frequently trapped in nonspecific collapsed states during
the RE atomistic simulations74, and GA cycles should be highly effective in assisting the peptide
to escape these trapped states and better sample local conformational states. Indeed, application
to a prototypical model IDP demonstrates that RE-GA achieves superior convergence in con-
formational properties with merely one-fourth of simulation time compared to the standard RE.
Importantly, no systematically difference was observed between the conformational ensembles
derived from RE and RE-GA simulations, except certain biopolymer properties where improved
sampling of RE-GA yields smooth and continuous distributions expected for highly disordered
peptides. At present, quantitative estimate of the potential systematic errors introduced by the
GA cycles does not appear feasible for an unknown system. This is an important caveat of the
proposed RE-GA protocols. Nonetheless, the numerical simulations based on ideal 2-state models
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suggest that the error in the calculated folding equilibrium constant is only ∼5% for model 2 with
modest barriers (∆H†f = 1 kcal/mol and ∆H
†
u = 7 kcal/mol; see Table 6.1 and Table S6.1). The
implication is that RE-GA should be applicable to most intrinsically disordered proteins, where
the activation barriers for transitions between conformational states are expected to be small. For
these systems, the systematic error introduced by the GA cycles is likely much smaller than the
achievable level of convergence (e.g., see Figure 6.3A). Therefore, we anticipate that RE-GA will
be very useful in simulation of disordered protein states in general, despite its inherent tendency
to introduce systematic errors for simulating folded proteins.
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6.5 Supplemental Materials
Figure S6.1: 2D Free energy surface as a function of the total fraction of native contacts formed (Qintra)
and the fractions of native contacts formed in either the C-terminal β-hairpin (Q-CT) or the N-terminal
β-hairpin (Q-NT). The free energy surfaces were derived based on conformations sampled at 300 K during
the last 8 µs of the standard RE and RE-GA coarse-grained simulations of protein GB1. Comparison of
results from the control and folding RE-GA runs demonstrates that the free energy surfaces are very well
converged but deviate significantly from those derived from the standard RE run.
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Table S6.1: Key parameters of kinetic models used in numerical RE simulations.
Condition Temperature (K) ∆Gf (kcal/mol) τf (ns) τu(ns)
Model 1
∆H†f = 0.25 kcal/mol, ∆S
†
f = -1.25 kcal/K/mol
∆H†u = 1.75 kcal/mol, ∆S
†
u = 2.5 kcal/K/mol
0 300.0 -0.375 2.86 5.35
1 343.4 -0.212 2.71 3.69
2 393.1 -0.026 2.58 2.67
3 450.0 0.188 2.48 2.01
Model 2
∆H†f = 1 kcal/mol, ∆S
†
f = -5.0 kcal/K/mol
∆H†u = 7 kcal/mol, ∆S
†
u = 10 kcal/K/mol
0 300.0 -1.5 66.28 820.81
1 343.4 -0.849 53.61 186.02
2 393.1 -0.103 44.55 50.86
3 450.0 0.75 37.89 16.37
Model 3
∆H†f = 1.5 kcal/mol, ∆S
†
f = -7.5 kcal/K/mol
∆H†u = 10.5 kcal/mol, ∆S
†
u = 15 kcal/K/mol
0 300.0 -2.25 539.64 23515.74
1 343.4 -1.273 392.6 2537.17
2 393.1 -0.155 297.34 362.62
3 450.0 1.125 233.25 66.28
Model 4
∆H†f = 2 kcal/mol, ∆S
†
f = -10 kcal/K/mol
∆H†u = 14 kcal/mol, ∆S
†
u = 20 kcal/K/mol
0 300.0 -3 4393.38 673718.08
1 343.4 -1.698 2874.79 34604.32
2 393.1 -0.207 1984.6 2585.81
3 450.0 1.5 1435.8 268.24
Model 5
∆H†f = -18 kcal/mol, ∆S
†
f = -61 kcal/K/mol
∆H†u = 20 kcal/mol, ∆S
†
u = 50 kcal/K/mol
0 300.0 -4.7 0.02 43.93
1 317.9 -2.71 0.09 6.648
2 336.8 -0.61 0.45 1.12
3 356.9 1.62 2.04 2.083
4 378.2 3.98 8.53 0.042
5 400.8 6.49 32.82 0.01
6 424.7 9.14 117.07 0.002
7 450.0 11.95 388.98 0.001
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Figure S6.2: The ratio between calculated and expected equilibrium constants as a function of guided
annealing frequency for different models. The error bars are not shown for clarity. Note that the RE-GA
numerical simulations were not well converged within 1 ms numerical simulation timescale for model 4
due to very slow conformational transitions.
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Figure S6.3: Number of reversible transitions as a function of guided annealing frequency calculated from
various RE simulations using different models.
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Figure S6.4: Representative structures of KID domain from RE simulation. Corresponding end-to-end
distance is listed below each structure.
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Figure S6.5: Representative structures of KID domain from RE-SA simulation. Corresponding end-to-end
distance is listed below each structure.
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Chapter 7
Accelerate Sampling in Atomistic Energy Landscapes
Using Topology-based Coarse-grained Models∗
Abstract
We describe a multi-scale enhanced sampling (MSES) method where efficient topology-based
coarse-grained models are coupled with all-atom ones to enhance the sampling of atomistic protein
energy landscape. The bias from the coupling is removed by Hamiltonian replica exchange, thus
allowing one to benefit simultaneously from faster transitions of coarse-grained modeling and
accuracy of atomistic force fields. The method is demonstrated by calculating the conformational
equilibria of several small but nontrivial β-hairpins with varied stabilities.
∗Reprinted (adapted) with permission from W. Zhang and J. Chen (2014), ”Accelerate sampling of atomistic
energy landscapes using topology-based coarse-grained models” J. Chem. Theory Comput. 10, 918-923. Copyright
(2014), American Chemical Society.
Author Contributions: Conceived and designed the experiments: JC WZ. Performed the experiments: WZ JC.
Analyzed the data: WZ JC. Contributed reagents/materials/analysis tools: WZ JC. Wrote the paper: WZ JC.
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7.1 Introduction
Generating statistically representative conformational ensembles remains a major challenge in
atomistic simulation of biomolecules179. This is not only due to the large and complex confor-
mational space, but also because of significant energy barriers that frequently separate different
subspaces. Temperature replica exchange (T-RE)104,177 is now widely accepted as a relatively
straightforward yet powerful technique for enhanced sampling. Multiple replicas of the system
are simulated independently at different temperatures, and periodically attempt to exchange sim-
ulation temperatures according to a Metropolis criterion that preserves the detailed balance. The
resulting random walk in the temperature space helps each replica to escape local energy minima
and thus facilitate conformational sampling. Extensive theoretical and simulation studies have
confirmed that T-RE enhances sampling compared to constant temperature simulations as long as
the activation enthalpies of conformational transitions are positive114,116,117,119. Nonetheless, the
efficiency of T-RE can be severely limited by the presence of sharp cooperative conformational
transitions such as protein folding120. Importantly, this limitation cannot be overcome by various
T-RE variants designed to accelerate either exchanges or diffusion in temperature space121. In
practice, virtually all T-RE protein simulations involve exchange attempt frequencies (∼ps−1)
that are several orders of magnitude faster than the slowest protein motions (folding; µs−1 or
slower249). As such, the efficiency of T-RE sampling of large-scale conformational transitions is
rarely limited by diffusion in temperature space, but mainly by the inherent rates of spontaneous
processes.
Fundamentally, the limited efficiency of T-RE in sampling cooperative transitions such as protein
folding can be attributed to large entropic components in the free energy barriers132,133. The fold-
ing rate only depends weakly on temperature and often displays anti-Arrhenius behaviors114,134,
such that tempering is ineffective in driving transitions. Instead, coarse-grained (CG) models304
are often utilized to significantly reduce the conformational space and allow faster reversible
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transitions; but this is achieved at the expense of reduced detail and accuracy. An ideal approach
could involve CG modeling to overcome major entropic barriers and at the same time seamlessly
propagates the transitions to atomistic simulations for detailed sampling of different conforma-
tional subspaces. A key requirement is that one must be able to recover canonical ensembles
at the atomistic level. The promise of such multi-scale enhanced sampling (MSES) has been
well recognized, and several clever ideas have been proposed towards this goal125,135–139. The
resolution exchange approach is particularly interesting137. It involves independent simulations of
the system at two or more resolutions and attempts to directly swap shared coordinates of low-
and high-resolution models according to Metropolis criteria. Resolution exchange in principle
allows the possibility of injecting high-resolution simulation into novel conformational subspaces
sampled at low-resolution. A key limitation is that conformations sampled at different resolutions
must be similar to be exchangeable for large biomolecules, as excessive bad contacts would
effectively prohibit successful exchange. A smart resolution replica exchange was proposed to
improve exchange acceptance, where a ladder of mixed atomistic and CG potentials are used
and CG-sampled configurations are relaxed prior to exchange attempt305. However, the detailed
balance is broken due to relaxation and only canonical sampling is achieved. More importantly,
the aggressive approach of direct coordinate swap in resolution exchange, with or without relax-
ation, requires configurations sampled at different resolutions to closely track each other, which
counteracts the purpose of rapid hopping among drastically different conformational subspaces
sampled at the CG level.
The efficacy of an MSES scheme, regardless of how sampling at different resolutions is coupled,
depends critically on the ability of CG simulations to generate transitions that are consistent with
inherent conformational dynamics of the atomistic model. Otherwise, CG simulations would
attempt to engage the atomistic model along unfavorable pathways and become ineffective in
accelerating atomistic transitions. For proteins, topology-based CG modeling has been highly suc-
cessful and demonstrated impressive correspondence between experiment and theory for folding
mechanisms229. This approach is based on to the minimal frustration theory of protein folding98,
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which argues that native interactions dictate the protein free energy landscape and that stabilization
due to non-native contacts (“frustration”) should be minimal. Accordingly, the true protein energy
landscape can be approximated by effective energy functions that only include native interactions.
These effective energy functions, commonly referred to as Go¯ or Go¯-like models, are highly
efficient, and yet powerful enough to generate realistic reversible folding pathways. As such,
they should be ideally suitable for driving conformational sampling on atomistic protein energy
landscapes. Here, we describe an MSES approach that utilizes the efficient sequence-flavored
Go¯-like model232 to accelerate the sampling of atomistic protein conformational equilibria, and
demonstrate its efficiency using a series of small but nontrivial β-hairpins with varied stabilities.
7.2 Methods
7.2.1 Multi-scale enhanced sampling (MSES) method
Our approach is inspired by Moritsugu et al.’s multi-scale essential sampling method139, where
both the CG and atomistic representations of the protein are simulated simultaneously in a hybrid
system. The atomistic and CG copies do not interact, and are only coupled through restraint
potentials designed to restrict the divergence between CG and atomistic configurations. The
overall potential function of the hybrid system is
Umix(rAT , rCG, λ) = UAT (rAT ) + UAT (rAT ) + λUMSES(rAT , rCG), (7.1)
where UAT and UCG are the atomistic and CG potential functions, respectively. Only the coupling
potential UMSES depends on both atomistic (rAT ) and CG (rCG) coordinates. Given a proper
coupling potential, the atomistic and CG copies can be restrained to track one and another when
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the overall coupling scaling factor λ = 1. Hamiltonian RE can be performed to communicate
coupled conformational dynamics to the limit of λ = 0, where the CG and atomistic copies are fully
independent and proper canonical ensembles are generated simultaneously at both resolutions.
Our MSES approach incorporates both Hamiltonian and temperature RE to further accelerate con-
formational sampling. Specifically, N replicas of the hybrid system are simulated independently
with increasing couple scaling factors and temperatures, {λi, Ti}, i = 1, 2, ..., N. λ1 = 0 and λN =
1. Replicas periodically attempt to exchange simulation conditions according to
Pm↔n = min(1, e∆mn), (7.2)
where ∆mn = βm[Umix(rAT,m, rCG,m, λm)−Umix(rAT,n, rCG,n, λm)]+βn[Umix(rAT,n, rCG,n, λn)−
Umix(rAT,m, rCG,m, λn)], and β = 1/kBT (kB is the Boltzmann constant). When the same
temperature is used for all replicas, the exchange probability is determined by the coupling term
only, allowing excellent scalability to large systems139.
Coupling the CG and atomistic models using restraint potentials is a significant advantage com-
pared to direct coordinate swapping in resolution exchange. It allows one to control the impacts of
large divergences between CG and atomistic configurations on the total energy, which dramatically
improves exchange efficiency and provides superior scalability to large systems. Motivated by
the notion that native contacts dictate protein folding transitions98, the CG and atomistic copies
are coupled by penalty functions that depend on the differences in Cα-Cα distances of residues
involved in all native contacts:
UMSES =
∑
Ei(∆di) =
∑ 1
2
ki(d
AT
i − dCGi )2, (7.3)
where ∆di = dATi − dCGi ,and dATi and dCGi are the Cα-Cα distances of the ith native contact in
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atomistic and CG copies, respectively. The force constant, ki, can be different for various subsets
of native contacts, for example, to emphasize the relative importance of tertiary contacts vs. local
secondary ones. For large proteins with hundreds of native contacts, the simple harmonic potential
of Equation 7.3 can lead to large penalty energies and result in severe exchange bottlenecks,
particularly between the uncoupled (λ1 = 0) and coupled (λ > 0) conditions. For this, a restraint
potential with a soft asymptote is used at large ∆di,
Ei(∆di) = A+
B
(∆di)s
+ fmax∆di, if ∆di > ds. (7.4)
In Equation 7.4, ds is the distance threshold where the penalty function Ei(∆di) switches from
the harmonic form (Equation 7.3) to the soft asymptote. The switching exponent s controls how
quickly the limiting slope, fmax, is approached at large ∆di. The parameters A and B are identified
by requiring bothEi(∆di) and its first derivative to be continuous at the switching distance (∆di =
ds). We note that similar penalty functions with soft asymptotes are widely employed in NMR
structure calculations306. The purpose is to avoid premature structural collapse due to a few large
distance restraint violations and thus allow better conformational sampling to generate structures
that are maximally consistent with all structural restraints. The simulations in the current work
only involve exchanging a ladder of models with different λi. More sophisticated Hamiltonian RE
schemes can be devised that involve additional parameters of the restraint potentials, particularly
ki, ds and fmax , to more carefully control how conformational transitions are communicated
between CG and atomistic copies for larger proteins.
7.2.2 Simulation protocols
The MSES method has been implemented in CHARMM216 and MMTSB215. Its efficacy is
examined here using a series of β-hairpins derived from the protein G B1 domain, including GB1p
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(GEWTYD DATK TFTVTE), GB1m1 (GEWTYD DATK TATVTE), and, GB1m3 (KKWTYN
PATG KFTVQE) (loop regions underlined and key mutations highlighted in bold fonts). The
wild-type GB1p is ∼42% folded at 278K based on NMR chemical shift analysis307. The Phe
to Ala mutation in GB1m1 reduces the hairpin stability to ∼6% folded, and the more rigid
proline-containing loop increases the stability of GB1m3 to ∼86% folded307. These β-hairpins,
albeit small, resemble larger proteins in many essential aspects including cooperative folding
transitions and microsecond folding timescales. The optimized generalized born with smooth
switching (GBSW) atomistic implicit solvent force field appears to recapitulate both the structures
and stabilities of these β-hairpins77. However, the previous T-RE simulations failed to generate
converged conformational ensembles for GB1p77. In fact, no reversible folding/unfolding transi-
tion was sampled by T-RE for any of these β-hairpins, and the apparent convergence for GB1m1
and GB1m3 ensembles was mainly due to mixing of conformational states sampled at different
temperatures.
A sequence-flavored Go¯-like model was first generated by the MMTSB Go¯-Model Builder232 and
then used in simulations of all three hairpins. The model represents each residue using a single
Cα bead and adopts the Miyazawa-Jernigan (MJ) statistical potential234 for residue-specific native
interactions. The Go¯-like model was coupled to the GBSW atomistic implicit solvent model (Fig-
ure 7.1a), by imposing the restraint potentials on all nine native contacts (see Equation 7.3-7.4).
All MSES simulations were performed using 8 replicas with (λi, Ti)= (0, 270), (0.05, 290), (0.1,
312), (0.25, 336), (0.4, 361), (0.6, 388), (0.8, 418), and (1.0, 450). These conditions were assigned
by having roughly exponential distributions for both λ and T. The exchange acceptance rates were
uniform and ∼25% for all MSES simulations. Other parameters of the MSES restraint potential
were: k = 1.0 kcal/mol/A˚2, s = 1, ds = 2.0 A˚ and fmax = 0.1 kcal/mol/A˚. We note that the soft
asymptote has minimal impacts on the exchange and sampling efficiencies for these small hairpins.
Langevin simulations were performed with a friction coefficient of 0.1 ps−1, and exchanges were
attempted every 2 ps. For each peptide, two independent simulations were performed, starting
from the folded (control) and fully extended (folding) structures, respectively. The length of
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all MSES simulations was 100 ns per replica. Control and folding T-RE simulations were also
performed for GB1p as a reference. These simulations are summarized in Table 7.1.
Figure 7.1: Folded structure and simulated ensembles of GB1p. (a) Left: Atomistic structure of GB1p.
Dashed lines indicate all seven native hydrogen bonds. Right: Hybrid model containing atomistic (cyan
cartoon) and Cα-only CG (red beads) copies. (b) Probability distributions of the number of native contacts
for CG ensembles derived from a reference T-RE simulation of the Go¯ model alone (solid line) and the
MSES control simulation of GB1p (solid line with circles).
7.3 Results and Discussion
7.3.1 MSES simulations recover the correct canonical ensembles
We first validate if MSES can indeed recover the correct canonical ensembles at the uncoupled
condition. Reliable reference atomistic ensembles are not available for these hairpins due to
apparent difficulty in achieving convergence using T-RE simulations77. Therefore, we compare the
CG ensembles derived from MSES simulations to a reference ensemble obtained from a 4-µs T-RE
simulation of the Go¯-like model alone. Over 1300 reversible folding transitions were sampled
in the T-RE simulation and the resulting reference CG ensemble at 270 K is fully converged.
As illustrated in Fig 1b, MSES simulations generated CG ensembles virtually identical to the
reference. That is, bias due to coupling between atomistic and CG models is completely removed
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Table 7.1: Summary of T-RE and MSES simulations of GB1p, GB1m1 and GB1m3. All simulations
involve 8 replicas and last 100 ns. NTS is the number of reversible folding transitions sampled by all
replicas during the entire course of the simulation. The effective reversible transition rate kTS is calculated
as NTS divided by total simulation time (800 ns in all cases).
Sequence Protocol Run NTS kTS(ns−1)
GB1p T-RE Control 1 0.0013
Folding 0 -
GB1p MSES Control 43 0.054
Folding 33 0.041
GB1m1 MSES Control 32 0.04
Folding 20 0.025
GB1m3 MSES Control 34 0.043
Folding 26 0.033
via Hamiltonian RE as expected. The co-evolution of the CG and atomistic copies during MSES
simulations is illustrated in Figure S7.1. As designed, the CG and atomistic conformations can
diverge at low temperature/weak coupling conditions, but strongly track one and another at high
temperature/strong coupling conditions.
7.3.2 Efficiency of MSES simulations
The efficacy of MSES in accelerating large-scale atomistic conformational transitions is first eval-
uated by calculating the number of reversible transitions between the folded (≥5 native hydrogen
bonds) and unfolded (no hydrogen bond) states at the atomistic level. Summarized in Table 7.1,
the results show that T-RE simulations rarely sampled reversible folding transitions, with only
one such event observed in the control and folding runs of GB1p. In contrast, many reversible
transitions (∼31 on average) were sampled in MSES simulations of all β-hairpins, reflecting
almost two orders of magnitude enhancement in the efficiency of sampling atomistic transitions.
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Figure 7.2 depicts the evolution of the number of native hydrogen bonds from representative
T-RE and MSES replicas. The T-RE replicas remain at either the folded or unfolded states
throughout the simulation (Figure 7.2a); whereas all MSES replicas undergo rapid reversible
transitions between the folded and unfolded states (Figure 7.2b), apparently driven by coupling
to the efficient Go¯-like model. To further evaluate the effects of MSES coupling on folding
kinetics and efficiency, we performed multiple sets of folding simulations of GB1p at 270 K using
the GBSW, Go¯-like, and hybrid potentials (Equation 7.1). 100 50-ns simulations were initiated
from unfolded atomistic and CG structures randomly selected from pre-generated equilibrium
ensembles (see Table S7.1 and Figure S7.2). The results show that coupling with the CG model
allowed the atomistic model to reach the folded state in 34% of the trajectories within <18 ns on
average, while all simulations in GBSW alone were trapped in various compact states and failed
to fold within 50 ns. The dramatic improvement in atomistic folding efficiency was achieved with
only a moderate 50% increase in the average folding time of the CG model (from 0.83 to 1.19
ns). Curiously, we observed that the CG model actually also underwent faster reversible folding
transitions in MSES simulations, with an average rate of kTS ∼ 0.084 ns−1 compared to kTS ∼
0.041 ns−1 in the T-RE simulation of the Go¯-like model alone. This is likely because that coupling
with the atomistic model accelerates unfolding transitions at the CG level.
Figure 7.2: Numbers of native hydrogen bonds as a function of time for representative replicas from (a)
T-RE and (b) MSES control simulations of GB1p. Gray lines depict the raw data, and black and red lines
show the 50-ps running averages.
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7.3.3 Convergence of MSES simulations
Ideally, a fully converged RE simulation should involve all replicas sampling the same entire
accessible conformational space. This limit is almost never achieved in atomistic T-RE simulations
of nontrivial peptides and proteins, where individual replicas generally sample separate major
conformational states throughout the simulations (e.g., see Figure 7.3a-c). Amazingly, MSES
simulations of all three β-hairpins display many characteristics of full convergence, with all
replicas sampling similar, complete atomistic conformational spaces (Figure 7.3e-g and Figure
S7.3). When combining information from all replicas, T-RE and MSES simulations appear to
cover similar conformational spaces (Figure 7.3d and 7.3h), even though T-RE under samples
most regions except the major free energy basins. Atomistic conformational ensembles derived
from independent control and folding runs were compared to further evaluate the ability of MSES
to achieve convergence in key thermodynamic properties. Figure 7.4 compares the probabil-
ity distributions of the number of native hydrogen bonds. The results show that MSES does
generate largely consistent ensembles from the control and folding runs. Especially for GB1p,
large discrepancies that persist between control and folding T-RE runs (Figure 7.4a) are greatly
reduced (Figure 7.4b). We also note that, although the same Go¯-like model was used for all three
β-hairpins, the MSES simulations were able to recapitulate varied stabilities of these sequences
in the GBSW implicit solvent as expected. Nonetheless, despite impressive conformational space
coverage by all replicas in MSES simulations (Figure 7.3e-g and Figure S7.3), substantial dif-
ferences persist in ensembles derived from control and folding MSES runs, except for GB1m3
with a more rigid proline-containing loop. This illustrates the formidable challenges in generating
converged equilibrium ensembles even for small but flexible peptides.
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Figure 7.3: Conformational space sampled by individual replicas in the T-RE (a)-(c) and MSES (e)-(g)
control simulations of GB1p. Panels (d) and (h) were calculated by including all replicas. All atomistic
conformations sampled during the last 80 ns of these simulations, regardless of the temperature or coupling
scaling factor, were included to compute the pseudo-free energy surfaces, which are plot in the unit of kT.
Contours are shown at 1, 3, 5, and 7 kT levels.
7.4 Conclusions
In conclusion, we have developed an effective MSES approach that utilizes efficient topology-
based CG models to accelerate the sampling of complex and rough atomistic energy landscapes.
The CG and atomistic model are coupled using native contact-based restraint potentials that
are motivated by the current understanding of protein folding mechanisms as well as lessons
from NMR structure calculations and allow excellent scalability to larger and more complex
systems. The bias from the coupling potential is removed by performing Hamiltonian/temperature
RE, allowing one to benefit simultaneously from faster transitions of the CG model and the
accuracy of the atomistic force field. Application to implicit solvent simulations of small but
nontrivial GB1p series of β-hairpins demonstrates that MSES dramatically accelerate atomistic
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Figure 7.4: Probability distributions of the number of native hydrogen bonds for GB1p (a)-(b), GB1m1
(c), and GB1m3 (d). These distributions were calculated from structure ensembles extracted from the last
80 ns of T-RE or MSES simulations at T = 270K (and λ = 0) (see Table 7.1).
folding/unfolding transitions and improves the convergence of various thermodynamic properties
of interest. We anticipate MSES to be highly useful whenever generation of well-converged
protein conformational ensembles is critical, including intensive current efforts that rely on peptide
simulations to optimize implicit and explicit solvent protein force fields76,308.
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7.5 Supplemental Materials
Figure S7.1: Co-evolution of the numbers of native H-bonds of the CG and atomistic copies for
a representative replica from the MSES control simulation of GB1p. The black and red traces are
the raw data and green and blue are 20-ps running averages in the lower panels. It illustrates that
the CG model often undergoes conformational changes first, which in turn drives the atomistic model
through similar transitions. It also illustrates how the CG and atomistic conformations tend to diverge
at low temperature/weak coupling conditions (small indices) but strongly track one and another at high
temperature/strong coupling conditions (large indices).
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Table S7.1: GB1p folding efficiency and rates at 270 K using the GBSW, Go¯-like, and hybrid potentials
(Equation 7.1 of the main text). The MSES constant temperature runs were performed with full coupling
strength (λ = 1, k = 1.0 kcal/mol/A˚2, s = 1, ds = 2.0 A˚ and fmax = 0.1 kcal/mol/A˚). The results show that
MSES coupling only slightly reduces the folding kinetics of the Go¯-like model (∼50%), but dramatically
improve the folding rate and efficiency of the atomistic model. In contrast, none of the 100 independent
atomistic simulations initiated from a representative ensemble of unfolded structures reached the folded
state within the 50-ns simulation time span.
Model Folded% Fastest folding time (ns) Average folding time (ns)
Go¯-like alone 100 0.019 0.83
Atomistic alone 0 N/A N/A
MSES-coupled Go¯-like 100 0.021 1.19
MSES-coupled atomistic 34 0.52 17.59
Figure S7.2: Representative trajectories from constant temperature MSES folding simulations of peptide
GB1p (see Table S7.1). (a) Number of native hydrogen bonds as a function of time for the atomistic model
in MSES simulation. (b) Number of native contacts as a function of time of the Go¯-like model in MSES
simulation. Colored lines correspond to individual folding trajectories, and the black lines are the results of
averaging over all trajectories that successfully reach the folded states.
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Figure S7.3: Conformational space during MSES control simulations of GB1m1 (a)-(d) and GB1m3 (e)-
(h) (see Table 7.1 in the main text). Conformations sampled during the last 80 ns of these simulations,
regardless of the temperature, were included to compute the pseudo-free energy surfaces, which are plot in
the unit of kT. Contours are shown at 1, 3, 5, and 7 kT levels.
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Chapter 8
Conclusions and Future Directions
The first section of this dissertation (chapter 2, 3 and 4) established a multi-scale molecular
modeling framework for understanding the structure properties and interactions of intrinsically
disordered proteins (IDPs) in general. Chapter 2 demonstrated that the implicit solvent force
field, coupled with advanced sampling, provides a viable approach for atomistic simulations of
IDPs. These simulations at atomistic level could offer the ultimate details of structure information
of unbound IDPs. Specifically, detailed structural characterizations of disordered ensemble of
unbound NCBD indicate there is a substantial amount of pre-existing folded-like populations. This
observation, along with the fact that NCBD is one of the most structured IDPs, is a strong evidence
for NCBD interacting with ACTR through a conformational selection mechanism. Intriguingly,
direct examination of the unfolding and unbinding pathway in high-temperature simulations sug-
gests an induced folding mechanism at baseline level. Further analysis revealed an intermediate
state on the coupled binding and folding pathway that mainly involves in the C-terminal helices
of NCBD and ACTR. The simulations showed in chapter 2 also reveal important limitations in
both protein force field accuracy and sampling efficiency. The GBSW implicit solvent force field
tends to favor non-specific collapsed states. The future directions would include optimization
of the implicit solvent force field for disordered proteins and reduce the systematic bias towards
compact states.
Chapter 3 utilize the topology-based coarse-grained model to directly simulate the synergistic
folding of NCBD and ACTR. Through careful calibration based on additional experimental data,
the topology-based model was able to properly capture the balance between the intrinsic folding
propensities of NCBD and ACTR and the strength of their intermolecular interaction. The simula-
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tions provided important mechanistic understandings for the coupled binding and folding between
NCBD and ACTR. Both NCBD and ACTR have cooperative binding and folding which involves
in a key intermediate state. In consistency with the atomistic simulation in chapter 2, the interme-
diate state is formed by C-terminal helices of NCBD and ACTR. More detailed analysis suggests
that the binding-induced tertiary folding of NCBD follows step-wised pathway involves in both
induced folding and conformational selection. A limitation of topology-based modeling is that
it ignores non-specific interactions which could contribute in stabilizing non-specific encounter
complexes or intermediate states.
In Chapter 4, we continue to investigate the recognition mechanisms and the roles of long-range
electrostatic interactions in forming of three IDP complexes, namely, p53-TAD1/TAZ2, HIF-
1α/TAZ1, and NCBD/ACTR. Using carefully calibrated topology-based coarse-grained models
with explicitly added charges, we demonstrated that nonspecific electrostatic interactions not
only enhance the protein-protein encounter kinetics but also promote folding-competent encounter
topologies to increase the efficiency of IDP folding upon encounter. The enriched charges on IDPs
not only play key roles in modulating the conformational properties of the unbound state, but also
likely play general and important roles in regulating efficient interactions of IDPs with specific
partners. In fact, IDPs are frequently regulated by post-translational modifications that add or
remove charges. The continuing work involves in thoroughly investigation of other factors such
as residual structure and mutations that could possibly impact on the kinetics or even mechanisms
of coupled binding and folding of IDPs. Such knowledge will aid in assessing related human
diseases and devising rational strategies to modulate IDP functions for therapeutic purposes.
This dissertation also focus on development of novel methods for enhanced sampling of protein
conformations. Chapter 5 examined and benchmarked two adaptive replica exchange (RE) pro-
tocols, namely, exchange equalization (EE) and current maximization (CM). Both adaptive RE
simulations aim to enhance the sampling efficiency by increase the temperature diffusion. By
designing a realistic yet computationally tractable coarse-grained protein model, we performed
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simulations using conventional constant temperature molecular dynamics (MD), standard REMD,
EE-REMD, and CM-REMD. The results demonstrate that both EE and CM can indeed enhance
temperature diffusion compared to standard RE, but both of them failed to increase the reversible
folding/unfolding transitions. The convergence rates of several key thermodynamic properties
are also similar among all three RE simulations. The conclusion form the benchmark is that the
efficiency of RE protocols does not appear to be limited by temperature diffusion, but by the
inherent rates of spontaneous large-scale conformational re-arrangements. A key lesson is that
it is unlikely that any protocol aims to accelerate temperature exchange will lead to substantial
enhancement in conformational sampling efficiency of REMD protein simulations.
In chapter 6, we demonstrated RE protocols that involve in guided annealing (GA) steps to
overcome the apparent conformational/temperature trapping and guide the trapped replicas to
visit higher temperatures more frequently. We examined the ability of various RE-GA schemes to
enhance conformational sampling and generate proper canonical ensembles. Theoretical analysis
suggests that introduction of GA cycles results in unbalanced exchange attempt probabilities and
thus breaks the detailed balance condition whenever spontaneous conformational transitions lag
temperature diffusion. This conclusion is validated by both coarse-grained protein simulations and
numerical RE simulations using 2-state kinetic models. However, systematic errors introduced
by GA cycles diminish for systems with low transition barriers. This observation suggests that
RE-GA may be uniquely suitable for disordered protein states such as IDPs. Specifically, due to
the bias of the force field, IDPs are frequently trapped in collapsed states during the RE atomistic
simulations, and GA cycles should be highly effective in assisting the peptide to escape these
trapped states and better sample local conformational states. Indeed, application to a model
IDP, KID domain, demonstrated that RE-GA achieves superior convergence in conformational
properties with merely one-fourth of simulation time compared to the standard RE. Therefore, we
anticipate that RE-GA will be very useful in simulation of disordered protein states in general,
despite its systematic errors for simulating folded proteins.
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Chapter 7 describes a multi-scale enhanced sampling (MSES) method where efficient topology-
based coarse-grained (CG) models are coupled with atomistic models to enhance the sampling
of atomistic protein energy landscape. The CG and atomistic model are coupled using native
contact-based restraint potentials that are motivated by the current understanding of protein folding
mechanisms as well as lessons from NMR structure calculations and allow excellent scalability to
larger and more complex systems. The bias from the coupling is removed by Hamiltonian replica
exchange, thus allowing one to benefit simultaneously from faster transitions of coarse-grained
modeling and accuracy of atomistic force fields. Application to implicit solvent simulations of
small but nontrivial GB1p series of β-hairpins demonstrates that MSES dramatically accelerate
atomistic folding/unfolding transitions and improves the convergence of various thermodynamic
properties of interest. Ongoing work related to chapter 7 involves in application of MSES method
to moderate sized/large proteins, including villin headpiece, protein A, protein GB1 and Trp-cage.
The preliminary MSES simulations of larger proteins further reveal the bias towards non-specific
collapsed states in implicit solvent force fields. The future work would involve in applying MSES
method to enhance the sampling for force field optimizations.
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Research involving human participants. All research involving human participants must have been approved by the authors' institutional review board or
equivalent committee(s), and that board must be named in the manuscript. For research involving human participants, informed consent must have been
obtained (or the reason for lack of consent explained — for example, that the data were analyzed anonymously) and all clinical investigation must have been
conducted according to the principles expressed in the Declaration of Helsinki. Authors should be able to submit, upon request, a statement from the research
ethics committee or institutional review board indicating approval of the research. PLOS editors also encourage authors to submit a sample of a patient consent
form, and might require submission on particular occasions.
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groupings, authors should, as much as possible:
make explicit their methods of categorizing human populations;
define categories in as much detail as the study protocol allows;
justify their choices of definitions and categories, including for example whether any rules of human categorization were required by their funding
agency;
explain whether (and, if so, how) they controlled for confounding variables such as socioeconomic status, nutrition, environmental exposures, etc.
In addition, outmoded terms and potentially stigmatizing labels should be changed to more current, acceptable terminology — for example: 'Caucasian' should
be changed to 'white' or 'of [western] European descent' (as appropriate); 'cancer victims' should be changed to 'patients with cancer.'
Reporting of animal studies and ethical treatment of animals. For studies involving animals, all work must have been conducted according to applicable
national and international guidelines. Prior approval must have been obtained for all protocols from the relevant author's institutional or other appropriate ethics
committee, and the institution name and permit numbers must be provided at submission (see example below). For research involving non-human primates, all
studies must be performed in accordance with the recommendations of the Weatherall (2006) report, The use of non-human primates in research. Where
unregulated animals are used or ethics approval is not required by a specific committee, the article should include a clear statement of this fact and the reasons
why ethical approval is not required.
We also strongly encourage all authors to comply with the 'Animal Research: Reporting In Vivo Experiments' (ARRIVE) guidelines, developed by NC3Rs to
improve standards of reporting to ensure that the data from animal experiments can be fully scrutinized and utilized. Relevant information should be included in
the appropriate section of the article (e.g. title, abstract, or method), as outlined in the ARRIVE guidelines. The ARRIVE guidelines can be applied to any area of
bioscience research using laboratory animals. Where research could be confused as pertaining to human clinical research, the animal model should also be
noted in the article title.
Example of statement of ethical approval. This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The protocol was approved by the Committee on the Ethics of Animal Experiments of the University of
Minnesota (Permit Number: 27-2956). All surgery was performed under sodium pentobarbital anesthesia, and every effort was made to minimize suffering.
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7. Sharing of Data, Materials, and Software
Publication is conditional upon the agreement of the authors to make freely available any materials and information described in their publication that may be
reasonably requested by others.
Data Availability
PLOS journals require authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception .
When submitting a manuscript online, authors must provide a Data Availability Statement describing compliance with PLOS's policy. If the article is accepted for
publication, the data availability statement will be published as part of the final article.
Refusal to share data and related metadata and methods in accordance with this policy will be grounds for rejection. PLOS journal editors encourage
researchers to contact them if they encounter difficulties in obtaining data from articles published in PLOS journals. If restrictions on access to data come to light
after publication, we reserve the right to post a correction, to contact the authors' institutions and funders, or in extreme cases to retract the publication.
Methods acceptable to PLOS journals with respect to data sharing are listed below, accompanied by guidance for authors as to what must be indicated in their
data availability statement and how to follow best practices in reporting. If authors did not collect data themselves but used another source, this source must be
credited as appropriate. Authors who have questions or difficulties with the policy, or readers who have difficulty accessing data, are encouraged to contact the
relevant journal office or data@plos.org.
Acceptable data-sharing methods:
Data deposition (strongly recommended). All data and related metadata underlying the findings reported in a submitted manuscript should be deposited in an
appropriate public repository , unless already provided as part of the submitted article. Repositories may be either subject-specific (where these exist) and
accept specific types of structured data, or generalist repositories that accept multiple data types, such as Dryad. Guidance on acceptable repositories is
included below . The Data Availability Statement must specify that data are deposited publicly and list the name(s) of repositories along with digital object
identifiers or accession numbers for the relevant datasets. In some cases authors may not be able to obtain DOIs or accession numbers until the manuscript is
accepted; in these cases, the authors must provide these numbers at acceptance. In all other cases, these numbers must be provided at submission.
Data in Supporting Information files. For smaller datasets and certain data types, authors may upload data as Supporting Information files accompanying the
manuscript. (See also additional information regarding appropriate use of Supporting Information files.) Authors should take care to maximize the accessibility
and reusability of the data by selecting a file format from which data can be efficiently extracted (for example, spreadsheets are preferable to PDF when
providing tabulated data).
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2
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If data deposition or provision in Supporting Information is not ethical or legal (e.g., underlying data pose privacy or legal concerns, or include human
participants ), the following two methods may be acceptable alternatives, subject to case-by-case evaluation:
Data made available to all interested researchers upon request. The Data Availability Statement must specify “Data available on request” and identify the
group to which requests should be submitted (e.g., a named data access committee or named ethics committee). The reasons for restrictions on public data
deposition must also be specified. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.
Data available from third party. In the case of a primary dataset that was not originally generated by the authors of the submitted manuscript, appropriate data
sharing may require that interested researchers obtain third-party data independently from the named original source. In this case, the Data Availability
Statement must state the source of the data with full citation and, if the dataset cannot be provided, indicate “Data available from (named source).” The reasons
for restrictions on public data deposition must also be specified.
Unacceptable data access restrictions:
PLOS journals will not consider manuscripts for which the following factors influence ability to share data:
Authors will not share data because of personal interests, such as patents or potential future publications.
The conclusions depend solely on the analysis of proprietary data (e.g., data owned by commercial interests, or copyrighted data). If proprietary data
are used, the manuscript must include an analysis of public data that validates the conclusions so that others can reproduce the analysis and build on
the findings.
Explanatory notes and guidance:
A compilation of frequently asked questions about the PLOS Data Policy is available and is updated periodically.
1. Definition of data that must be shared
PLOS defines the “minimal dataset” to consist of the dataset used to reach the conclusions drawn in the manuscript with related metadata and methods, and
any additional data required to replicate the reported study findings in their entirety. Core descriptive data, methods, and study results should be included within
the main paper, regardless of data deposition. PLOS does not accept references to “data not shown”. Editors and reviewers may require particular data types
for certain articles on a case-by-case basis. Authors who have datasets too large for sharing via repositories or uploaded files should contact the relevant
journal for advice.
2. Guidance on data repositories
PLOS requires that authors comply with field-specific standards for preparation and recording of data and select repositories appropriate to their field, for
example deposition of microarray data in ArrayExpress or GEO; deposition of gene sequences in GenBank, EMBL or DDBJ; clinical trials data in
ClinicalTrials.gov; and deposition of ecological data in Dryad. Authors are encouraged to select repositories that meet accepted criteria as trustworthy digital
repositories, such as criteria of the Centre for Research Libraries or Data Seal of Approval. Large, international databases are more likely to persist than small,
local ones. Copyright licensing for data held in repositories may be unclear. If authors use repositories with stated licensing policies the policies should not be
more restrictive than CC-BY.
3. Guidance on sharing datasets that derive from clinical studies or other work involving human participants
For studies involving human participants, data must be handled so as to not compromise study participants' privacy. PLOS recommends that researchers follow
established guidance and applicable local laws in ensuring they do not compromise participant privacy. Resources which researchers may consult for guidance
include:
US National Institutes of Health: Protecting the Rights and Privacy of Human Subjects
Canadian Institutes of Health Research Best Practices for Protecting Privacy in Health Research
UK Data Archive: Anonymisation Overview
Australian National Data Service: Ethics, Consent and Data Sharing
Steps necessary to protect privacy may include de-identification, blocking portions of the database, or license agreements directed specifically at privacy
concerns. Authors should indicate, as part of the ethics statement, the ways in which the study participants' privacy was preserved. If license agreements apply,
authors should note the process necessary for other researchers to obtain a license.
Availability of materials
PLOS is committed to ensuring the availability of materials that underpin any articles published in PLOS journals. PLOS's ideal is to make all readily replaceable
materials relevant to a given article immediately available without restrictions (while not compromising confidentiality in the context of human-subject research).
PLOS journal editors encourage researchers to contact them if they encounter difficulties in obtaining materials from articles published in PLOS journals. PLOS
reserves the right to post corrections on articles, to contact authors' institutions and funders, and in extreme cases to withdraw publication, if unreasonable
restrictions on access to materials come to light after publication of a PLOS journal article.
Availability of Software
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PLOS supports the development of open source software and believes that, for submissions in which software is the central part of the paper, adherence to
appropriate open source standards will ensure that the submission conforms to (1) our requirements that methods be described in sufficient detail that another
researcher can reproduce the experiments described, (2) our aim to promote openness in research, and (3) our intention that all work published in PLOS
journals can be built upon by future researchers. Therefore, if new software or a new algorithm is central to a PLOS paper, the authors must confirm that the
software conforms to the Open Source Definition, have deposited the following three items in an open software archive, and included in the submission as
Supporting Information:
The associated source code of the software described by the paper. This should, as far as possible, follow accepted community standards and be
licensed under a suitable license such as BSD, LGPL, or MIT (see http://www.opensource.org/licenses/alphabetical for a full list). Dependency on
commercial software such as Mathematica and MATLAB does not preclude a paper from consideration, although complete open source solutions are
preferred.
Documentation for running and installing the software. For end-user applications, instructions for installing and using the software are prerequisite;
for software libraries, instructions for using the application program interface are prerequisite.
A test dataset with associated control parameter settings. Where feasible, results from standard test sets should be included. Where possible, test
data should not have any dependencies — for example, a database dump.
Acceptable archives should provide a public repository of the described software. The code should be easy to locate and download without the requirement for
creating user accounts, logging in or otherwise registering personal details. The repository must have been in existence for over five years or be hosting more
than 1,000 projects. Examples of such archives are: SourceForge, Bioinformatics.Org, Open Bioinformatics Foundation (O|B|F), Google Code, BerliOS
Developer, Savannah, GitHub and the Codehaus. Authors should provide a direct link to the deposited software from within the paper.
Deposition with the journal and in an open source archive ensures that the original source associated with the paper is available as well as any enhancements
made after the paper is published. An article can be considered for publication if it covers a well-established project that has been providing an open source
code repository for an extended amount of time. A condition of acceptance is that the software can be run by reviewers accessing the public software and that
the results presented in the paper are reproducible. The software need run on only one hardware-software platform in common use by the readership (including
MATLAB), although it must run without dependencies on proprietary or otherwise unobtainable ancillary software. Articles describing software that requires
access to databases and other resources whose persistence is not guaranteed (e.g. individual laboratory databases without funding support) will not be
considered. In addition, the results described in the paper must be reproducible when peer reviewers, editors, or readers run the software on the deposited
dataset and with the provided control parameters.
When the software or algorithm is not central to the paper, we nevertheless encourage authors to make all relevant materials freely available.
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8. Reporting Guidelines for Specific Study Designs
Authors should check the EQUATOR Network site for any reporting guidelines that apply to their study design, and ensure that any required Supporting
Information (checklists, protocols, flowcharts, etc.) be included in the article submission.
Clinical trials. PLOS follows the WHO definition of a clinical trial: "...any research study that prospectively assigns human participants or groups of humans to
one or more health-related interventions to evaluate the effects on health outcomes...Interventions include but are not restricted to drugs, cells and other
biological products, surgical procedures, radiologic procedures, devices, behavioural treatments, process-of-care changes, preventive care, etc."
PLOS supports the position of the International Committee of Medical Journal Editors (ICMJE) on trial registration. All trials initiated from 1 July 2005 must be
registered prospectively in a publicly accessible registry (i.e., before patient recruitment has begun) or they will not be considered for publication. For trials
initiated before 1 July 2005, all trials must be registered before submission to any PLOS journal. The ICMJE FAQ on trial registration has further details, and
WHO provides a list of approved registries. PLOS editors reserve the right to inform authors' institutions or ethics committees if they become aware of
unregistered trials.
Authors of trials must adhere to the CONSORT reporting guidelines appropriate to their trial design, available on the CONSORT Statement Website. Before the
paper can enter peer review, authors must: (1) record, in the paper trial registry, the trial registration number and institutional review board, and (2) provide a
copy of the trial protocol and a completed CONSORT checklist as supporting information (these documents will also be published alongside the paper, if
accepted). The CONSORT flow diagram must be included as the manuscript's "Figure 1." Any deviation from the trial protocol must be explained in the paper.
Authors must explicitly discuss informed consent in their paper, and PLOS reserves the right to ask for a copy of the patient consent form. Information on
statistical methods or participants, beyond that indicated in the CONSORT statement, should be reported in the Methods section.
PLOS supports the public disclosure of all clinical trial results, as mandated, for example, by the FDA Amendments Act, 2007. Prior disclosure of results on a
clinical trial registry site will not affect the decision to peer review or accept papers in PLOS journals.
Systematic reviews and meta-analyses. Reports of systematic reviews and meta-analyses should use the PRISMA statement as a guide, and include a
completed PRISMA checklist and flow diagram to accompany the main text. Blank templates of the checklist and flow diagram can be downloaded from the
PRISMA Web site. Authors must also state within their Methods section whether a protocol exists for their systematic review, and if so, provide a copy of the
protocol as Supporting Information. The journal supports the prospective registration of systematic reviews. Authors whose systematic review was prospectively
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registered (e.g. in a registry such as PROSPERO) should also provide the registry number in their abstract. Registry details and protocols will be made
available to editors and reviewers, and included alongside the paper for readers if the report is ultimately published.
Diagnostic studies. Reports of studies of diagnostic accuracy should conform to the STARD requirements.
Epidemiological studies. For reports of epidemiological studies, authors should consult the STROBE initiative.
Microarray experiments. Reports of microarray experiments should conform to the MIAME guidelines published by the Functional Genomics Data Society
(FGED), and the data from the experiments must be deposited in a publicly accessible database.
Checklists for biological and biomedical research investigations. PLOS recommends that authors refer to the MIBBI Portal (Minimum Information for
Biological and Biomedical Investigations) for prescriptive checklists for reporting biological and biomedical research where applicable.
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9. Policies Regarding Submission of a New Taxon Name
Zoological names. When publishing papers that describe a new zoological taxon name, PLOS aims to comply with the requirements of the International
Commission on Zoological Nomenclature (ICZN). However, the ICZN does not yet recognize online-only journals, and so, unless PLOS adapts its publication
process for taxonomic papers (which it does, as detailed below), any scientific animal name published by PLOS would not be considered 'available' under the
rules of the Code ('available' is the formal term for legally published under the Code, and is equivalent to the term 'nomenclaturally valid' in botanical literature).
There is a proposal to amend the Code to accommodate online-only publication, which, as of February 2011, awaits an ICZN vote.
Until acceptance of this amendment, the ICZN has proposed an interim solution for authors publishing in PLOS journals that allows PLOS to comply with the
code by providing a limited hardcopy print run of the article and making it publicly obtainable. Therefore, for all papers that include the naming of a new
zoological taxon, PLOS will make a printed version available for outside parties (at a cost of $10, to cover postage and printing) at the same time as the
publication of the online open access article. This additional printed version of the article will contain text in the footer of the first page. This text will be added by
PLOS staff, and, apart from this new footer, the printed version will be identical to the PDF of the online version. Footer text: "This printed document was
produced by a method that assures numerous identical and durable copies, and those copies were simultaneously obtainable for the purpose of providing a
public and permanent scientific record, in accordance with Article 8.1 of the International Code of Zoological Nomenclature. Date of publication: XXXXXXXX.
This document is otherwise identical to DOI: XXXXX."
In addition, we ask that authors add the following information about archiving and ZooBank registration to the online version of the article before it is finally
accepted.
Digital archiving. Please include the names of the digital archives where PLOS articles are deposited (currently, PubMedCentral and LOCKSS). If an
author's institute (or those of co-authors) has its own repository, we recommend that authors also deposit the published online article there and include
the names of such repositories in the article.
ZooBank registration. Authors should contact ZooBank about the registration of the new species name and request a unique digital identifier (a Life
Science Identifier [LSID]). The LSID also needs to be included in the published paper. ZooBank has not yet been officially recognized by the ICZN, but it
is still important to register there, because the ICZN are likely to request mandatory registration of new names in ZooBank for all online-only journals.
The following paragraphs provide an example of the type of wording that we recommend for a new taxon description in a PLOS journal. The first paragraph
below is required for the online-only version but is overruled by the footer note above, added to the print-only edition. The names of the libraries and institutional
repositories should be included, as appropriate.
Please insert a modification of the following example text into the Methods section, in a subsection called 'Nomenclatural Acts'.
The electronic version of this document does not represent a published work according to the International Code of Zoological Nomenclature (ICZN),
and hence the nomenclatural acts contained in the electronic version are not available under that Code from the electronic edition. Therefore, a
separate edition of this document was produced by a method that assures numerous identical and durable copies, and those copies were
simultaneously obtainable (from the publication date noted on the first page of this article) for the purpose of providing a public and permanent scientific
record, in accordance with Article 8.1 of the Code. The separate print-only edition is available on request from PLOS by sending a request to PLOS,
1160 Battery Street, Suite 100, San Francisco, CA 94111, USA along with a check for $10 (to cover printing and postage) payable to 'PLOS'. In addition,
this published work and the nomenclatural acts it contains have been registered in ZooBank, the proposed online registration system for the ICZN. The
ZooBank LSIDs (Life Science Identifiers) can be resolved and the associated information viewed through any standard web browser by appending the
LSID to the prefix 'http://zoobank.org/'. The LSID for this publication is: [insert here] Anochetus boltoni Fisher sp. nov.
urn:lsid:zoobank.org:act:B6C072CF-1CA6-40C7-8396-534E91EF7FBB
Botanical names. When publishing papers that describe a new botanical taxon name, PLOS aims to comply with the requirements of the International Code of
Botanical Nomenclature (ICBN). Following from a test case (Knapp S [2010] PLOS ONE. doi:10.1371/journal.pone.0010502) and in association with the
International Plant Names Index (IPNI), the following guidelines for publication in an online-only journal have been agreed such that any scientific botanical
name published by PLOS is considered effectively published under the rules of the Code. These guidelines differ from those for zoological nomenclature (see
above) and will change in concert with the Code. The online version of the article in itself does not represent a published work according to the ICBN, and hence
the new names contained in the online version are not effectively published under that Code from the online edition alone.
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To comply with Article 29 of the code, therefore, we ask all authors (one author if the paper has multiple authors) to print out copies (in a single print run) of their
paper from the relevant PLOS journal website on the day of publication and ensure that they post these copies on that day to multiple relevant institutions (ten
are recommended in ICBN Rec. 30.2 of the Vienna Code), including the names indexing centre for the group in question (i.e. IPNI for flowering plants and ferns,
MycoBank and Index Fungorum for fungi). Confirmation that the article has been posted can be added as a comment to the online publication.
PLOS will also make a printed version available for outside parties (at a cost of $10, to cover postage and printing) of the online-only article (which remains
freely available).
In addition, we ask that authors add the following information about archiving to the online version of the article before it is finally accepted.
Digital archiving. Please include the names of the digital archives where PLOS articles are deposited (currently, PubMedCentral and LOCKSS). If an
author's institute (or those of co-authors) has its own repository, PLOS recommends that authors also deposit the published online article there and
include the name of such repositories in their article.
Unique digital identifier. Please provide a unique digital identifier (a Globally Unique Identifier [GUID]; currently an LSID) that indicates listing in IPNI
for flowering plants, ferns, and fern allies, or MycoBank/Index Fungorum number for fungi. The IPNI GUID/MB number/IF number also must be included
in the published paper. We recommend that authors contact IPNI or MycoBank/Index Fungorum to request a unique digital identifier.
The following paragraphs provide an example of the type of wording that is recommended for a new botanical taxon description in a PLOS journal. The names
of the libraries and institutional repositories should be included, as appropriate.
Please insert a modification of the following example text into the Methods section, in a subsection called 'Nomenclatural Acts' (taken from
Knapp S [2010] PLOS ONE. doi:10.1371/journal.pone.0010502).
Nomenclature
The electronic version of this document in itself does not represent a published work according to the International Code of Botanical Nomenclature, and
hence the new names contained in the electronic version are not effectively published under that Code from the electronic edition alone. Therefore, a
separate edition of this document was produced by a method that assures numerous identical printed copies, and those copies were simultaneously
distributed (on the publication date noted on the first page of this article) for the purpose of providing a public and permanent scientific record, in
accordance with Article 29 of the Code. Copies of the print-only edition of this article were distributed on the publication date to botanical or generally
accessible libraries of the following institutions (BM, COL, GH, HUA, K, MEXU, MO, NY, QCA, QCNE, USM). The separate print-only edition is available
on request from PLOS (Public Library of Science) by sending a request to PLOS, 1160 Battery Street, Suite 100, San Francisco, CA 94111, USA along
with a check for $10 (to cover printing and postage) payable to 'PLOS'.
In addition, new names contained in this work have been submitted to IPNI, from where they will be made available to the Global Names Index. The
IPNI LSIDs (Life Science Identifiers) can be resolved and the associated information viewed through any standard web browser by appending the LSID
contained in this publication to the prefix http://ipni.org/. The online version of this work is archived and available from the following digital repositories:
PubMedCentral and Solanaceae Source: a web resource for the nightshade family.*
The institutions listed are to be chosen by the author, and GUIDs are likely to replace LSIDs and should be cited where available. Also, neither MycoBank nor
Index Fungorum has a local resolution service, so for fungal names please use, and refer to, the TDWG LSID resolver.
Globally unique identifier. In the results section, the GUID (LSID) should be listed under the new species name:
Solanum aspersum S. Knapp, sp. Nov. [urn:lsid:ipni.org:names:77103633-1] Type: Colombia. Putumayo: vertiente oriental de la Cordillera, entre
Sachamates y San Francisco de Sibundoy, 1600-1750 m, 30 Dec 1940, J. Cuatrecasas 11471 (holotype, COL; isotypes, F [F-1335119], US [US-
1799731]).
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10. Submission of Related Manuscripts
When submitting an article, all authors are asked to indicate that they do not have a related or duplicate manuscript under consideration (or accepted) for
publication elsewhere. If related work has been submitted elsewhere, then a copy must be included with the article submitted to PLOS. Reviewers will be asked
to comment on the overlap between related submissions.
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11. Reviewer and Editor Exclusions
Upon submission of a manuscript, authors are asked whether they wish to exclude any specific academic editors or reviewers from the peer review of their
article. The editorial team will respect these requests so long as this does not interfere with the objective and thorough assessment of the article. See the
relevant guidelines for reviewers and more general information on PLOS policy regarding competing interests.
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12. Confidentiality
Editors and reviewers are required to treat all submitted manuscripts in strict confidence.
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13. Corrections and Additions
PLOS publishes corrections, retractions, and expressions of concern as appropriate, and as quickly as possible. We follow the ICMJE (http://www.icmje.org/)
and COPE (http://publicationethics.org/) guidelines where applicable.
A notice of correction will be issued by PLOS to document and correct substantial errors that appear in online articles when these errors significantly affect the
content or understanding of the work reported (e.g., error in data presentation or analysis) or when the error affects the publication's metadata (e.g., misspelling
of an author's name). In these cases, PLOS will publish a correction that will be linked to the original article.
In very rare cases, we may choose to correct the article itself and re-post it online. If that course is taken, a correction notice will also be created to document
the changes to the original article.
Authors who wish to alert PLOS to a situation where a correction may be warranted are requested to contact us with the relevant details (journal, full citation of
the article, and description of the error) at: corrections@plos.org or the respective journal office.
Authors are encouraged to post comments to their articles to note typographical errors, and other problems that do not significantly affect the scientific integrity
of the work.
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14. Publication Ethics
All PLOS Journals are members of the Committee on Publication Ethics (COPE), abide by its Code of Conduct and aim to adhere to its Best Practice
Guidelines.
We will vigorously investigate allegations of publication misconduct in PLOS journals (both before and after publication) and reserve the right to contact authors’
institutions, funders or regulatory bodies if needed. If we find conclusive evidence of misconduct we will take steps to correct the scientific record, which may
include issuing a correction or retraction. PLOS journals have a Journal Ethics Committee composed of representatives of all the journals, which sets ethical
policies for PLOS journals and also investigates specific issues.
The following list outlines some key issues in Publication Ethics. It is not an exhaustive list. For further details authors should consult the journals’ specific
policies and the references below.
Authors are expected to be aware of, and comply with, best practice in publication ethics specifically with regard to authorship (for example avoidance of
ghost or guest authorship), dual submission, plagiarism, manipulation of figures, competing interests and compliance with policies on research ethics
PLOS has incorporated CrossCheck (http://www.crossref.org/crosscheck.html), powered by iThenticate, into its journal-wide submission system in order
to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted papers. Authors will
be contacted if needed following the screening process.
Reviewers and Editors are required to treat manuscripts fairly and in confidence, and to declare any competing interests.
In cases of suspected or alleged misconduct, the COPE flowcharts will be followed. We may also seek advice on specific cases at the COPE forum.
Any concerns about the above should be addressed to the Editor in Chief, Chief Editor, or Executive Editor as appropriate of the respective PLOS journal.
Please direct inquiries to these individuals via the respective journal address.
More extensive resources are available here: COPE, WAME.
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15. Blogs, Wikis, Embargoes, and the Media
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Authors may present and discuss their findings ahead of publication: at medical or scientific conferences, on preprint servers, in public databases, and in blogs,
wikis, tweets, and other informal communication channels. We recommend, however, that authors not contact the media or respond to such contact unless an
article has been accepted for publication and an embargo date has been established. Respect for press embargoes will help to ensure that the work is reported
accurately in the popular media and that the full peer-reviewed paper is freely available to any interested reader when the news item is published. However, if a
journalist has covered a piece of work ahead of publication, this will not affect consideration of the work for publication. See also our embargo guidelines for
journalists and scientists.
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16. Studies Sponsored by Specific Funders
Pharmaceutical companies. We support GPP2 Good Publication Practice for Communicating Company-Sponsored Medical Research.
Tobacco industry. PLOS Medicine, PLOS Biology, and PLOS ONE will not consider for publication papers in which any of the research costs or authors'
salaries have been funded, in whole or in part, by a tobacco company. For an editorial giving the reasoning behind these journals' policy, see: The PLOS
Medicine Editors (2010) doi:10.1371/journal.pmed.1000237.
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17. Biosecurity and Dual Use Research of Concern
PLOS recognizes that certain research may fall into the category of "dual use research of concern". This is defined by the NSABB as any "biological research
with legitimate scientific purpose that may be misused to pose a biologic threat to public health and/or national security." As an Open Access publisher, PLOS
remains committed to the widespread dissemination of research while being sensitive to the issues of responsible publication standards. We expect that the
potential risks of publishing a scientific paper will outweigh the benefits in only the rarest circumstances. On occasion, PLOS reserves the right to consider
manuscript submissions within this context. In addition to the usual scientific scrutiny, such submissions may also be referred to an internal PLOS Dual Use
Committee for further deliberation. Authors submitting to any PLOS journal are obligated to disclose potential bioethics/dual use concerns to the journal office at
the time of initial submission.
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18. FAQs for Editorial Policy
Q. Why does PLOS require that data underlying research published in PLOS journals be made publicly available?
A. PLOS strongly believes that, to best foster scientific progress, the underlying data from an article should be made freely available for researchers to use,
wherever this is legal and ethical. Data availability allows validation, replication, reanalysis, new analysis, reinterpretation, or inclusion into meta-analyses,
facilitates reproducibility of research and extends the value of the investment made in funding scientific research. Thus, PLOS believes that ensuring access to
the underlying data should be an intrinsic part of the scientific publishing process. Furthermore, by getting data into the right place on publication we can reduce
the burden on authors in unearthing old data, retaining old hard drives and answering email requests.
Effective data sharing leads to more citations and should lead to more offers of co-authorship and greater opportunities. We understand that some authors may
not want to share data, just as some choose not to make their articles available Open Access, but believe that most authors publish their work precisely in order
to allow others to benefit from it. More importantly researchers want to see their work used and cited by others. Making that easier can benefit everyone.
Q. To what data does this policy apply?
A. The policy applies to the dataset used to reach the conclusions drawn in the manuscript with related metadata and methods, and any additional data required
to replicate the reported study findings in their entirety. You need not submit your entire dataset, or all raw data collected during an investigation, but you must
provide the portion that is relevant to the specific study.
Q. What should I do if the PLOS Data Policy does not appear to take into account my type of data?
A. If after reviewing the policy and FAQs, you have questions about how the policy applies to your data, please contact the relevant PLOS journal or
data@plos.org. We will consider each situation on a case-by-case basis.
Q. How should the data be made available?
A. PLOS strongly recommends that data be made available in a public repository. Repositories may be subject-specific (eg, GenBank for sequences,
clinicaltrials.gov for clinical trials data, and PDB for structures), general (Dryad or FigShare), or institutional, as long as DOIs or accession numbers are provided
and the data are at least as open as CCBY. Alternatively, data may be made available in supporting information files (preferably in a file format from which data
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can be efficiently extracted) or in the manuscript itself.
Q: What if my dataset is too large to submit to a repository?
A: For very large datasets that are difficult to deposit in a repository, we encourage you to note details of your situation when submitting your data availability
information to PLOS and we will work with you to find a solution.
Q. What are the exceptions to making the data publicly available?
A: The exceptions to making the data publicly available are:
Data cannot be publically available for ethical or legal reasons, e.g., public availability would compromise patient privacy, or could represent some other
threat such as specific locations of fossil deposits or endangered species. Please contact us via the journal office or at data@plos.org if you have
concerns about the ethics or legality of sharing your data and they do not fit one of these criteria.
Data were obtained from a third party, i.e., the authors did not generate the primary dataset themselves. (This may also apply to component sets of data
used as part of a meta-analysis, see below.) If this is the case, details of the source and contact information should be provided that others can use to
request access.
Q. My funding agency or government law only permits sharing of human participants data with researchers with whom they have a written
agreement. What should I do?
A. Please provide the contact information of the individuals and institution(s) where an interested researcher would need to apply to start the process to gain
access to the data. If you have questions, please contact the relevant journal or data@plos.org.
Q. The national privacy standards that apply to my research would seem to prevent my publishing the research in PLOS. What should I do?
A. None of the policy is intended to over-rule local regulations, legislation or ethical frameworks. However, note that authors are probably already committing to
providing access to data on request when they sign agreements with many journals, not just PLOS. It is these kinds of issues that we would be very keen to
work with the relevant bodies to help educate researchers on their local obligations and how they might need to adapt or declare limitations on data access
when they publish their work. Where these frameworks prevent or limit data release, these limitations should be made clear at the time of publication to anyone
who reads the paper.
Q: I need to make my data "available on request" because of privacy concerns but my institution does not have a Data Access Committee and the
IRB is not willing to take this on. What should I do?
A. While PLOS strongly believes that data should be freely available, we recognize that in some instances patient privacy or other concerns may preclude
making data freely available to all, and that not all institutions have Data Access Committees at this time. If that is the case, please note details of your situation
when submitting your data availability information to PLOS. We are still investigating potential solutions to this issue and until we have determined a standard
course of action, we will work with authors for whom this presents a challenge. We encourage academic institutions without a data access committee to
consider the importance of this function for their research and researchers.
Q: I want to run additional analyses on my dataset for future studies. What portion of my dataset do I need to make freely accessible?
A. The PLOS Data Policy states that the minimal dataset needs to be made available. The "minimal dataset" consists "of the dataset used to reach the
conclusions drawn in the manuscript with related metadata and methods, and any additional data required to replicate the reported study findings in their
entirety." This does not mean that you must submit your entire dataset, or absolutely all raw data collected during an investigation, but that you must provide the
portion that is relevant to the specific study.
Q. I don't want to share my data because another researcher may “scoop” me using my dataset.
A. PLOS believes that after publication (in particular, after publication in an Open Access journal), data underlying a study should be available for re-use by
others. This is not just our view: it was the principle underlying the very first journal: the motto of the UK's Royal Society can be roughly translated as “never
take someone's word for it”. Many institutions and funding agencies (e.g., NIH, Research Councils UK) already require data relating to publications be stored for
up to ten years and to be shared with the minimal possible restrictions.
Q. What if I cannot provide accession numbers or DOIs at submission?
A. We understand that accession numbers or DOIs may not be available until a paper has been accepted, although once a decision to accept has been made,
we cannot proceed with publishing the paper until the accession numbers or DOIs are received.
Q. What if the data are needed for peer review but are not yet publicly available?
A. Many repositories permit private access for review purposes, and have policy for public release at publication. If this is not possible, authors can provide the
data via other means, such as zipped files via email, dropbox etc. Please contact the relevant journal office or data@plos.org for assistance.
Q: What if I am submitting an individual patient data meta-analysis?
A: For an individual patient data meta-analysis, authors should make freely available data that can be shared legally and ethically. If authors cannot share the
data, they should provide information on how to access the datasets used in the study as specified under “data available on request” or “data available from
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third parties.”
Q. How can I make a very large amount of data available through a repository without a DOI?
A. Authors are encouraged to provide the information they have regarding accessing the data from a repository (eg, URLs, registration numbers, and other
identifying information). Authors should submit their manuscript and PLOS will work with them to determine how best to present the information.
Q. I cannot afford the cost of depositing a very large amount of data. What should I do?
A. PLOS encourages authors to contact their institutions if they have difficulty providing access to the data underlying the research. Many institutions and
funding agencies (e.g., NIH, Research Councils UK) share this view and make data sharing a requirement. Regardless, authors facing these challenges are
encouraged to submit their manuscript and PLOS will work with them to help find a solution.
Q. I don't have the time or institutional infrastructure to deposit all my data. What should I do?
A. We encourage you to contact your institution if you have difficulty. If you have questions, please contact the relevant journal office or data@plos.org.
Q. What if data are found to not be accessible or other issues are found after publication?
A. As is our current policy, we will follow up with the authors and take action as necessary. We reserve the right to issue corrections, notifications, or retractions
when authors do not comply with our policies.
Q. My paper was under consideration at PLOS before March 3, 2014. Does it need to adhere to the new policy?
A. Manuscripts submitted prior to March 3rd will not be required to include the Data Availability information or include a Data Availability statement (although
authors who would like to include are welcome to).
Q. What if my question is not addressed here?
A. Authors who have questions about the policy, or readers who have difficulty accessing data, are encouraged to contact the relevant journal office or
data@plos.org.
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